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ABSTRACT 
Trimethoprim-Based Chemical Tags for High Resolution Live Cell Imaging 
Chaoran Jing 
 
Over the past decade chemical tags have been developed to complement the use of 
fluorescent proteins in live cell imaging. Chemical tags retain the specificity of protein 
labeling achieved with fluorescent proteins through genetic encoding, but provide smaller, 
more robust tags and modular use of organic fluorophores with high photon-output and 
tailored functionalities. The trimethoprim-based chemical tag (TMP-tag) was initially 
developed based on the high affinity interaction between E.coli dihydrofolatereductase 
and the antibiotic trimethoprim and subsequently rendered covalent and fluorogenic via 
proximity-induced protein labeling reactions. To date, the TMP-tag is one of the few 
chemical tags that enable intracellular protein labeling and high-resolution live cell 
imaging. In this dissertation I first focused on the development of the fluorogenic TMP-
tag that enabled high resolution live cell imaging with redeced background noise. Then 
some efforts to further improve the fluorogenic TMP-tag were described. Furthermore, I 
worked with collaborators to apply the TMP-tag technology to study the dynamics of the 
focal adhesion complex at the single-molecule level. Finally, I also tried to develop a 
short peptide tag for protein labeling with minimal perturbation of the function and 
dynamics of the target molecule. Together, these studies exemplified the maturation of 
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1 Chapter 1 
Chemical Tags For Labeling Proteins Inside Living Cells 
2 
 
1.1 Chapter Overview 
To build on the last century’s tremendous strides in understanding the workings of 
individual proteins in the test tube, we now face the challenge of understanding how 
macromolecular machines, signaling pathways, and other biological networks operate in 
the complex environment of the living cell. The fluorescent proteins (FPs) revolutionized 
our ability to study protein function directly in the cell by enabling individual proteins to 
be selectively labeled through genetic encoding of a fluorescent tag. Although FPs 
continue to be invaluable tools for cell biology, they show limitations in the face of the 
increasingly sophisticated dynamic measurements of protein interactions now called for 
to unravel cellular mechanisms.  Therefore, just as chemical methods for selectively 
labeling proteins in the test tube significantly impacted in vitro biophysics in the last 
century, chemical tagging technologies are now poised to provide a breakthrough to meet 
this century’s challenge of understanding protein function in the living cell. 
With chemical tags, the protein of interest is attached to a polypeptide rather than 
an FP. The polypeptide is subsequently modified with an organic fluorophore or another 
probe. The FlAsH peptide tag was first reported in 1998. Since then, more refined protein 
tags, exemplified by the TMP- and SNAP-tag, have improved selectivity and enabled 
imaging of intracellular proteins with high signal-to-noise ratios. Further improvement is 
still required to achieve direct incorporation of powerful fluorophores, but enzyme-
mediated chemical tags show promise for overcoming the difficulty of selectively 
labeling a short peptide tag. 
In this chapter, we focus on the development and application of chemical tags for 
studying protein function within living cells. Thus, in our overview of different chemical 
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tagging strategies and technologies, we emphasize the challenge of rendering the labeling 
reaction sufficiently selective and the fluorophore probe sufficiently well behaved to 
image intracellular proteins with high signal-to-noise ratios. We highlight recent 
applications in which the chemical tags have enabled sophisticated biophysical 
measurements that would be difficult or even impossible with FPs. Finally, we conclude 
by looking forward to (i) the development of high-photon-output chemical tags 
compatible with living cells to enable high-resolution imaging, (ii) the realization of the 
potential of the chemical tags to significantly reduce tag size, and (iii) the exploitation of 
the modular chemical tag label to go beyond fluorescent imaging.  
1.2 Introduction 
Chemical methods for site-specifically labeling proteins with organic 
fluorophores and other biophysical probes significantly impacted fundamental studies of 
proteins in vitro in the last century.  Evidence of the utility of these chemical probes, 
chemical modification of purified proteins for microinjection into cells is still utilized 
today for live cell imaging, despite the fact that microinjection is technically demanding 
and damaging to the cell.1  The chemical probes designed to react selectively with Cys 
and Lys residues that are so effective at labeling purified proteins in vitro, however, 
simply do not provide the selectivity required to label an individual protein of interest in 
the sea of proteins and other reactive species present in the cell.  
A breakthrough for live cell imaging came with the introduction of fluorescent 
proteins (FPs) in 1994 as selective, genetic protein tags.2,3   The original green fluorescent 
protein (GFP) from A. victoria is a 238 amino acid protein, which upon folding 
spontaneously forms a fluorescent chromophore by rearrangement and oxidation of Ser, 
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Tyr, and Gly residues in the core of the eleven-stranded -barrel.4,5  Since these original 
reports, naturally occurring and engineered FPs have been optimized for spectral 
variation, increased brightness and other properties to provide a wealth of reagents for 
cell biologists.6,7  FP tags are used routinely to observe the timing and location of protein 
expression in living cells, often providing significant mechanistic insight.4,6,8  However, 
FPs have limitations for more sophisticated biophysical and mechanistic studies. As ~ 
30kD proteins, FPs can disrupt the assembly, interaction, or function of the labeled 
protein; FPs typically have broad absorption and emission spectra, making it technically 
demanding to monitor even just three different proteins simultaneously using multi-color 
imaging;7 FPs can suffer from oligomerization and/or slow folding and chromophore 
maturation;9 it is difficult to manipulate the fluorophore for specialized properties since it 
is inherent to the sequence of the FP; and significantly, none of the FPs can be compared 
to the best organic fluorophores, much less nanoparticles or other emerging chemical 
probes, in terms of photon output (often measured as brightness and photostability), 
critical for single-molecule resolution. Thus, chemical tags have been developed to 
provide an alternative for labeling proteins with chemical probes directly in living cells. 
1.3 Protein Labeling Via Chemical Tags 
With chemical tags, rather than tagging the target protein with an FP, the protein 
is tagged with a polypeptide, which is subsequently modified with an organic fluorophore.  
Technically, labeling a target protein with a chemical tag is very similar to labeling with 
FPs: a plasmid encoding a fusion between the target protein and polypeptide tag is 
constructed using standard molecular cloning techniques and then introduced into the 
desired cell.  The transfected cells are briefly incubated with the organic fluorophore, 
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which diffuses into cells and is then specifically bound by or conjugated to the 
polypeptide tag.  Thus, chemical tags retain the specificity of protein labeling achieved 
with FPs through genetic encoding, but provide smaller, more robust tags and modular 
use of organic fluorophores with high photon-output and tailored functionalities.  
 
Figure 1-1 Schematic illustration of representative example technologies of different 
strategies for selectively labeling proteins in living cells. 
  (A)  The FlAsH tag features a short peptide with a tetracysteine core that directly binds 
bisarsenical fluorogens. (B) The eDHFR/TMP labeling strategy is based on non-covalent, high-
affinity binding of TMP-probe heterodimers by the protein eDHFR. (C) In the SNAP-Tag, the 
enzyme hAGT utilizes a guanine-probe heterodimer as a suicide substrate. (D) Biotin ligase 
enzymatically modifies a short peptide tag with a biotin analogue, which then reacts with the 
probe in a second step. 
The first report of a chemical surrogate to FPs for labeling proteins with organic 
fluorophores in living cells was FlAsH from Tsien and co-workers in 1998.10  In design, 
FlAsH is the ideal chemical tag—a short 15 amino acid polypeptide tag with a 
tetracysteine core (CCXXCC) that is covalently labeled with a fluorogenic bisarsenical 
fluorescein ligand whose fluorescence increases upon binding to the polypeptide tag 
(Figure 1-1A).  To date, a number of bisarsenical fluorophores and corresponding 
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tetracysteine (TC) tags have been reported,11-13 among which the original green-
fluorescent FlAsH and the red-fluorescent ReAsH are most frequently utilized.  Despite 
its elegant design, the FlAsH technology suffers practically from non-specific labeling of 
thiol-rich biomolecules in the cell and toxicity of the bisarsenical ligands and labeling 
conditions.14  Nonetheless, benefiting from its small size, FlAsH often is the only viable 
tag for labeling proteins or complexes impaired by the ~ 250 amino acid FPs and is 
widely reported and has enabled many experiments not otherwise possible.15 
Table 1-1 Chemical tags and corresponding fluorophores used to image functional 
proteins inside living mammalian cells. 
Chemical Tag Fluorophore Target Protein Reference 
FlAsH; ReAsH Fluorescein; Oxazine Cx43; α-tubulin; Cytochrome c; β-actin 15-18 
TMP-tag 
Fluorescein  MLC 19,20 
Hexachlorofluorescein MLCK; α-tubulin 20 





Vimentin; Cx43 22-24 
Atto633 STAT5b 25 
Fluorescein α-tubulin; γ-tubulin 26 
Peroxy-Green NK1R; H2B 27 
Quenched Fluorescein 
(Q-Fl) MEK1; FRB protein 28 
HaloTag TMR p65, IκBα 29 
Coumarin ligase Coumarin β-actin, Vimentin; MAP2 30 
1.3.1 Protein-based chemical tags 
To overcome the selectivity limitations of a short peptide tag, protein-based 
chemical tags were introduced that allowed the target protein to be tagged with a protein 
receptor or enzyme, which can be subsequently labeled with a cell-permeable organic 
ligand- or substrate-probe heterodimer.  There are several critical design issues for these 
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protein receptor-ligand or enzyme-substrate tags.  One, and perhaps most importantly, the 
organic fluorophore ligand or substrate must be readily cell-permeable and not binding 
non-specifically to endogenous proteins or other biomolecules or, equally important but 
perhaps less appreciated, otherwise partitioning to particular organelles within the cell.  
Two, the synthesis of the ligand or substrate derivatives should be straightforward and 
minimally disruptive to the receptor binding or enzyme function.  Three, the protein 
receptor or enzyme should be small, monomeric, and well behaved for minimal 
perturbation of the biological pathway being studied.  Fourth, the labeling reaction 
between the protein tag and the ligand/substrate-probe should be rapid and near 
quantitative.  To date, the advantage of protein tags over other chemical tags is that they 
are sufficiently selective and efficient to enable intracellular proteins to be imaged with 
high signal-to-noise.   
In collaboration with the Sheetz group, our laboratory has exploited the high-
affinity interaction between dihydrofolate reductase (DHFR) and folate analogs to label 
proteins in living cells.  Briefly, we tag the target protein with E. coli DHFR (eDHFR).  
Because eDHFR binds trimpethoprim (TMP) with high affinity (1 nM KD) and selectivity 
(affinities for mammalian DHFRs are KD > 1 µM), the eDHFR tag can then be labeled 
with near stoichiometric concentrations of TMP-probe heterodimers that bind to eDHFR 
non-covalently with a dissociation half-life of tens of minutes (Figure 1-1B).20,31,32  
Consistent with TMP’s use therapeutically as an antibiotic, the TMP-probe heterodimers 
have excellent cell permeability and solubility properties.  As anticipated based on high-
resolution structural and SAR data, commercially available TMP can be modified at the 
para-methoxy position with only minor perturbation of high-affinity binding to eDHFR, 
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making the synthesis of TMP-probe labels very straightforward.  As a 159 amino acid, 
monomeric, well-behaved protein, eDHFR is about two-thirds the size of FPs, does not 
suffer from oligomerization and expression problems, folds rapidly, and circumvents the 
issue of chromophore maturation half-life.33,34  Among chemical tags, the TMP-tag 
stands out for enabling the imaging of intracellular proteins with high resolution in living 
cells. 
Our efforts to image individual proteins in the focal adhesion complex in 
mammalian cells using the TMP-tag taught us that the key performance issue for the tag 
is not so much the cell-permeability of the TMP-probe label, but really the solubility of 
the TMP-probe label once it is inside the cell.  Significantly, through optimization of 
protecting groups and linkers, we obtained TMP-fluorophore labels that exhibited 
minimal non-specific partitioning to lipid-rich cellular compartments and could thus be 
utilized to image more dilute, rapidly diffusing cytoplasmic proteins with high signal-to-
noise.20  The palette of TMP-fluorophores able to image intracellular proteins has been 
expanded from fluorescein-based green and red dyes to include a far-red photo-switching 
Atto-655, a two-photon fluorophore BC575, and lanthanide probes.21,35,36  Important for 
adoption by cell biologists and biophysicists (i.e. laboratories not specializing in organic 
synthesis), the TMP-tag is commercially available from Active Motif as LigandLink. 
Remarkably, the TMP-tag now has also been rendered covalent by installing a 
unique Cys residue on eDHFR in position to react with a latent acrylamide electrophile 
added to the TMP-probe molecule via a classic proximity-induced Michael addition.37  
While under optimization, already this first-generation covalent TMP-tag undergoes rapid, 
quatitative covalent labeling (in vitro t1/2 ~ 50 min) and enables imaging of nuclear-
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localized eDHFR in live NIH3T3 cells. This work demonstrates that an advantage to a 
chemical tag based on high-affinity binding is that it does not require the high 
concentration of ligand-probe conjugate necessary with enzyme-based chemical tags, 
where KMs typically range from µM to mM, leading to high background noise from 
unbound fluorophore and necessitating extensive washing steps.30,38   
An alternative strategy to protein-based chemical tags, the “SNAP-tag” utilizes 
O6-modified guanine-fluorophore heterodimers to covalently label proteins fused to 
human O6-alkylguanine-DNA-alkyltransferase  (hAGT), a 20kD, monomeric DNA repair 
protein that naturally dealkylates O6-alkylated guanine residues in damaged DNA by a 
single turnover alkylation of an active-site Cys residue (Figure 1-1C).38  A fast-reacting 
SNAP-tag variant has been engineered to minimize background labeling of endogenous 
mammalian AGT.39  Impressively, an orthogonal AGT variant that selectively uses 
cytosine-fluorophores as substrates, called CLIP-tag, has been evolved, although it will 
require further optimization to be as robust as the SNAP-tag.38,40  A wide range of SNAP- 
and CILP-fluorophores are commercially available from New England Biolabs, and a 
subset of these have been confirmed to work inside living cells (Table 1-1).  Likewise, 
Promega has developed a covalent chemical tag based on the reaction of an engineered 
dehalogenase enzyme with a suicide substrate—“HaloTag”,27,29 which has been shown to 
be a useful tag in vitro, but reports indicate may suffer efficiency and selectivity issues 
inside cells.41    
New protein-based chemical tags continue to be introduced, but most of these are 
yet to be sufficiently vetted, particularly for the demanding task of labeling proteins 
intracellularly, to judge their practical performance at this time. These tags include a 
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cutinase variant that reacts with a suicide substrate;42  a fluorogen-activating single-chain 
antibody that binds and activates molecular rotor fluorophores;43 a fluorogenic tag in 
which a β-lactamase variant displaces a quencher from a cephem suicide substrate;44,45 
and a non-covalent tag where synthetic ligand of FK506 (SLF) binds to FKBP12:F36V.46   
1.3.2 Peptide-based chemical tags 
With chemical tagging, it should be possible to replace protein tags, which can 
interfere with protein interactions and pathway function, with very short peptide tags.  
The challenge for the field now is to devise conceptually new strategies for chemically 
modifying short peptides with fluorophores that overcome current limitations in the 
selectivity with which a short peptide tag can be recognized over the many other reactive 
molecules present in a living cell.  
The Ting laboratory has pioneered the re-engineering of natural enzymes that 
modify short peptides with organic molecules to fluorophore labeling.47  The most 
advanced of these chemical tags, the E. coli biotin ligase (BirA) enzyme, whose natural 
function is biotinylation of proteins containing a peptide recognition motif, is used to 
label a 15 amino acid peptide tag with a biotin analog, which is subsequently modified 
with a fluorophore (Figure 1-1D).47,48  To date BirA has resisted more dramatic 
modification to enable direct incorporation of a biotin-fluorophore conjugate.  
Intracellular protein labeling, therefore, is still difficult because the second reaction 
between the biotin analog and the fluorophore is slow and incompletely selective at the 
µM concentrations typical in the cell.  An exciting recent advance for the potential it 
illustrates, a lipoic acid ligase variant was evolved to use a coumarin derivative directly, 
although coumarin itself is not an ideal fluorophore for live cell imaging.  
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A variety of enzyme-mediated peptide tags have now been reported, including the 
acyl-carrier protein (ACP)-based tag modified by phosphopantetheine transferase 
(PPTase);49 the 6-amino acid peptide modified by sortase;50,51 and the formylglycine-
generating enzyme-based tag reported by Bertozzi.52  To date all of these aforementioned 
peptide tags have only been demonstrated to work on the cell surface. 
Beyond enzyme-mediated peptide tags, other clever approaches to short peptide 
tags are being explored.  Similar to the FlAsH tag, a tetraserine peptide tag was 
demonstrated to bind a fluorogenic bis-boronic acid derivative.53  In a very recent report, 
Chang and coworkers developed a peptide tag that undergoes a Michael addition with a 
BODIPY fluorophore.54  Inspired by the popular polyhistidine tag for protein purification, 
various metal-chelating peptides have been adapted for protein labeling.55-59  In an 
interesting approach, Nolan and co-workers evolved a 38-amino acid peptide that binds 
the Texas red fluorophore with high affinity.60  An N-terminal Cys residue generated in 
vivo with a sequence-specific protease has been labeled with thioesters, analogous to 
native chemical ligation.61  Although these different strategies are at an early stage of 
development, they illustrate the creativity with which chemistry can be exploited in a 
living cell, making a significant impact not only for live cell imaging, but more broadly 
for synthetic biology. 
1.4 Application Of Chemical Tags 
The chemical tags have come of age, and the measure of their value is now their 
ability to enable experiments in living cells that are difficult or not otherwise possible 
with FPs.  Because the best organic fluorophores emit about 10-times as many photons as 
their FP counterparts,62,63 there is intense interest in exploiting chemical tags for single-
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molecule imaging in living cells.   Moreover, with their modular design, chemical tags 
are not limited to fluorescent labeling and can be creatively co-opted as useful tools for a 
variety of applications in living cells, and also in vitro.  Here we highlight just a few of 
the numerous applications of chemical tags to outstanding questions of biological 
mechanism that illustrate some of the different unique capabilities of chemical tags.  
1.4.1 High-resolution imaging enabled by chemical tags 
In very recent results, our TMP-tag has been exploited in combination with the 
SNAP-tag to enable single-molecule imaging of the spliceosome in yeast cell extracts 
(Figure 1-2), an experiment not possible with the lower photon-output FPs.64  Despite 
intense interest in understanding the mechanism by which pre-mRNAs are correctly 
spliced to mature mRNAs, the spliceosome is difficult to study because it is a complex 2-
3 MD machinery of protein and RNA and cannot be reconstituted in vitro from purified 
components.  The TMP- and SNAP-tags allowed pairs of the small nuclear 
ribonucleoprotein (snRNP) components of the spliceosome to be labeled directly in cell 
extracts with high photon-output dyes and imaged as they assembled on individual pre-
mRNAs.  The next advance will be to have 2-3 orthogonal, high photon-output chemical 
tags enabling single-molecule imaging inside cells (the cyanine dyes employed in this 




Figure 1-2 Experimental set up and representative single-molecule trace of pre-mRNA 
splicing in yeast cell extracts imaged with chemical tags, providing a unique way to 
access the dynamic mechanism of pre-mRNA splicing. 
 (A) Pre-mRNA labeled with Alexa488 is immobilized on a glass slide. Pairs of the snRNP 
complexes that make up the spliceosome, shown here U1 and U2, are genetically encoded in 
fusion with eDHFR and hAGT, respectively, allowing for orthogonal labeling with TMP-Cy5 and 
SNAP-DY549 in yeast cell extract. (B) The arrival and departure of each snRNP complex is 
visualized as the appearance and disappearance of fluorescence signal above the baseline.  The 
delay between U1 binding and U2 binding provided direct evidence that assembly of the 
spliceosomal components is a highly ordered process and, surprisingly, the single-molecule 
traces also showed the association and disassociation of each component is highly dynamic. 
Likewise, the high photon-output chemical tags are beginning to impact ‘super-
resolution’ (SR) imaging technologies that break the diffraction barrier to allow 
fluorescence imaging at the nanometer length-scale of natural proteins (Figure 1-3).65-67  
Stochastic SR imaging technologies including PALM (photo-activatable localization 
microscopy) and STORM (stochastic optical reconstruction microscopy) hinge on  photo-
switchable fluorophores with high photon-output that enable the locations of subsets of 
the total fluorophore population to be determined precisely over time.  Until recently, SR 
imaging has typically relied on either photo-activatable FPs, which have limited photon-
output and palletes, or antibodies conjugated with organic fluorophores, which offer 
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higher resolution and many more colors, but are incompatible with live cells.  Chemical 
tags have the potential to combine the advantages of these two contrasting labeling 
methodologies—they are genetically encoded and thus compatible with live cells, and 
they are modular and thus allow use of photo-switchable high photon-output organic 
fluorophores.21,68,69  Bringing this potential to reality, this past year, building on the 
discovery by Sauer et al. that the reducing environment of the cell catalyzes reversible 
photo-switching of high photon-output Atto organic fluorophores at time scales well 
suited for direct STORM (dSTORM) imaging,70 we demonstrated dynamic dSTORM 
imaging of H2B labeled with TMP-Atto-655.  Significantly, we achieved exceptional 
spatial (~ 20 nm) and temporal (~ 10 s) resolutions, which are not possible with FPs. 
 
 
Figure 1-3 Super-resolution dSTORM imaging of histone protein 2B (H2B) using TMP-tag. 
 (A) In conventional confocal microscopy, the resolution set by the diffraction limit of light is ~200 
nm, and thus individual protein molecules cannot be resolved. In PALM/STORM, small 
percentages of the total population of fluorophores are randomly photo-activated over time, 
allowing all individual fluorophores to be localized to resolutions of ~20 nm from the Gaussian fits 
of their point spread functions.  (B) Total internal reflection fluorescence image of TMP-Atto655 
tagged H2B in the nucleus of living HeLa cells and (C) corresponding dSTORM image with 
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improved resolution. The expanded views and cross-sectional profiles (D, E) demonstrate 
superior resolution well below the diffraction barrier. Adjacent histone proteins separated by ~ 
100 nm are clearly resolved. 
1.4.2 Themes and variations on cell imaging with chemical tags 
Unlike FPs, chemical tags are not limited to traditional fluorescent imaging.  For 
example, in a creative adaptation of classic pulse-chase labeling, the FlAsH tag was 
exploited for correlative fluorescence and electron microscopy (EM) of the assembly of 
connexin43 (Cx43) to form gap junctions between cells (Figure 1-4).  Cx43 is a small 
protein forming tightly-packed oligomers at gap junctions on the plasma membrane.  
Tagged Cx43 was labeled with FlAsH (pulse) and, after a period of time, ReAsH (chase).  
Fluorescence and EM unequivocally showed, for the first time, that nascent Cx43s are 
added to the periphery of the gap junction plaque.15   
 
Figure 1-4 Pulse-chase labeling of Cx43 with FlAsH and ReAsH and correlative 
fluorescence and EM images. 
Oligomers of Cx43 form gap junctions on plasma membranes through which metabolites and 
signaling molecules are exchanged between cells.  Tetracysteine tags have enabled pulse-chase 
16 
 
experiments to observe the dynamic assembly and turnover of junctional plaque with minimal 
disturbance on Cx43 structure and function.  (A) Cellular Cx43 is first ‘pulsed’ with green-
fluorescent FlAsH tag and then the nascent Cx43 is ‘chased’ with red-fluorescent ReAsH tag. (B) 
Nascent Cx43 are observed to be added to periphery of the junctional plaque, indicated by the 
arrows. (C) Correlative EM shows high-resolution image of Cx3 juncitional plaque (indicated by 
arrow) in the context of other subcellular structures.  (B, C courtesy of R.Y. Tsien) 
Enzyme-mediated peptide tags have been re-invented as unique reporters of 
endocytosis. To monitor the internalization of cell surface receptors, it is necessary to 
differentially label receptors on the cell surface and those internalized into the cell, which 
is difficult with FPs. Using chemical tags, however, the receptors on the cell surface can 
be selectively labeled with fluorophores that are not cell permeable and subsequently 
quenched if they are on the cell surface, in order to detect internalized receptors. The 
biotin ligase (BirA)/streptavidin labeling technology has been applied to image the 
endocytosis of low density lipoprotein (LDL) receptor, showing that LDL receptors are 
internalized as oligomers in the presence and absence of LDL ligand (Figure 5).71  
 
Figure 1-5 Cartoon and live cell imaging of the BirA-based peptide tag used to visualize 
internalization of low density lipoprotein (LDL) receptors. 
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  (A) LDL receptors are fused to biotin acceptor peptide (AP) and are expressed both inside and 
on the surface of the cell. Only cell surface receptors can be labeled with Alexa568 via 
monomerized streptavidin (mSA), which is not cell-permeable. After endocytosis, cell surface 
receptors are quenched with QSY quencher, such that internalized receptors can be selectively 
visualized.  (B) Fluorescence images of cells immediately before and after surface fluorescence 
quenching (+QSY).  With no incubation to allow for endocytosis, very few internalized receptors 
are detected. (C) With 5 min incubation at 37oC, some LDL receptors are internalized and thus 
protected from QSY quenching.  (B, C courtesy of A.Y. Ting) 
There seems to be no limit to the creative extensions of chemical tags.  The TMP-
tag, SNAP-tag and FlAsH tag all have been exploited for chromophore assisted laser 
inactivation (CALI), in which the target protein is selectively inactivated by locally 
damaging reactive oxygen species released by the fluorophore upon irradiation;19,26,72  
The SNAP- and CLIP-tags have been used in conjunction to detect protein-protein 
interactions;73 and a variant of the tetracysteine-FlAsH tag has been designed to read-out 
protein folding and association.74  Arguably chemical tags are all “chemical inducers of 
dimerization” (CIDs) just applied specifically to fluorescent imaging, and, thus, the 
corollary of this argument is that chemical tags can be utilized as CIDs for myriad 
applications.75 
1.4.3 Chemical tags are biotin/streptavidin surrogates for in vitro applications 
While this review focuses on live cell imaging, it should be noted that the 
chemical tags also can be viewed as a modern equivalent to biotin/streptavidin for in vitro 
engineering, with the benefits of being monomeric, possibly covalent, and more readily 
reversible.29  Already chemical tags (notably HaloTag) have been utilized as orthogonal 
alternatives to biotin/streptavidin for protein purification and immobilization; labeling 
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proteins in sensitive macromolecular complexes; and, in materials chemistry, for surface 
patterning, although a comprehensive survey on these in vitro applications is beyond the 
scope of this review.76 
1.5 Future Development Of The Chemical Tagging Technology 
As the chemical tagging technology transitions from a proof-of-principle stage to 
widespread adoption by cell biologists and biophysicists interested in studying protein 
function in the complex environment of the cell, there is an immediate need for multiple 
orthogonal chemical tags for multi-color imaging in living cells.  Perhaps surprisingly, 
given that new chemical tags are now regularly reported in the literature, the field still 
needs additional chemical tags that are sufficiently selective for intracellular protein 
labeling.  Moreover, while virtually any known fluorophore can be conjugated to the now 
large repertoire of chemical tags; there are still very few reports of high photon-output 
fluorophore tags that work inside the cell. 
Another important advance will be the realization of the potential of chemical tags 
to dramatically decrease tag size.  There are tantalizing recent results showing that it will 
be possible to render the existing enzyme-mediated peptide tags functional inside living 
cells.  In our opinion, unnatural amino acid mutagenesis has the potential to provide a 
breakthrough with direct incorporation of organic fluorophores as amino acid side 
chains—although this advance will require (1) expanding the substrate specificity of the 
translational machinery for incorporation of the high photon-output, red-shifted organic 
fluorophores and (2) overcoming ubiquitous incorporation of the fluorescent amino acid 
in response to the numerous stop codons present in the transcriptome.   
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Finally, while chemical tags offer advantages for fluorescence imaging over FPs 
with modular incorporation of fluorophores with higher photon-output and specialized 
properties such as photo-switching, the potential of these modular tags for introducing 
probes beyond fluorophores is surprisingly largely unexplored.  It will be exciting to see 
if chemists are able to exploit these modular tags in the coming decade to invent entirely 
new spectroscopies to meet the challenge of understanding biological mechanism in the 
context of the living cell. 
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2 Chapter 2 
A Fluorogenic TMP-Tag For High Signal-To-Background Intracellular 





2.1 Chapter Overview 
Developed to compliment the use of fluorescent proteins in live cell imaging, 
chemical tags enjoy the benefit of modular incorporation of organic fluorophores, 
opening the possibility of high photon output and special photophysical properties. 
However, the theoretical challenge in using chemical tags as opposed to fluorescent 
proteins for high-resolution imaging is background noise from unbound and/or non-
specifically bound ligand-fluorophore. We envisioned we could overcome this limit by 
engineering fluorogenic trimethoprim-based chemical tags (TMP-tags) in which the 
fluorophore is quenched until binding with E. coli dihydrofolate reductase (eDHFR) 
tagged protein displaces the quencher. Thus, we began by building a non-fluorogenic, 
covalent TMP-tag based on a proximity-induced reaction known to achieve rapid and 
specific labeling both in vitro and inside of living cells. Here we take the final step and 
render the covalent TMP-tag fluorogenic. In brief, we designed a trimeric TMP-
fluorophore-quencher molecule (TMP-Q-Atto520) with the quencher attached to a 
leaving group that, upon TMP binding to eDHFR, would be cleaved by a cysteine residue 
(Cys) installed just outside the binding pocket of eDHFR.  We present the in vitro 
experiments showing that the eDHFR:L28C nucleophile cleaves the TMP-Q-Atto520 
rapidly and efficiently, resulting in covalent labeling and remarkable fluorescence 
enhancement. Most significantly, while only our initial design, TMP-Q-Atto520 achieved 
the demanding goal of not only labeling highly abundant, localized intracellular proteins, 
but also less abundant, more dynamic cytoplasmic proteins. These results suggest that 




further establish the potential of proximity-induced reactivity and organic chemistry more 
broadly as part of the growing toolbox for synthetic biology and cell engineering.  
2.2 Introduction 
The past two decades have seen a transformation in cell biology brought about by 
the fluorescent proteins (FPs) as selective, genetic protein tags for live cell imaging.1,2  
The original green fluorescent protein (GFP) from A. victoria is a 238 amino acid protein, 
which, upon folding, spontaneously forms a fluorescent chromophore by rearrangement 
and oxidation of Ser, Tyr, and Gly residues in the core of the eleven-stranded β-barrel.3,4  
Since these original reports, naturally occurring and engineered FPs have been routinely 
used to observe the timing and location of protein expression in living cells, often 
providing significant mechanistic insight.3,5,6  While FPs continue to be invaluable tools 
for cell biology, they have limitations for the increasingly sophisticated biophysical 
experiments necessary to make dynamic measurements of protein interactions critical to 
unraveling the molecular mechanism of cellular processes. Thus, chemical tags have been 
developed to provide an alternative for labeling intracellular proteins with modular 
organic fluorophores that have high photon outputs and other specialized functionalities.7 
With chemical tags, rather than tagging the target protein with a FP, the protein is 
tagged with a polypeptide or protein receptor, which is subsequently modified with an 
organic fluorophore. The TMP-tag, developed by Cornish and Sheetz, relies on the high-
affinity interaction between E. coli dihydrofolate reductase (eDHFR) and the folate 
analog trimethoprim (TMP).8,9 In brief, the target protein is tagged with eDHFR, which 
binds TMP with high affinity (~ 1 nM KD) and selectivity (affinities for mammalian 




minor perturbation of the high-affinity binding to eDHFR. Among numerous chemical 
tags reported in the past decade, TMP-tag is one of few chemical tags that can label 
proteins with high efficiency and selectivity both in vitro and inside of live cells.7 
Significantly, the advantage of TMP-tag for high-resolution imaging has been verified by 
several recent reports, including single-molecule (SM) imaging of spliceosome assembly 
in yeast cell extracts and super-resolution imaging of nucleosomes in live HeLa cells.12,13  
Nevertheless, one major challenge to realizing the potential of TMP-tag for high-
resolution imaging is background from unbound and/or non-specifically bound 
fluorophore. Therefore, we set out to build a fluorogenic TMP-tag in which the 
fluorophore is switched on as TMP binds to eDHFR, minimizing the background 
fluorescence. Looking back into the rich history of fluorogenic probes, we found a 
number of viable designs for switch-on fluorophores. One widely used approach relies on 
fluorophores with protecting groups that are cleaved by an enzyme or light 
irradiation.14,15 The widely utilized Ca2+ sensors  Fluo-3 and Rhod-2 represent a class of 
fluorogenic probes modulated via photon-induced electron transfer (PeT).16 Other 
strategies include solvatochromes that are sensitive to the polarity of the 
microenvironment and molecular rotors that only fluoresce when intramolecular rotation 
is constrained.17-19 Notably, the first chemical tag - the fluorogenic FlAsH tag reported in 
1998 - utilizes fluorogenic biarsenical fluorophores hypothetically based on the molecular 
rotor or PeT concept.20 Here we designed a fluorogenic TMP-tag by conjugating the 
TMP-fluorophore to a quencher that is cleaved when TMP binds to eDHFR. We choose 
the cleavable fluorophore/quencher strategy because: (1) it gives among the highest 




receptor/ligand binding; and (3) it allows for modular incorporation of virtually any 
organic fluorophore. 
In the primary stage of achieving our goal of developing a fluorogenic TMP-tag, 
we first rendered the TMP-tag covalent via proximity-induced Michael addition.21 In 
brief, we installed a unique Cys residue on eDHFR in position to react with a latent 
acrylamide electrophile added to the TMP-probe molecule. Exceeding our expectation, 
the first-generation covalent TMP-tag undergoes rapid, quantitative covalent labeling (in 
vitro t1/2 ~ 50 min at 1 µM eDHFR and TMP-tag) and enables imaging of nuclear-
localized eDHFR in live NIH3T3 cells. Nevertheless, the original covalent TMP-tag was 
not efficient enough to label cytoplasmic proteins that are less abundant and more 
dynamic, likely due to its modest reactivity. Therefore, by designing a shorter, optimized 
linker between TMP and the acrylamide electrophile as well as screening a panel of 
eDHFR variants, we recently engineered a second-generation covalent TMP-tag that 
undergoes rapid, quantitative covalent labeling (in vitro t1/2 ~ 8 min at 1 µM eDHFR and 
TMP-tag) and enables live cell imaging of several different cytoplasmic proteins.22  
Here we further challenge the potential of proximity-induced reactivity by 
applying another classic type of reaction in organic chemistry, the SN2 reaction, to 
generate a fluorogenic TMP-tag suitable for live cell imaging (Figure 2-1). First, a 
tosylate electrophile and Cys nucleophile were selected as the reactive functional groups 
for modification of TMP and eDHFR, respectively.  Using molecular modeling programs, 
we designed and synthesized a heterotrimeric TMP-tosylate-fluorophore with a quencher 
attached to the tosylate leaving group, with the Cys installed on the surface of eDHFR in 




live cells in order to determine the efficiency and selectivity of labeling.  Finally, the 
utility of the fluorogenic TMP-tag was assessed by challenging it to label several 
different fusion proteins in live cells.  Not only does this work provide a new fluorogenic 
tag for live cell imaging with high signal-to-background (S/B), but also it demonstrates 
that proximity-induced labeling is a viable tool for engineering cellular reagents.  
 
Figure 2-1 Cartoon of fluorogenic TMP-tag. 
Fluorogenic TMP-tag is based on the proximity-induced reaction between the E. coli dihydrofolate 
reductase (eDHFR) variant and the trimethoprim (TMP) – fluorophore (F) – quencher (Q) 
heterotrimer.  The target protein (purple) is tagged with eDHFR (blue) and then labeled with TMP 
analogue. The high affinity interaction between TMP and eDHFR induces the SN2 reaction 
between a nucleophilic amino acid residue (Nu:)  engineered on eDHFR and an electrophilic 
linker attached to the quencher as the leaving group. 
2.3 Results 
2.3.1 Design Of A Fluorogenic TMP-Tag 
We envisioned constructing the fluorogenic TMP-tag based on our covalent TMP-




fluorogenic TMP-tag as a heterotrimeric molecule with the TMP, the fluorophore, and the 
quencher linked via an electrophilic leaving group. Upon binding to the eDHFR:Cys 
variant, the electrophilic leaving group is attacked by the Cys nucleophile on eDHFR, 
leading to displacement of the quencher along with the leaving group, producing a 
fluorescence enhancement (Figure 2-1A). To achieve live cell imaging with high S/B, we 
selected a fluorophore, quencher, and electrophile that would be cell permeable and well 
behaved inside of living cells. 
 
Figure 2-2 The fluorogenic TMP-tag. 
(A) Cartoon of the fluorogenic TMP-tag, which centers a trimeric TMP- quencher (Q) - fluorophore 
(F) molecule to be cleaved in a proximity-induced SN2 reaction. Specifically, we selected the Cys 
side chain as the nucleophile and a tosylate linker as the electrophile. When TMP binds to 
eDHFR, the unique Cys near binding pocket would replace the tosylate leaving group attached to 
the quencher, and thus the probe is switched on. (B) Structure of TMP-BHQ1-Atto520 (TMP-Q-




For the fluorophore, we chose Atto520 because it is a green dye (Ex: 516 nm; Em: 
538 nm) with excitation and emission spectra similar to that of enhanced green 
fluorescent protein (EGFP) and is compatible with most fluorescence microscopes.23 
More importantly, Atto520 has been reported to have high photon output and 
photostability, verified by its application in super-resolution imaging in fixed cells.24 
Compared to other commonly used green fluorophores such as fluorescein, Alexa488 and 
Atto488, the unique positive charge on Atto520 is supposed to render it readily cell 
permeable, which is crucial to live cell imaging. 
To achieve maximal quenching effect, the absorption spectrum of the quencher 
has to match the emission spectrum of the fluorophore. Thus we chose the black hole 
quencher 1 (BHQ1®, Biosearch Technologies) that shows broad and strong absorption 
across the green-yellow region peaking at 534 nm (ε = 38,000 M-1cm-1). The BHQ1 
quencher is frequently used in nucleic acid detection technologies such as quantitative 
PCR and for molecular beacons, demonstrating high quenching efficiency with many 
green fluorophores.25  
The key to our fluorogenic design is the choice and precise modification of the 
electrophilic leaving group. Specifically, the electrophilic functional group has to be 
reactive enough to facilitate rapid protein labeling upon TMP binding, yet resistant to the 
numerous nucleophilic biomolecules inside of live cells.21,26 Among various leaving 
groups commonly used in organic synthesis, we focused on the tosylates and mesylates 
because they potentially balance low reactivity towards endogenous cellular molecules 




Particularly, we found the quenched ligand-directed tosyl (Q-LDT) chemistry to 
be promising because it has been reported to have rapid proximity-induced in vitro 
reactivity with minimal non-specific hydrolysis.27,28 Furthermore, we anticipated we 
could significantly accelerate the labeling reaction by using the Cys nucleophile that is 
much stronger than the His nucleophile originally reported for the Q-LDT chemistry. 
Specifically, we built the TMP-quencher-fluorophore (TMP-Q-Atto520) molecule with 
the tosylate group 12 atoms away from the TMP para-methoxy group that locates at the 
opening of the TMP binding pocket.  With this design the eDHFR/TMP interaction is 
minimally perturbed, yet the tosylate electrophile is positioned close to the surface of 
eDHFR to efficiently induce the SN2 reaction with the Cys nucleophile (Figure 2-2B). 
2.3.2 Synthesis Of TMP-Q-Atto520 
The synthetic design of the fluorogenic TMP-tag was planned around a tri-
branched core with 3 orthogonally reactive functional groups for coupling the TMP, the 
fluorophore, and the leaving group and quencher, respectively. Specifically, we used 
propargylglycine, taking the amino group and a carboxylic acid group to be attached to 
the fluorophore and the TMP, respectively, and the alkyne group for introduction of the 





Scheme 2-1 Synthesis of intermediate 2-6. 
Reaction conditions: a. 48% HBr, 95 °C, 15 min.; b. tert-butyl-N-(3-iodopropyl)carbamate, Cs2CO3, 
DMF, 70 °C, 5 h; c. 1:1 TFA:DCM, RT, 1 h; d. N-Boc-propargylglycine, EDCI, HOBt, DIEA, DMF, 
RT, 16 h; e. 1:1 TFA:DCM, RT, 1 h; f. DIEA, DMF, RT, 16 h. 
As outlined in Scheme 2-1, the synthesis of the first half of the molecule, the 
TMP-Atto520-alkyne, started from the derivatization of TMP at the 4’-methoxy position, 
well established not to disrupt binding to eDHFR. The TMP-OH (intermediate 2-1) thus 
generated was then alkylated with commercially available tert-butyl-N-(3-
iodopropyl)carbamate to produce TMP-C3-NHBoc 2-2. Then after removing the Boc 
group with trifluoroacetic acid (TFA), the TMP-C3-amine 2-3 was coupled to N-Boc-
propargylglycine under standard peptide coupling conditions, yielding TMP-NHBoc-
alkyne 2-4. In the next step, the fluorophore Atto520-NHS ester was reacted with 
intermediate 2-5 in which the amino group was exposed by another TFA deprotection, 
producing intermediate 2-6. Notably, this synthetic route allowed us to introduce the 




expense but also to allow for future synthesis of fluorogenic TMP-tags at different 
wavelengths. 
 
Scheme 2-2 Synthesis of TMP-Q-Atto520 2-12. 
Reaction conditions: a. Di-tert-butyl dicarbonate, DIEA, DCM, RT, 20 min; b. NaHCO3, H2O, 
MeOH, 0 °C, 2 h; c. 1:1 TFA:DCM, RT, 1 h; d. 3-(chlorosulfonyl)benzoyl chloride, DIEA, DCM, 
0 °C, 1 h; e. 3-azidoethanol, DIEA, DMAP, DCM, RT, 4 h; f. CuSO4·5H2O, DMF, RT, 24 h. 
In parallel, the synthesis of the BHQ1 quencher was initiated with Boc protection 
of the commercially available N-(3-aminopropyl)-N-methylaniline.  The product, 
intermediate 2-7, was then coupled to fast Corinth V salt in an azo coupling reaction 
following the patent US 7019129 B1.29 With the Boc protective group removed by TFA, 




chloride to produce BHQ1-tosyl chloride 2-10. In the next step BHQ1-tosyl chloride was 
reacted with excess 2-azidoethanol, catalyzed by 4-dimethylaminopyridine (DMAP), 
yielding intermediate 2-11.  
Finally, the TMP-Atto520-alkyne (intermediate 2-6) and BHQ1-azide 
(intermediate 2-11) were conjugated via click chemistry under mild conditions 
(CuSO4·5H2O and ascorbic acid in anhydrous DMF). Importantly, the ascorbic acid kept 
the solution slightly acidic and thus minimized alkaline hydrolysis of the tosylate. The 
final product TMP-Q-Atto520 2-12 was obtained in 2 percent overall yield from TMP or 
3 percent overall yield from N-(3-aminopropyl)-N-methylaniline, both in five linear steps.  
2.3.3 Engineering Of The Edhfr:Cys Variant Library 
It is well established in the covalent inhibitor literature that the position of the Cys 
nucleophile strongly affects the reaction rate and labeling efficiency.22,26 Thus, we 
decided to screen a small library of eDHFR variants in search of the eDHFR:Cys variant 
with maximal reactivity.  The eDHFR:Cys variant candidates were selected based on a 
homology model of the eDHFR/TMP complex. Since no high-resolution crystal structure 
of eDHFR binding TMP is available, we built an eDHFR/TMP homology model by 
aligning eDHFR to the highly homologous L. casei DHFR/TMP complex.30,31 We have 
learned from the optimization of covalent TMP-tag that a 10-atom spacer between the 4’-
OH group of TMP and the β-carbon of the electrophile would enable rapid proximity-
induced reaction.22 To choose the Cys variants to evaluate, we started from all 39 
residues on eDHFR that are within 12 Å (approximately the distance of nine C-C bonds) 
from the 4’-OH group of TMP. Among these 39 candidates, we selected 16 residues 




the electrophile; (2) the residue should orient towards the TMP binding pocket; and (3) 
mutation of the residue should not significantly impair eDHFR/TMP binding or the 
stability of eDHFR (Figure 2-3).32 The estimated distance between the 4’-OH group of 
TMP and the 16 amino acid residues are listed in Section 2.6.2.1.  
 
Figure 2-3 Depiction of the designed eDHFR:Cys mutant library. 
Cartoon of TMP bound to eDHFR, with all 16 amino acid residues around the binding pocket 
mutated to Cys highlighted. The eDHFR protein is represented in violet as a ribbon diagram, with 
the highlighted residues in orange.  The TMP is represented as sticks with coloring based on 
elements.  Since no structure has been solved of TMP bound to eDHFR, the model was created 
by structural alignment of eDHFR with the L. casei DHFR.  The graphic was prepared using 
PyMOL. 
Experimentally, we created the eDHFR:Cys mutant library by first fusing the 
eDHFR gene with a His6-tag in an E. coli expression vector and then mutating 16 amino 
acids individually using standard site-directed mutagenesis (SDM) technology. We also 
removed the two naturally occurring cysteines, Cys85 and Cys152, by mutating them to 




folding and purification.  A variant containing the C85S and C152S mutations, but 
lacking any other Cys mutation, was used as a control and is referred to as eDHFR-2C.  
2.3.4 In Vitro Characterization Of Fluorogenic TMP-Tags 
To verify that the designed fluorogenic TMP-tag undergoes efficient and specific 
quencher cleavage, the TMP-Q-Atto520 was first characterized in vitro using purified 
eDHFR:Cys variants. By screening the eDHFR:Cys library, we identified eDHFR:L28C 
as the variant with the fastest reactivity.  Then we confirmed its efficiency and specificity 
using fluorometry and gel shift assays.  
2.3.4.1 Fluorometric Measurements 
The library of 16 different eDHFR:Cys mutants was initially screened by 
fluorometric measurement to identify the eDHFR:Cys mutant that induces the greatest 
fluorescence enhancement upon reacting with TMP-Q-Atto520. In brief, 1 μM of each 
eDHFR:Cys variant was incubated with 1 μM TMP-Q-Atto520 in phosphate buffered 
saline (PBS) supplemented with 100 μM NADPH and 1 mM reduced glutathione (GSH) 
at 37 °C.  As described for our initial and second-generation covalent TMP-tags, we 
chose this buffer to mimic the intracellular environment considering (1) NADPH affects 
eDHFR binding to TMP and its intracellular concentration is close to 100 μM; and (2) 
GSH represents the pool of various bio-molecules bearing non-specific thiol groups that 
may potentially compete with the eDHFR:Cys variants for reaction with TMP-Q-
Atto520.21,22  Figure 2-4 displays the fluorescence intensity over time for all 16 
eDHFR:Cys variants that induced significant fluorescence enhancement with TMP-Q-
Atto520. Significantly, the TMP-Q-Atto520 showed the greatest fluorescence 




Atto520 incubated with buffer only or with the eDHFR-2C control showed little 
fluorescence enhancement over time, confirming that the BHQ1 quencher can only be 
cleaved rapidly in the presence of a specific Cys residue engineered on the surface of 
eDHFR. 
 
Figure 2-4 Screening of the eDHFR:Cys variant library. 
Purified eDHFR:Cys variants at a concentration of 1 µM were incubated with 1 µM TMP-Q-
Atto520 in PBS (pH = 7.40) with 100 µM NADPH and 1 mM glutathione at 37 ˚C.   Fluorescence 
intensity (Fl. Intensity) was measured at various time points. Four eDHFR:Cys mutants, namely 
the eDHFR:N23C, P25C, L28C and K32C showed significant fluorescence enhancement. As 
controls, the eDHFR-2C variant that lacks Cys and the buffer without eDHFR induced little 
increase in fluorescence intensity. Relative standard deviation (RSD) < 10% for all data. Error 
bars were not shown for clarity. 
The best variant eDHFR:L28C was further evaluated with TMP-Q-Atto520 for 




emission spectra (Figure 2-5) under the same labeling conditions as described above. 
Fluorescence enhancement (EF) was calculated as EF = F/F0-1, in which F is the 
fluorescence intensity of TMP-Q-Atto520 labeling the eDHFR:L28C; F0 is the 
fluorescence intensity of the control group with buffer and GSH while lacking eDHFR 
protein. As presented in Figure 2-5B, 1 μM eDHFR:L28C incubated with 1 μM TMP-Q-
Atto520 for 3 h at 37 °C produced 20 fold fluorescence enhancement. 
 
Figure 2-5 The fluorescence excitation (A) and emission (B) spectra of TMP-Q-Atto520. 
 Purified eDHFR:L28C was labeled under the same reaction conditions as in Figure 2-4 for 3 h. 
The fluorescence spectrum showed 20 fold enhancement compared to the control group in which 
1 µM TMP-Q-Atto520 was incubated with the buffer without eDHFR:L28C. By contrast, 1 µM 
TMP-Q-Atto520 incubated with 1 µM bovine serum albumin (BSA) which does not bind TMP 
shows no significant fluorescence enhancement compared to control group with buffer. In 
addition, the specific quencher cleavage is further demonstrated by the competition assay in 
which 1 µM TMP-Q-Atto520 was incubated with 1 µM eDHFR:L28C and 10 µM TMP. Standard 
deviation < 5% and error bards are not shown. 
Importantly, we also performed a TMP competition assay in which TMP-Q-
Atto520 was incubated with eDHFR:L28C in the presence of various concentrations of 
TMP. As reported in Figure 2-5B as well as Figure 2-6, 1 – 10 equivalents of TMP could 




that the mechanism of the fluorogenic TMP-tag is proximity-induced labeling of 
eDHFR:L28C. 
 
Figure 2-6 TMP competition assay. 
 Purified eDHFR:L28C at 1 µM concentration was labeled with 1 µM TMP-Q-Atto520 in presence 
of TMP at various concentration (see legend), under the same condition as in Figure 2-4. The 
TMP-Q-Atto520 incubated with buffer without eDHFR:L28C was used as a negative control. 
2.3.4.2 MS Analysis 
The covalent and site-specific labeling of eDHFR:L28C by fluorogenic TMP-tag 
was further validated by mass spectroscopy (MS) analysis. Primarily, the molecular 
weight of eDHFR:L28C labeled with fluorogenic TMP-tag was measured using matrix-
assisted laser desorption/ionization (MALDI) MS in comparison with unlabeled 
eDHFR:L28C, showing an increase in molecular weight as anticipated for covalent 
conjugation with the fluorogenic TMP-tag. Then the labeled eDHFR:L28C was digested 
by chymotrypsin followed by liquid chromatography-tandem MS (LC-MS/MS) analysis 
to identify the amino acid residue being labeled. The fragmentation pattern revealed by 





Figure 2-7 MS analysis of eDHFR:L28C labeled with TMP-Q-fluorescein. 
(A) MALDI-TOF graphs of unlabeled eDHFR:L28C (left) and eDHFR:L28C labeled with TMP-Q-
fluorescein (right), respectively. The increase in MW confirmed the covalent labeling with 
fluorogenic TMP-tag. (B) MS/MS graph of labeled peptide generated by chymotrypsin digestion. 
The fragmentation pattern was consistent with covalent labeling on L28C. 
 
2.3.4.3 Gel-shift Assay 
Next we measured the kinetics of the labeling reaction by gel-shift assay. 
Specifically, the in vitro eDHFR:L28C labeling reaction with TMP-Q-Atto520 was 
quenched at various time points and analyzed with SDS-PAGE. With Coomassie staining, 




increase in molecular weight of the labeled protein, allowing the progress of the reaction 
to be monitored by densitometry analysis. Significantly, both in-gel fluorescence and gel-
shift assay demonstrated the accumulation of covalently labeled eDHFR:L28C over time 
(Figure 2-8).The half time of the labeling reaction (t1/2) was estimated to be ~ 10 min for 
TMP-Q-Atto520 labeling eDHFR:L28C. And the rate constant for the labeling reaction 
has been estimated to be 53 M-1s-1 assuming a second-order reaction mechanism (Section 
2.6.2.2). 
 
Figure 2-8 Determination of the rate of covalent labeling. 
In the same buffer as in (a), 2 µM of eDHFR:L28C was incubated with 10 µM TMP-Q-Atto520 at 
37 °C. At various time points, aliquots were quenched by boiling at 95 °C with 6X SDS.  The 
reaction was analyzed by sodium dodecyl sulfate (SDS)-PAGE followed by fluorescence gel 
scanning and Coomassie staining, and it was determined that 50% labeling occurs in 
approximately 10 minutes. 
Taken together, the in vitro assays confirmed that TMP-Q-Atto520 rapidly 
produced a highly specific, covalent label with significant fluorescence enhancement, 
suggesting it would be robust enough to label proteins in living cells. 
2.3.5 Live Cell Imaging Of H2B 
Encouraged by the efficient and rapid labeling reaction between eDHFR:L28C 
and TMP-Q-Atto520 with strong fluorescence enhancement, we next evaluated the 
potential of fluorogenic TMP-tag for live cell imaging with high S/B. We started by 




specifically stains the target protein in live cells with significantly lower background 
compared to the non-fluorogenic TMP-Atto520. Then we confirmed the robustness of the 
fluorogenic TMP-tag by successfully labeling cytosolic proteins that are more diffuse and 
dynamic, characterized by both microscopy and in-gel fluorescence analysis.  
First we evaluated the efficiency and selectivity of TMP-Q-Atto520 for labeling 
nuclear localized human histone H2B in HEK 293T cells. Specifically, HEK 293T cells 
were transiently transfected with plasmid encoding H2B-eDHFR:L28C and incubated 
with 5 μM TMP-Q-Atto520 in tissue culture media. To compare the fluorogenic TMP-tag 
with non-fluorogenic TMP-tag, we transfected another group of cells with H2B-eDHFR 
(wild type) and labeled them with 5 μM TMP-Atto520. As controls, untransfected HEK 
293T cells were stained with 5 μM TMP-Q-Atto520 or 5 μM TMP-Atto520, respectively 
(Figure 2-9). For comparison, all images in Figure 2-9 were taken under identical 
microscope setting including the objective, laser intensity, pinhole size, and gain value of 
the photon multiplier tube (PMT). Remarkably, the TMP-Q-Atto520 efficiently labeled 
the nucleus of live cells with no visible background staining. By contrast, the non-
fluorogenic TMP-Atto520 displayed high background fluorescence from non-specific 
staining and/or unbound fluorophores. In the control groups with untransfected cells, the 






Figure 2-9 Live cell imaging of cell nucleus with fluorogenic TMP-tag in comparison with 
non-fluorogenic TMP-tag. 
 (A) HEK 293T cells were transiently transfected with plasmid encoding histone 2B (H2B)-
eDHFR:L28C and labeled with 5 µM TMP-Q-Atto520 for 3 h. Live cell imaging was achieved 
using confocal microscope, displaying the specific labeling of cell nucleus. (B) As control, 
untransfected cells were treated with TMP-Q-Atto520 under the same condition as A, showing 
very weak background fluorescence. (C, D) The same imaging experiments were carried out with 
the first generation, noncovalent TMP-tag. Significant background staining was observed with 
both H2B-eDHFR transfected and untransfected cells. For comparison, all four images were 
obtained using the same microscope setup with excitation at 488 nm. Scale bars are 25 µm. 
In addition, we also evaluated the robustness of the fluorogenic TMP-tag by 
carrying out live cell imaging under various conditions. Significantly, labeling H2B-
eDHFR:L28C with low concentration (1 µM) of TMP-Q-Atto520 or short staining time 
(1 h) still enabled live cell imaging with high S/B (Figure 2-10). The labeling efficiency 
in live HEK 293T cells has been quantified using western blot: 38% of intracellular 
eDHFR:L28C was covalently labeled within 1 h; 3 h staining with 10 µM TMP-Q-
Atto520 resulted in 67% labeling yield (Figure 2-11). Based on these results we 
recommend 5 –10 µM of TMP-Q-Atto520 staining for 2 – 3 h to provide maximal S/B 





Figure 2-10 Live cell imaging of H2B-eDHFR:L28C labeled with TMP-Q-Atto520 using 
different staining protocols. 
HEK 293T cells were transiently transfected with plasmid encoding H2B-eDHFR:L28C and 
subsequently labeled with TMP-Q-Atto520 with different protocol as indicated above each column.  
 
Figure 2-11 Gel-shift of eDHFR:L28C in live HEK 293T cells labeled with 10 µM TMP-Q-
Atto520. 
HEK 293T cells were transiently transfected with plasmids encoding eDHFR:L28C-His6 for 
mammalian expression. Transfected cells were labeled with 10 µM TMP-Q-Atto520 and lysed at 
different time points as indicated in the figure. Cell lysates were analyzed with SDS-PAGE gel 
and eDHFR:L28C was detected by western blot using anti-His6 monoclonal antibody conjugated 
with horseradish peroxidase for chemiluminescence imaging. Because of change in molecular 
weight, covalent labeling on eDHFR:L28C by TMP-Q-Atto520 causes upward gel shift so that the 




2.3.6 Live Cell Imaging Of Cytosolic Proteins 
After demonstrating the advantage of the fluorogenic TMP-Q-Atto520 over non-
fluorogenic TMP-Atto520, we further assessed the robustness of the fluorogenic TMP-
tag by labeling a series of different proteins in various cell lines. The target proteins we 
tested included the translocase of outer mitochondrial membrane 20 (TOMM20); myosin 
light chain (MLC); and α-actinin. All of these target proteins are less abundant and more 
dynamic than H2B, making them more challenging targets for live cell imaging. To label 
the target proteins with fluorogenic TMP-tag, HEK 293T cells were transiently 
transfected with plasmids encoding TOMM20-eDHFR:L28C and MEF cells were 
electroporated to introduce plasmids encoding MLC-eDHFR:L28C and α-actinin-
eDHFR:L28C. All cells were also transfected with a control vector encoding H2B-
mCherry as the transfection indicator. As presented in Figure 2-12A, TMP-Q-Atto520 
labeled all target proteins with high S/B, showing the desired sub-cellular localizations: 
TOMM20 at mitochondria that distributed around the nucleus; MLC in stress fibers as 
well as lamilipodia; α-actinin (an actin crosslinker) developing the ‘dash line’ pattern 
along the stress fibers and also localized to the focal adhesions.33-36 In all experiments we 
observed no evidence of cytotoxicity, as the cells labeled with TMP-Q-Atto520 showed 
no loss of viability or any other phenotypic variations compared with mock treated 
control cells (Figure 2-13). The correct sub-cellular localization of target proteins also 





Figure 2-12 Live cell imaging of cytosolic proteins with TMP-Q-Atto520. 
Three cytosolic proteins, TOMM20, α-actinin, MLC, in addition to H2B were successfully imaged 
in two distinct cell lines. (A) Live cell imaging using TMP-Q-Atto520. HEK 293T cells (for 
TOMM20) or mouse embryonic fibroblast (MEF) cells (for MLC, α-actinin, and H2B) transiently 
co-transfected with vectors encoding target protein-eDHFR:L28C and H2B-mCherry (for 
TOMM20, MLC and α-actinin labeling) fusion proteins, respectively, were incubated with 10 μM 
TMP-Q-Atto520 in media for 3 h at 37 °C, washed twice with media, and imaged using confocal 
and differential interference contrast (DIC) microscopy. Untransfected MEF cells were treated 
under the same condition and imaged using the same microscope setup as for H2B in MEF cells. 




column shows merges images from the green, red (594 nm excitation), and DIC channels.  Scale 
bars are 25 μm. (B) In-gel fluorescence analysis to confirm the labeling specificity. The cells 
transfected with corresponding target protein-eDHFR:L28C vectors were harvested after 3 h 
incubation with 10 μM TMP-Q-Atto520, lysed, and analyzed by SDS-PAGE and in-gel 
fluorescence scanning with an excitation laser at 488 nm. As controls, untransfected (UT) cells 
were stained with TMP-Q-Atto520 under the same condition and analyzed in parallel. These 
results show the target versatility of the fluorogenic TMP-tag for live cell protein labeling. 
 
Figure 2-13 Evaluation of cytotoxicity of TMP-Q-Atto520 using Alamar Blue assay and DIC 
imaging, 
HEK 293T cells were incubated for 3 h at 37 °C with 10 µM TMP-Q-Atto520 and DMF, 
respectively, with the untreated cells as control. Then the cells were treated with 10% Alamar 
Blue for 4 h at 37 °C and fluorescence intensity (Ex: 580 nm; Em: 620 nm) was measured to 
indicate cell viability. Error bar represents standard deviation from three trials. With Alamar Blue 
assay, 10 µM TMP-Q-Atto520 was not found to significantly impact the cell viability of HEK 293T 




HEK 293T cells treated with 10 µM TMP-Q-Atto520 also showed normal morphology and viability 
compared with DMF treated and untreated cells. 
Finally, the specificity of TMP-Q-Atto520 labeling in living cells was examined 
by SDS-PAGE and in-gel fluorescence scanning. The HEK 293T cells and MEF cells 
were transfected and labeled with TMP-Q-Atto520 following the same procedures as for 
live cell imaging. As negative controls, untransfected HEK 293T cells and MEF cells 
were stained with TMP-Q-Atto520 as well. After cell lysis, the supernatants of the lysates 
were loaded onto SDS-PAGE and the gels were scanned for in-gel fluorescence. As 
presented in Figure 2-12B, in all lanes only one major band correlating to the expected 
fusion protein was observed: 33 kDa H2B-eDHFR:L28C; 34 kDa TOMM20-
eDHFR:L28C; 37 kDa MLC-eDHFR:L28C; 121 kDa α-actinin-eDHFR:L28C. The 
absence of any visible band for both untransfected HEK 293T cells and MEF cells 
confirms the high specificity of TMP-Q-Atto520. Interestingly, there are a few minor 
bands with lower molecular weight in the lysate of the cells transfected with H2B-
eDHFR:L28C and TOMM20-eDHFR:L28C.  Because these lower molecular weight 
bands are absent in other supernatants, we interpret these bands as degradation products 
of the fusion protein.  These results demonstrate that TMP-Q-Atto520 efficiently forms a 
covalent bond with intracellular eDHFR:L28C fusion proteins with high specificity, 
verifying the utility of the fluorogenic TMP-tag as a robust cellular reagent for live cell 
imaging. 
2.3.7 Synthesis And Characterization Of TMP-Q-Fluorescein 
Importantly, while this initial report focuses on TMP-Q-Atto520, the fluorogenic 




readily introduced.  Thus, to verify the modularity of the fluorogenic design, we also 
synthesized a TMP-Q-fluorescein tag that is identical to TMP-Q-Atto520, just with a 
different fluorophore (Scheme 2-3). 
 
Scheme 2-3 Synthesis of TMP-Q-fluorescein. 
Reaction conditions: a. EDCI, HOBt, DIEA, DMF, RT, 16 h; b. CuSO4·5H2O, DMF, RT, 24 h. 
We characterized the TMP-Q-fluorescein in vitro following all of the assays 
described above. As expected, the TMP-Q-fluorescein also demonstrated specific and 
rapid labeling, in this case with > 50 fold fluorescence enhancement – the background 






Figure 2-14 Screening of the eDHFR:Cys variant library with TMP-Q-fluorescein. 
Purified eDHFR:Cys variants at a concentration of 1 µM were incubated with 1 µM TMP-Q-
fluorescein under the same condition as in Figure 2-4.   Fluorescence intensity was measured at 
various time points. As controls, the eDHFR-2C variant that lacks Cys and the buffer without 
eDHFR induced little increase in fluorescence intensity. 
 




Purified eDHFR:P25C at 1 µM concentration was labeled with 1 µM TMP-Q-fluorescein under the 
same condition as in Figure 2-4. The fluorescence spectrum showed > 50 fold enhancement 
compared to the control group in which 1 µM TMP-Q-fluorescein was incubated with the buffer 
without eDHFR:P25C.  
Interestingly, the reactivity of TMP-Q-fluorescein with the eDHFR:Cys variants 
was distinct compared to TMP-Q-Atto520. In brief, the TMP-Q-fluorescein labeled 
eDHFR:P25C faster than all other mutants, followed by eDHFR:L28C, and the reaction 
half time was estimated to be ~ 50 min with eDHFR:P25C and ~ 150 min with 
eDHFR:L28C – slower than for TMP-Q-Atto520 (Figure 2-16). One explanation for this 
difference in reactivity is that the proximity-induced reaction is affected by electrostatic 
interactions between the fluorophore and eDHFR — fluorescein is negatively charged 
while Atto520 is positively charged at physiological pH. 
 
Figure 2-16 Gel shift assay of TMP-Q-fluorescein. 
In the same buffer as in Figure 2-4, 2 µM of eDHFR:P25C or eDHFR:L28C was incubated with 10 
µM TMP-Q-fluorescein at 37 °C. At various time points, aliquots were quenched with 6X SDS.  
The reaction was analyzed by SDS-PAGE followed by Coomassie staining, and it was 
determined that 50% labeling occurs in approximately 50 minutes with eDHFR:P25C and 150 min 




Notably, the TMP-Q-fluorescein also enabled nuclear and plasma membrane-
localized eDHFR to be labeled in live HEK 293T cells with high efficiency and 
specificity (Figure 2-17), although its applications in live cell imaging of diffused 
cytosolic proteins were limited by the modest cell permeability of the negatively charged 
fluorescein. Together these results confirm that our fluorogenic design is modular and 
can be readily adapted to new fluorophores with diverse chemical properties.  
 
Figure 2-17 Live cell imaging using TMP-Q-fluorescein. 
HEK 293T cells were transiently transfected with plasmid encoding H2B-eDHFR:L28C (A) and 
plasma membrane localization sequence (PM)-eDHFR:L28C (B), respectively, and labeled with 
10 µM TMP-Q-fluorescein for 3 h. Live cell imaging was achieved using confocal microscope, 
displaying the specific labeling of cell nucleus (A) and plasma membrane (B), respectively. For 
PM labeling, the cells were co-transfected with H2B-mCherry as transfection indicator. (C) As 




showing very weak background fluorescence. For comparison, images in A and C were obtained 
using the same microscope setup with excitation at 488 nm. Black bars: 50 µm. 
2.4 Discussion 
Together these results establish that TMP-Q-Atto520 is a viable fluorogenic 
chemical tag for live cell imaging with high S/B. The in vitro labeling reaction is rapid 
(t1/2 ~ 10 min) and efficient even in the presence of high concentrations of thiol species. 
The proximity-induced quencher displacement yields a 20 fold fluorescence enhancement 
for TMP-Q-Atto520, which means 20 fold increase in S/B compared to the non-
fluorogenic TMP-tag. Perhaps most significantly, TMP-Q-Atto520 is sufficiently reactive 
and selective to enable live cell imaging with high S/B, labeling not only nuclear 
localized H2B, but also diffuse cytosolic proteins involved in cell motility.  
We envision that the fluorogenic TMP-tag will be a valuable tool for SM imaging. 
TMP- tag is an attractive chemical tag because eDHFR is a small (18 kD), monomeric 
protein and TMP analogs are readily cell-permeable, straightforward to synthesize, and 
show no apparent cross-reactivity or toxicity in mammalian cells. Working with 
collaborators we have begun to tackle sophisticated biophysical experiments in live cells, 
including SM analysis of spliceosome assembly in yeast cell extracts and the molecular 
mechanism of mechanical sensing in live mammalian cells.13,37 These SM studies will 
significantly benefit from the improvement in S/B brought by the fluorogenic TMP-tag.  
The fluorogenic TMP-tag features a modular design that can be readily adapted to 
new fluorophores spanning the whole visible-infra red spectral region. To date, reported 
fluorogenic probes based on solvatochromes, molecular rotors and PeT mostly hinge on 




challenging to generalize the fluorogenic design to new fluorophores at different 
wavelengths, especially those with high photon outputs and the desired photo-physical 
properties for high-resolution imaging.  In contrast, the cleavable quencher strategy is 
more generalizable.  Fluorogenic chemical tags based on cleavable quenchers have been 
reported recently for SNAP-tag and a β-lactamase tag, although these were mainly used 
to label cell surface or nuclear localized proteins.39-42  With a fluorogenic TMP-tag based 
on a cleavable quencher that works inside cells, we should be in place to build a series of 
fluorogenic TMP-tags using different fluorophores for multi-color SM imaging. 
The fluorogenic design minimizes non-specific background staining of cellular 
compartments often observed for the highly charged, high photon-output fluorophores.  
On its own TMP-Atto520, like many high photon output fluorophores, has a delocalized 
positive charge on the fluorophore, rendering the tag readily cell permeable but prone to 
aggregation and non-specific staining of mitochondria. The fluorogenic design suppresses 
the background fluorescence from unbound and non-specifically bound TMP-Atto520, 
making TMP-Q-Atto520 a viable reagent for live cell imaging.  Going forward, we are 
exploring the potential of this fluorogenic design to make other high photon output 
fluorophores that also suffer from non-specific staining of cellular compartments, such as 
the cyanine and oxazine-based fluorophores, viable reagents for SM imaging in live cells. 
Furthermore, the elegance of the proximity-induced reactivity strategy is that it 
can be easily extended to converting other high affinity ligand/receptor pairs into new 
chemical tags that are orthogonal to the fluorogenic TMP-tag. For the fluorogenic TMP-
tag, the remarkable selectivity is guaranteed by high affinity enzyme/inhibitor recognition; 




protein Cys nucleophile and mild ligand electrophile (tosylate). Using similar approaches, 
the vast pool of drug/receptor pairs could be potentially utilized to build a toolbox for 
multi-color SM imaging in live cells, to provide insight into the molecular mechanism of 
complex biological pathways.  
Finally, the implementation of fluorogenic TMP-tag for live cell imaging further 
validates the proximity-induced reaction as a viable strategy to develop chemical tools for 
probing and manipulating live cells. We have previously engineered the covalent TMP-
tag based on proximity-induced Michael addition, enabling high resolution live cell 
imaging of a variety of target proteins with modular organic fluorophores . Now we 
introduce the SN2 reaction – another type of classic reaction in organic synthesis – as a 
modular tool for site-specific modification of various intracellular biomolecules. 
Together this work shows that organic chemistry can be added to the arsenal of tools 
available for synthetic biology and cell engineering, as it has thrived in the field of 
protein and nucleic acid engineering. 
2.5 Conclusion 
Here we successfully developed a fluorogenic TMP-tag that is sufficiently 
reactive and selective to enable live cell imaging of intracellular proteins with high S/B. 
Remarkably, TMP-Q-Atto520 was shown to be readily cell permeable and well-behaved 
in live cells, such that not only localized but also diffuse cytosolic proteins can be labeled 
via a straightforward staining procedure. The highly modular design of our fluorogenic 
TMP-tag should allow it to be readily generalized to new chemical tags with different 
fluorophores and orthogonal ligand/receptor pairs. Using this strategy we envision 




live cells, which will greatly impact the field of biophysics and cell biology. Just as 
chemical methods for selectively labeling proteins in the test tube deeply impacted in 
vitro biophysics in the last century, chemical tag technologies have the potential to enable 
organic chemistry to provide the breakthrough needed to meet this century’s challenge of 
understanding multi-component biological pathways in the living cell. 
2.6 Experimental Methods 
2.6.1 Synthesis of TMP-Q-Atto520 
2.6.1.1 General Methods 
Unless otherwise noted, reagents and solvents were obtained from Aldrich and 
were used without further purification. Anhydrous N,N-dimethylformamide (DMF) was 
from Sure SealTM bottles purchased from Aldrich. N-(3-aminopropyl)-N-methylaniline 
and 3-(chlorosulfonyl)benzoyl chloride are purchased form Tokyo Chemical Industry 
(TCI) Co., Ltd.  N-Boc-propargylglycine is purchased from Chem-Impex International, 
Inc. Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 400 (400 
MHz) or Bruker 300 (300 MHz) Fourier Transform (FT) NMR spectrometers at 
Columbia University, Chemistry Department. 1H NMR spectra are tabulated in the 
following order: multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; p, pentet; m, 
multiplet; br, broad), number of protons. Fast Atom Bombardment (FAB) high resolution 
mass spectra (HRMS) were recorded on a JMS-HX110A mass spectrometer, and low 





2.6.1.2 Synthesis of compound 2-1 
A round bottom flask containing 48% aqueous hydrobromic acid (250 mL) was 
heated to 100 ˚C.  Trimethoprim (25.0 g, 86 mmol) was suspended and stirred for 20 
minutes.  The flask was removed from the oil bath and 50% (v/w) sodium hydroxide in 
water (75 mL) was added.  The reaction mixture was then cooled to room temperature 
and the resulting crystals were filtered and rinsed with cold water.  The crystals were then 
dissolved in hot water (350 mL), neutralized with aqueous NH4OH and allowed to 
crystallize.  The crystals were filtered, rinsed with cold water, and dried under vacuum to 
produce 15.9 g (67% yield) compound 2-1.  1H NMR (400 MHz, CD3OD)  ppm: 7.18 (s, 
1H), 6.53 (s, 2H), 3.81 (s, 6H), 3.62 (s, 2H). 13C NMR (400 MHz, CD3OD)  ppm: 
163.45, 156.58, 148.88, 135.25, 130.78, 107.16, 106.90, 56.50, 33.98. HRMS (FAB+) 
m/z Calcd. for C13H16O3N4 [M+H]+:277.1222. Found:277.1312. 
2.6.1.3 Synthesis of compound 2-2 and 2-3 
Compound 2-1 (600 mg, 2.16 mmol), tert-butyl N-(3-iodopropyl)carbamate (618 
mg, 2.16 mmol) and cesium carbonate (1.41 g, 4.32 mmol) were dissolved in anhydrous 
DMF (30 mL). The reaction was allowed to stand at 70 °C for 7 h, followed by the 
removal of solvent in vacuo. The crude mixture was purified by column chromatography 
with silica gel (1:9 methanol:DCM) to yield TMP-C3-NHBoc 2-2 (Rf = 0.3 in 1:9 
methanol:DCM), which was subsequently deprotected by directly dissolving in 10 mL 
trifluoroacetic acid (TFA) while stirring. After 4 h, the TFA was removed in vacuo to 
yield compound 2-3 in the form of its TFA salt (715 mg, 1.66 mmol, 77% yield in two 
steps) as colorless solid. Rf = 0.02 in 1:9 methonal:DCM. 1H NMR (400 MHz, CD3OD) 




3.30 (t, J = 6.0 Hz, 2 H); 2.08 (m, 2 H). 13C NMR (400 MHz, CD3OD)  ppm: 164.45, 
163.25, 155.96, 154.71, 136.84, 136.04, 108.03, 106.63, 74.31, 56.52, 41.95, 34.50, 30.95. 
HRMS (FAB+) m/z Calcd. for C16H24O3N5 [M+H]+: 334.1879. Found: 334.1883. 
2.6.1.4 Synthesis of compound 2-4 and 2-5 
N,N-Diisopropylethylamine (DIEA, 871 μL, 4 mmol)  was added dropwise to a 
solution of compound S1 (192 mg, 0.4 mmol, in the form of TFA salt), N-Boc-
propargylglycine (85.3 mg, 0.4 mmol), hydroxybenzotriazole (HOBt, 16.2 mg, 0.12 
mmol) and 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCl, 230 mg, 1.2 mmol) 
in 3 mL anhydrous DMF at RT. The reaction was stirred under Ar for 12 h at RT and 
then concentrated. The mixture was then purified by silica gel flash chromatography (1:6 
methanol:DCM) yielding the coupling product 2-4 (Rf = 0.45 in 1:6 methanol:DCM), 
which was subsequently dissolved in 20 mL TFA-DCM (1:1, v/v) and stirred for 4 h at 
RT. The solvent was removed in vacuo to yield compound 2-5 (TFA salt, 140 mg, 257 
μmol, 64% yield in two steps) as a colorless solid. Rf = 0.05 in 1:6 methonal:DCM. 
Compound 2-4 1H NMR (400 MHz, CDCl3) δ ppm: 7.66 (s, 1H), 6.39 (s, 2H), 5.43 (d, J 
= 8 Hz, 1H), 5.06 (s, 1H), 4.29 (q, J = 8, 6.5 Hz, 1H), 4.03 (m, 2H), 3.80 (s, 6H), 3.64 (S, 
2H), 3.53 (m, 2H), 2.74 (d, J = 17.1 Hz, 1H), 2.59 (m, 1H), 1.99 (m, 2H), 1.91 (m, 2H), 
1.37 (s, 9H). 13C NMR (400 MHz, CD3OD)  ppm: 168.60, 166.25, 162.98, 155.08, 
153.89, 140.44, 133.94, 111.02, 107.29, 77.33, 74.97, 72.22, 56.68, 53.05, 38.49, 30.79, 
25.46, 22.43. Compound 2-5 HRMS (FAB+) m/z Calcd. for C21H28O4N6 




2.6.1.5 Synthesis of compound 2-6 
DIEA (15 μL, 89 µmol) was added to a solution of compound 2-5 (7 mg, 13 μmol) 
and Atto520-NHS ester (5.0 mg, 8.9 μmol) in 0.5 mL anhydrous DMF. The mixture was 
stirred under Ar at RT for 12 h before concentrated. Reaction residue was purified by 
reverse phase HPLC to yield compound 2-6 (TFA salt, 6 mg, 6.7 μmol, 76% yield). 
HPLC condition: start with 10:90 acetonitrile:water, gradient elution for 80 min, end with 
60:40 acetonitrile:water. Retention time: 40–41 min. 1H NMR (400 MHz, CD3OD) δ ppm: 
7.91 (s, 2H), 7.23 (s, 1H), 6.85 (s, 2H), 6.56 (s, 2H), 4.40 (dd, J = 7.2, 4.8 Hz, 1H), 3.98 (t, 
J = 5.9 Hz, 2H), 3.81 (s, 6H), 3.73 (m, 2H), 3.65 (s, 2H), 3.52 (q, J = 7.2 Hz, 6H), 3.22 
(m, 2H), 2.87 (s, 1H), 2.67 (m, 2H), 2.52 (m, 2H), 2.35 (s, 6H), 2.30 (m, 1H), 1.87 (p, J = 
6.3 Hz, 2H), 1.33 (m, 6H). HRMS (FAB+) m/z Calcd. for C43H53O8N8 M+:777.41. Found: 
777.41. 
2.6.1.6 Synthesis of compound 2-7 
N-(3-aminopropyl)-N-methylaniline (1 mL, 6.09 mmol) was dissolved in 10 mL 
DCM. Then DIEA (2.1 mL, 12.18 mmol) and Di-tert-butyl dicarbonate (7 mL, 30.45 
mmol) were added to the solution and the reaction was stirred under Ar for 20 minutes. 
Then the solvent was removed in vacuo and the product was purified by column 
chromatography on silica gel (1:5 EtOAc:hexane) to yield compound 2-7 (1.6 g, 6.05 
mmol, 99% yield) as colorless oil. Rf = 0.35 in 1:5 EtOAc:hexane. 1H NMR (400 MHz, 
CDCl3) δ ppm: 7.23 (m, 2H), 6.70 (m, 3H), 4.56 (s, 1H), 3.40 – 3.32 (t, J = 7.2 Hz, 2H), 
3.17 (q, J = 6.8 Hz, 2H), 2.92 (s, 3H), 1.77 (p, J = 7.0 Hz, 2H), 1.45 (s, 9H). 13C NMR 




38.69, 28.53, 27.41. HRMS (FAB+) m/z Calcd. for C15H24O2N2 [M]+:264.1838. Found: 
264.1826. 
2.6.1.7 Synthesis of compound 2-8 and 2-9 
Fast Corinth V Salt (472 mg, dye content 90%, 1.02 mmol) was disolved in 8 mL 
water and chilled to 0 °C in ice bath. Compound 7 (600 mg, 2.27 mmol) was dissolved in 
8 mL methanol and 6 mL 5% NaHCO3 aqueous solution, and then added dropwise to the 
Fast Corinth V Salt solution. The reaction mixture was stirred in ice bath for 2 h during 
which the color changed from orange to dark red. The crude product was filtered and 
washed with 3 X 10 mL of cold water and then dried in vacuo. The product was purified 
by column chromatography on silica gel (4:6 EtOAc:hexane) to yield compound 2-8 as 
dark red solid. Compound 2-8 was subsequently deprotected by dissolving in 10 ml 30% 
TFA in DCM (v/v) and stirring for 1 h; the color changes from red to dark blue. Then the 
product was obtained by removing solvent in vacuo, yielding compound 2-9 (TFA salt, 
360 mg, 0.61 mmol, 60% yield in 2 steps) as dark purple solid. Rf = 0.3 in 1:2 
EtOAc:hexane. Compound 2-8 1H NMR (400 MHz, CDCl3) δ ppm: 7.91 (m, 2H), 7.77 (s, 
1H), 7.66 (d, J = 8.0 Hz, 2H), 7.58 (s, 1H), 7.47 (m, 2H), 7.40 (s, 1H), 6.4 (m, 2H), 4.57 
(s, 1H), 4.02 (s, 3H), 3.49 (t, J = 7.3 Hz, 2H), 3.20 (q, J = 6.7 Hz, 2H), 3.08 (s, 3H), 2.70 
(s, 3H), 2.51 (s, 3H), 1.84 (p, J = 7.1 Hz, 2H), 1.46 (s, 9H). Compound 2-9 HRMS 
(FAB+) m/z Calcd. for C25H29O3N7 [M+H]+:476.2332. Found: 476.2408. 
2.6.1.8 Synthesis of compound 2-10 
Compound 2-9 (TFA salt, 100 mg, 0.173 mmol) was dissolved in anhydrous 
DCM and chilled to 0 °C in ice bath. Then 3-(chlorosulfonyl)benzoyl chloride (55 µL, 




mmol). The reaction mixture was stirred in ice bath under Ar for 15 min, and then 
warmed to RT and stirred for 1 h. The crude product was collected by evaporating the 
solvent, and was subsequently purified by column chromatography on silica gel (7:3 
EtOAc:hexane), yielding compound 2-10 (99 mg, 0.145 mmol, 84% yield) as dark red 
solid. Rf = 0.42 in 2:1 EtOAc:hexane. 1H NMR (400 MHz, CDCl3) δ ppm: 8.38 (t, J = 
1.8 Hz, 1H), 8.16 (ddd, J = 8.0, 2.0, 1.1 Hz, 1H), 8.10 (dt, J = 8.0, 1.4 Hz, 1H), 7.91 (m, 
2H), 7.70 (m, 2H), 7.66 (d, J = 8.2 Hz, 1H), 7.6 (s, 1H), 7.47 (ddd, J = 8.1, 1.8, 0.9 Hz, 
1H), 7.39 (s, 1H), 6.78 (d, J = 8.8 Hz, 2H), 4.01 (s, 3H), 3.59 (m, 4H), 3.10 (s, 3H), 2.70 
(s, 3H), 2.51 (s, 3H), 2.03 (p, J = 7.2 Hz, 3H). MS (FAB+) m/z Calcd. for 
C32H32ClO6N7S [M+H]+:678.18. Found: 660.27 (hydrolysis product). 
2.6.1.9 Synthesis of compound 2-11 
Compound 2-10 (99 mg, 0.146 mmol)  and DMAP (18 mg, 0.164 mmol) was 
dissolved in 2 mL anhydrous DCM. Then 2-azidoethanol (25 µL, 0.292 mmol) and DIEA 
(128 µL, 0.73 mmol) were added and the reaction mixture was stirred under Ar at RT for 
4 h. After removing the solvent in vacuo, the product was purified by column 
chromatography on silica gel (100% EtOAc), yielding compound 2-11 (65 mg, 89 µmol, 
61% yield) as dark red solid. Rf = 0.58 in 100% EtOAc. 1H NMR (400 MHz, CDCl3) δ 
ppm: 8.30 (s, 1H), 8.11 (m, 1H), 8.07 (m, 1H), 7.93 (m, 3H), 7.71 (m, 2H), 7.66 (m, 2H), 
7.58 (s, 1H), 7.48 (m, 1H), 7.39 (s, 1H), 4.24 (t, J = 4.8 Hz, 2H), 4.02 (s, 3H), 3.78 (t, J = 
5.0 Hz, 1H), 3.59 (m, 4H), 3.50 (t, J = 4.8 Hz, 2H), 3.12 (s, 3H), 2.70 (s, 3H), 2.52 (s, 
3H), 2.02 (m, 2H). 13C NMR (400 MHz, CDCl3) δ ppm: 165.58, 158.31, 156.70, 147.80, 




119.28, 119.12, 100.24, 100.13, 68.99, 59.79, 58.13, 56.56, 49.81, 29.85, 21.50, 16.84. 
HRMS (FAB+) m/z Calcd. for C34H36O7N10S [M+H]+:729.2489. Found: 729.2531. 
2.6.1.10 Synthesis of compound 2-12 
Compound 2-6 (TFA salt, 6 mg, 6.7 μmol) and compound 2-11 (9 mg, 12.3 μmol) 
were transferred to the same vial and dissolved in 0.2 mL DMF.  Then ascorbic acid 
(0.68 mg, 3.86 μmol) and CuSO4·5H2O (0.19 mg, 0.771 μmol) were added and the 
reaction mixture was stirred under Ar at RT for 24 h. After removing the solvent in vacuo, 
the product was purified by HPLC to yield compound 2-12 (1.3 mg, 0.86 μmol, 11% 
yield) as dark purple solid. HPLC condition: start with 30:70 acetonitrile:water, gradient 
elution for 80 min, end with 80:20 acetonitrile:water. Retention time: 49-51 min. Rf = 
0.72 in 1:4 methanol:DCM with 0.5% acetic acid (v/v). 1H NMR (400 MHz, CD3OD) δ 
ppm: 8.86 (t, J = 5.7 Hz, 1H), 8.24 – 8.14 (m, 3H), 8.05 (t, J = 5.6 Hz, 1H), 7.93 (m, 1H), 
7.79 (dd, J = 1.8, 0.9 Hz, 1H), 7.73 – 7.58 (m, 7H), 7.28 (d, J = 0.8 Hz, 1H), 7.22 (d, J = 
1.1 Hz, 1H), 7.17 (s, 1H), 6.61 (s, 2H), 6.56 (s, 2H), 4.66 – 4.56 (m, 3H), 4.50 (m, 2H), 
3.92 (m, 2H), 3.86 (s, 3H), 3.80 (s, 6H), 3.63 (s, 2H), 3.62 – 3.56 (m, 3H), 3.55 – 3.50 (m, 
2H), 3.38 (q, J = 7.2 Hz, 4H), 3.33 (d, J = 1.6 Hz, 2H), 3.11 (s, 3H), 3.06 (dd, J = 14.9, 
5.7 Hz, 1H), 2.90 (dd, J = 14.9, 8.3 Hz, 1H), 2.57 (s, 3H), 2.54 (s, 3H), 2.18 (s, 6H), 2.01 
(m, 2H), 1.82 (m, 2H), 1.29 (t, J = 7.2 Hz, 6H). MS (ESI) m/z Calcd. for C77H89O13N18S 
[M]+:1505.66. Found: 1506.5. 
The TMP-Q-Atto520 was dissolved in anhydrous DMF and the stock solution can 
be stored at -80 °C for long-term (> 18 months) or -20 °C for short-term (up to 6 months) 




Q-Atto520 stock solution, warm up the container to room temperature before opening the 
vial. Do not store the compound in aqueous solution. 
2.6.2 Engineering of the eDHFR:Cys variant library 
2.6.2.1 Molecular design 
Using the model described in Figure 2-3, an approximation was made of the 
minimum linker length between TMP and the electrophile that would allow proximity-
induced SN2 reaction to occur upon binding to a mutant eDHFR containing each of these 
Cys mutants (Table 2-1). The minimum length was approximated as the arc, L = 
πRθ/180°, where R is the radius of gyration and θ is the angle between the 4’-OH and the 
β-atom of each selected residue, using the center of mass of eDHFR as the vertex. 
Table 2-1 Estimation of the Minimum Linker Length for Proximity-Induced Covalent 
Labeling. 
Residue  Angle θ  Radius R (Å)  Length L (Å) 
Glu17  50.8°  15.2  13.47 
Asn18  47.8°  15.2  12.68 
Ala19  38.7°  15.2  10.27 
Met20  33.7°  15.2  8.94 
Pro21  46.7°  17.2  14.01 
Asn23  30.8°  15.2  8.18 
Pro25  28.6°  15.2  7.59 
Leu28  35.6°  15.2  9.45 
Ala29  55.9°  15.2  14.82 
Lys32  54.8°  15.2  14.53 
Ser49  33.0°  15.2  8.75 
Ile50  29.3°  15.2  7.77 
Gly51  29.0°  17.3  8.75 
Arg52  35.9°  15.2  9.51 
Leu54  45.6°  15.2  12.10 





2.6.2.2 Site-Directed Mutagenesis 
Genes encoding eDHFR variants were produced using Strategene’s QuikChange 
Mutagenesis Kit. The parent vector was the previously published p2247 (eDHFR C85S 
and C152S in pAED4), encoding eDHFR-2C. 16 individual rounds of mutagenesis 
yielded 16 eDHFR variants with additional Cys mutations: E17C, N18C, A19C, M20C, 
P21C, N23C, P25C, L28C, A29C, K32C, S49C, I50C, P51C, R52C, L54C, P55C, 
respectively.  The forward primers for site-directed mutagenesis to generate 16 
eDHFR:Cys mutants are listed in Table 2-2. The reverser primers are anti-parallel 
(reverse complementary) to the forward primers. 


















2.6.2.3 Protein purification 
The resulting eDHFR:Cys plasmid was expressed in BL21(DE3)pLysS cells 




0.4 mM IPTG for three hours and purified using nickel-NTA spin columns (Qiagen). All 
16 recombinant eDHFR:Cys variants were judged to be >95% pure by Coomassie 
staining of a SDS-PAGE gel. The protein was dialyzed three times in phosphate buffered 
saline (PBS) at 4 ˚C, snap frozen and stored at –80 ˚C. 
2.6.3 In vitro characterization of fluorogenic TMP-tags 
2.6.3.1 In vitro fluorometric measurement 
Purified eDHFR:Cys variants at a concentration of 1 µM were incubated with 1 
µM TMP-Q-Atto520 in PBS with 100 µM NADPH and 1 mM glutathione at 37 ˚C.   
Fluorescence intensity was measured at various time points in a 96-well plate using a 
Tecan Infinite® M200 fluorometer, excited at 520 nm (bandwidth 9 nm) and emission 
collected at 550 nm (bandwidth 20 nm). To take fluorescence spectra, eDHFR:L28C (1 
µM) was incubated with TMP-Q-Atto520 (1 µM) at 37 ˚C for 3 h. For emission spectrum, 
the excitation wavelength was 488 nm. For excitation spectrum (Supporting Information 
Figure S4), the emission wavelength was 580 nm. 
2.6.3.2 In vitro alkylation reactions 
Purified eDHFR:L28C (2 µM) was incubated with TMP-Q-Atto520 (10 µM) in 
PBS with reduced 100 µM NADPH and glutathione (1 mM) at 37 ˚C.  At selected time 
points, aliquots (30 µL) were removed from the reaction mixture, quenched with 6X SDS.  
Samples from the in vitro alkylation experiments were run on Criterion 15% Tris-HCl 
gels (BioRad) for 55 min at 200 V. Bands were quantified by densitometry analysis of 




fluorescence scanning using a Typhoon Trio scanner excited by the 488 nm laser and 
an emission filter of 520 (BP 40) nm. 
2.6.3.3 MALDI-TOF and LC-MS/MS Analysis 
MALDI-TOF analysis was performed to further confirm that eDHFR:L28C was 
covalently labeled by fluorogenic TMP-tag. MALDI-TOF analysis was carried out on an 
AB Sciex Voyager DE Pro MALDI mass spectrometer with the following instrument 
parameters: accelerating voltage, 25,000 V; grid voltage, 93%; guide wire 0.15%; 
extraction delay time, 200 ns; laser intensity 2100 - 2200.  The MH+ and M2H2+ ions of 
myoglobin were used for internal two-point calibration. Matrix solution for intact protein 
analysis was prepared by dissolving sinapinic acid in 50% acetonitrile/0.1% TFA (v/v) at 
a concentration of 10 mg/mL. A 1 µL aliquot of unlabeled protein (0.21 mM in PBS) was 
mixed with 5 µL of matrix and 0.6 µL was spotted onto a sample plate and allowed to dry. 
When the spot was dry, it was washed with 2 µL of water and dried again. A calibration 
standard of 130 fmol myoglobin in sinapinic acid matrix was applied on top of the 
protein spot and allowed to dry completely. The same procedure was followed for the 
TMP-Q-fluorescein labeled protein: 1 µL (0.07 mM in PBS) was mixed with 5 µL of 
matrix solution and spotted on the sample plate. The spot was dried and washed, dried 
again and spotted on top with the myoglobin standard solution. 
The labeling residue was identified by chymotrypsin digestion followed by LC-
MS/MS. For chymotrypsin digestion, eDHFR:L28C labeled with TMP-Q-fluorescein was 
first purified by SDS-PAGE and gel bands were transferred to a clean tube and 100 µL 
0.01 M DTT/0.1 M Tris, pH 8.5 was added. The tube was placed in a heating block at 55° 




replaced with 100 µL 0.015 M iodoacetamide/0.1 M Tris, pH 8.5.  This was allowed to 
react for 30 min. in the dark after which the liquid was removed and the gel was washed 
as described below. The gel was prepared for digestion by washing once with 200 µL 
0.05 M Tris, pH 8.5/25% acetonitrile (v/v) and twice with 200 µL 0.05 M Tris, pH 8.5/50% 
acetonitrile (v/v) for 20 min. with shaking.  After removing the washes, the gel piece was 
dried for 30 min in a Speed-Vac concentrator.  
In-gel digestion was carried out by adding 0.1 µg chymotrypsin (sequencing 
grade, Roche Molecular Biochemicals) in 15 µL 0.025 M Tris, pH 8.5. The tube was 
placed in a heating block at 32° and left overnight. Peptides were extracted with 2X 50 
µL 50% acetonitrile/2% TFA (v/v) and the combined extracts were dried in a Speed-vac 
concentrator then re-dissolved in 20 µL 0.2% formic acid (v/v). 
LC-MS/MS analysis was carried out on a Waters Q-Tof Ultima hybrid 
quadrupole/time-of-flight mass spectrometer with a nanoelectrospray source. Capillary 
voltage was set at 1.8 kV and cone voltage 32 V; collision energy was set according to 
mass and charge of the ion, from 14 eV to 50 eV. Chromatography was performed on an 
LC Packings HPLC with a C18 Inertsil column (75 µm x 15 cm) using a linear 
acetonitrile gradient with flow rate of 200 nL/min. The molecular mass spectrum of the 
labeled peptide was created from the raw MS/MS spectrum using the MaxEnt 3 program 
in the Waters MassLynx software suite. 
Sequence of recombinant eDHFR:L28C: 
1MISLIAALAV    11DRVIGMENAM    21PWNLPADCAW    31FKRNTLNKPV    41IMGRHTWESI  




101EQFLPKAQKL  111YLTHIDAEVE  121GDTHFPDYEP  131DDWESVFSEF  141HDADAQNSHS 
151YCFEILERRH 161HHHHH 
Chymotrypsin cleaves the C-terminus of large hydrophobic residues 
(Tyr/Phe/Trp-Xaa), indicated by red letters. L28C mutation is highlighted as bold and 
underlined letter. 
2.6.3.4 In Vitro Labeling Kinetics 
Hypothesized mechanism for the proximity-induced SN2 reaction: 
 
Derive the rate equation using steady-state hypothesis: 
ࢊሾࡾࡸሿ
ࢊ࢚ ൌ ࢑૚ሾࡾሿሾࡸሿ െ ࢑૛ሾࡾࡸሿ െ ࢑૜ሾࡾࡸሿ ൌ ૙            Equation 2-1 
ሾࡾࡸሿ ൌ ࢑૚ሾࡾሿሾࡸሿ࢑૛ା࢑૜                   Equation 2-2 
The reaction rate: 
 ࢘ ൌ െࢊሾࡾሿࢊ࢚ ൌ
ࢊሾࡼሿ
ࢊ࢚ ൌ ࢑૛ሾࡾࡸሿ ൌ
࢑૚࢑૛ሾࡾሿሾࡸሿ
࢑૛ା࢑૜ ൌ ࢑ࢇ࢖࢖ሾࡾሿሾࡸሿ        Equation 2-3 
In which ݇௔௣௣ ൌ ௞భ௞మ௞మା௞య. 
Initial concentration: ሾܴሿ଴ ൌ ሾܮሿ଴ ൌ 1.0 ൈ 10ିହ	M; 
Therefore during the reaction at any given time: ሾܴሿ ൌ ሾܮሿ; 
Which is plugged into Equation 2-3 to get: 
 െࢊሾࡾሿࢊ࢚ ൌ ࢑ࢇ࢖࢖ሾࡾሿ૛                Equation 2-4 






ሾࡾሿ૙ ൅ ࢑ࢇ࢖࢖࢚        Equation 2-5 
In gel-shift assay, [R] is determined as: 
 ሾࡾሿ ൌ ሾࡾሿ૙ ࡵ࢛࢖࢖ࢋ࢘ࡵ࢛࢖࢖ࢋ࢘ାࡵ࢒࢕࢝ࢋ࢘                Equation 2-6 
In which Iupper and Ilower represents the intensity of the upper and lower bands, 
respectively. 
Linear regression of ଵሾ௘஽ுிோ:௅ଶ଼஼ሿ versus time should result in kapp as the slope. 
Figure 2-18 shows the gel-shift assay and linear regression to determine kapp. I 
also tried to fit the kinetic curve based on a first-order reaction hypothesis. However, the 
R2 was found to be 0.84, implying that the first-order reaction mechanism does not 
appropriately describe the nature of the reaction kinetics. 
 
Figure 2-18 In vitro labeling kinetics of fluorogenic TMP-tag. 
 (A) The gel-shift assay was performed using 10 µM TMP-Q-Atto520 and 10 µM eDHFR:L28C in 
the same buffer as in figure S3. (B) (C) Density of bands were quantified by ImageJ and fitted to 




2.6.4 Live Cell Imaging 
2.6.4.1 Construction of eDHFR:L28C fusion proteins 
The plasmid encoding H2B-mCherry was purchased from Addgene (plasmid 
20972).  
Construction of H2B-eDHFR:L28C: The gene encoding eDHFR was amplified 
using PCR from the previously published V1008 vector8 with primers pDHFR-AgeI: 5’- 
ACG TCA CCG GTC GCC ACC ATG GTG GGT TCT GGT GGT TCT GGT ATC 
AGT CTG ATT GCG GCG -3’ (AgeI, coding strand) and pDHFR-NotI 5’-ACG TCG 
CGG CCG CTT TAG TGA TGG TGA TGG TGA TGC CGC CGC TCC AGA ATC T -
3’ (NotI, noncoding strand). The fragment was then inserted between the AgeI and NotI 
sites of vector encoding H2B-EGFP (Addgene p11680) replacing the EGFP gene. The 
resulting vector (V2606) encoding H2B-eDHFR was then subject to site-directed 
mutagenesis (SDM) using the primers listed in Table 2-2 to give H2B-eDHFR:L28C 
(V2607). The resulting coding region was sequenced in full. 
Construction of TOMM20-eDHFR:L28C: The parent vector pSNAP-Cox8A 
was purchased from New England Biolab. The gene of eDHFR was amplified from 
V1008 using primers pDHFR-EcoRV: 5’ -GCA TAC GTC GAT ATC AAG CTT ACC 
ATG ATC AGT CTG ATT GCG G -3’ (EcoRV, coding strand) and pDHFR-XhoI: 5’-
GCA TAC GTC CTC GAG TTA CCG CCG CTC CAG AA - 3’ (XhoI, noncoding 
strand), and then inserted between the EcoRV and XhoI sites of pSNAP-Cox8A, creating 
V2492. Human Tomm20 gene (Invitrogen) was amplified with primers pTOMM20-ClaI: 
5’ -GTC GAC ATC GAT ATG GTG GGT CGG AAC AG -3’ (ClaI, coding strand) and 




noncoding strand), and then inserted between the ClaI and EcoRV sites of V2492 to give 
V2605 encoding TOMM20-eDHFR. Subsequent SDM on V2605 yielded TOMM20-
eDHFR:L28C (V2608). The mutagenesis primers were the same as for H2B-
eDHFR:L28C. 
Construction of MLC-eDHFR:L28C: The parent vector encoding MLC-eDHFR 
was previously published.37 The eDHFR gene in this vector was changed to 
eDHFR:L28C  by SDM using the same set of  mutagenesis primers as for eDHFR:L28C 
expression vector (Table 2-2). 
Construction of α-Actinin-eDHFR:L28C: Vector p2606 encoding H2B-eDHFR 
was used as the parent vector. Human α-Actinin gene (Addgene) was amplified with 
primers pActinin-SalI: 5’- CGA ATT CTG CAG TCG ACG GTA CCG CCA TGG ACC 
ATT ATG ATT CTC AGC AAA CC -3’ (SalI, coding strand) and pActinin-AgeI: 5’- 
CAT GGT GGC GAC CGG TGG ATC GAG GTC ACT CTC GCC GTA CA-3’ (AgeI, 
noncoding strand), and then inserted between the SalI and AgeI sites of V2606. The 
resulting plasmid (V2611) was subject to SDM to create α-Actinin-eDHFR:L28C vector 
(V2612). The mutagenesis primers were the same as for H2B-eDHFR:L28C. 
Construction of eDHFR:L28C-6xHis: Vector V2607 encoding H2B-
eDHFR:L28C was used as the parent vector. eDHFR:L28C gene  was amplified with 
primers pDHFR-KpnI: 5’- TAA GAC GGT ACC ATG ATC AGT CTG ATT GCG GCG 
-3’ (KpnI, coding strand) and pDHFR-NotI2: 5’-ACG TCG CGG CCG CTT TAG TGA 
TGG TGA TGG TGA TGC CGC CGC TCC AGA ATC T -3’ (NotI, noncoding strand), 
and then inserted between the KpnI and NotI sites of V2607. The resulting coding region 




2.6.4.2 Cell culture and transfection 
HEK 293T cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) 
w/ glutamine (Gibco #11995) with 10% v/v fetal bovine serum (FBS) and 1% v/v 
Pen/Strep. All cells were maintained under 5% CO2 at 37 °C. For live cell protein 
labeling, cells were plated in 8-well chambered #1 borosilicate coverglass (Thermo, Nunc 
155411) 24 h before transfected with expression plasmids for eDHFR:L28C fused target 
protein (0.4 μg DNA for one well) using Fugene HD (Roche). MEF cells were cultured in 
DMEM (Gibco #11965) with 10% v/v FBS, 1.5% v/v HEPES and 1% v/v Pen/Strep. All 
cells were maintained under 5% CO2 at 37 °C. Transient transfection of plasmids was 
performed 1 day before labeling experiment through electroporation using a Nucleofector 
(Lonza VPD-1004) kit according to the manufacturer’s protocol (MEF 1 kit and program 
T-20). 
2.6.4.3 Intracellular protein labeling 
24 h after transfection, cells were stained with TMP-Q-Atto520 in 200 µL 
supplemented DMEM media in 8-well chambered coverglass (5 μM of TMP-Q-Atto520 
for H2B labeling; 10 μM for other target proteins). Cells were incubated with this 
staining solution for 3 h at 37 °C, followed by washing with fresh media for 2 times 
before imaging or cellular analysis. 
2.6.4.4 Live cell imaging 
Confocal images were obtained using LEICA TCS SP5 confocal microscope with 
a HCX PL APO CS 20x 0.70 dry UV objective or a HCX PL APO CS 100x 1.46 oil 




collected between 520 – 580 nm; red channel was excited with a 594 nm laser and 
emission collected between 620 – 680 nm. Images were processed by LAS AF software. 
2.6.4.5 In-gel fluorescence scanning 
Cells labeled with TMP-Q-Atto520 were trypsinized and the cell density was 
determined.  The cells were then pelleted by centrifugation at 1000 rpm for 4 minutes.  
The supernatant was removed, and the pellet was washed with 1 mL of PBS/1x106 cells 
and repelleted.  Again, the supernatant was removed and the pellet was resuspended in 
lysis buffer to a concentration of 1x106 cells/12.5 µL of lysis buffer and lysed on ice for 
20 minutes.  The lysate was then centrifuged at 13,000 rpm for 10 minutes and the 
supernatant was mixed with loading buffer and heated to 95 ˚C for five minutes.  Samples 
from the live cell staining were run on Criterion 15% Tris-HCl gels (BioRad) for 1.5 
hours at 150 V.  The BenchMark Fluorescent Protein Standard from Invitrogen 
(Catalog No: LC5928) was used to determine the protein molecular weights.  The labeled 
proteins were also detected by in-gel fluorescence scanning using a Typhoon Trio 
scanner excited by the 488 nm laser and an emission filter of 520 (BP 40) nm. 
2.6.5 Synthesis of TMP-Q-fluorescein 
2.6.5.1 Synthesis of compound 2-13 
DIEA (188 μL, 1.08 mmol)  was added dropwise to a solution of compound 2-5 
(59 mg, 0.108 mmol, in the form of TFA salt), 5-carboxyfluorescein (40 mg, 0.108 
mmol), HOBt (4.4 mg, 32.4 µmol) and EDCl (62.1 mg, 0.324 mmol) in 2 mL anhydrous 
DMF at RT. The reaction was stirred under Ar for 12 h at RT and then concentrated. The 




acetic acid) and then refined by HPLC, yielding the coupling product 2-13 (16 mg, 20.3 
µmol, 19%) as orange solid. HPLC condition: start with 27:73 acetonitrile:water, gradient 
elution for 50 min, end with 60:40 acetonitrile:water. Retention time: 10–11 min. Rf = 
0.25 in 1:4 methanol:DCM with 1% acetic acid. 1H NMR (400 MHz, CDCl3) δ ppm: 8.34 
(d, J = 1.7 Hz, 1H), 8.14 (m, 1H), 7.23 (m, 2H), 6.71 (s, 2H), 6.55 (m, 4H), 6.51 (m, 2H), 
4.77 (m, 1H), 4.02 (m, 2H), 3.77 (s, 6H), 3.60 (s, 2H), 3.53 (m, 2), 2.91 (m, 1H), 2.75 (m, 
1H), 2.39 (t, J = 2.6 Hz, 1H), 1.91 (p, J = 6.3 Hz, 2H). Compound 3 MS (FAB+) m/z 
Calcd. for C42H38O10N6 [M+H]+:787.26. Found: 787.23. 
2.6.5.2 Synthesis of compound 2-14 
Compound 2-13 (10 mg, 12.7 μmol) and compound 2-11 (9.3 mg, 12.7 μmol) 
were transferred to the same vial and dissolved in 0.2 mL DMF.  Then ascorbic acid (1.1 
mg, 6.35 μmol) and CuSO4·5H2O (0.32 mg, 1.27 μmol) were added and the reaction 
mixture was stirred under Ar at RT for 24 h. After removing the solvent in vacuo, the 
product was purified by HPLC to yield compound 2-14 (4.7 mg, 3.1 μmol, 24% yield) as 
dark purple solid. HPLC condition: start with 30:70 acetonitrile:water, gradient elution 
for 80 min, end with 60:40 acetonitrile:water. Retention time: 67-68 min. Rf = 0.53 in 1:3 
methanol:DCM with 0.5% acetic acid (v/v). 1H NMR (400 MHz, CD3OD) δ ppm: 8.32 (s, 
1H), 8.12 (m, 3H), 7.87 (dt, J = 8.0, 1.4 Hz, 1H), 7.76 (m, 4H), 7.70 (d, J = 8.2 Hz, 1H), 
7.67 (t, J = 7.8 Hz, 1H), 7.58 (dd, J = 8.0, 1.6 Hz, 1H), 7.50 (s, 1H), 7.33 (s, 1H), 7.17 (m, 
2H), 6.85 (d, J = 9.0 Hz, 2H), 6.69 (d, J = 2.1 Hz, 2H), 6.57 – 6.49 (m, 4H), 6.47 (s, 2H), 
4.93 (dd, J = 9.5, 4.9 Hz, 1H), 4.63 (t, J = 4.7 Hz, 2H), 4.46 (m, 2H), 4.01 – 3.89 (m, 5H), 




3.14 (s, 3H), 2.65 (s, 3H), 2.51 (s, 3H), 2.01 (m, 2H), 1.867 (m, 2H). MS (ESI) m/z Calcd. 
for C76H74O17N16S [M+H]+:1514.51. Found: 1515.04. 
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3 Chapter 3 
Further Engineering Of Fluorogenic TMP-Tag 
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3.1 Chapter Overview 
In Chapter 2 I reported the development of the first fluorogenic TMP-tag TMP-Q-
Atto520, which has been demonstrated to enable high resolution live cell imaging with 
reduced background fluorescence. Although it was a considerable advance in the TMP-
tag technology, the TMP-Q-Atto520 showed modest labeling efficiency inside of live 
cells – 67% eDHFR:L28C labeled within 3 h. Near quantitative labeling efficiency is 
crucial for some sophisticated biological assays, eg. pulse-chase experiments. Therefore 
it is highly desired to improve the reactivity and fluorescence enhancement in the next 
generation fluorogenic TMP-tag. In this chapter I first describe several attempts to 
synthesize the second generation fluorogenic TMP-tag with a shorter, more flexible 
linker, which would potentially lead to higher reactivity. 
Additionally, after demonstrating the viability of the proximity-induced reaction 
to construct fluorogenic chemical tags, we would step forward and expand the palette of 
fluorogenic tag from green dyes (fluorescein and Atto520) to far red fluorophores. 
Specifically, we are interested in the far red dye Atto655 that is (1) spectrally resolvable 
with mCherry to enable 3 color live cell imaging; (2) high photon output, which is crucial 
for high resolution imaging; and (3) photo-switching inside of cells, which is a favorable 
property for super-resolution imaging. Examples of the biological application of TMP-
Atto655 will be covered in Chapter 4. Here I discuss the initial design of a fluorogenic 
TMP-Atto655 and attempts to improve it. 
Finally, modern protein engineering technology has been extensively used to 
construct chemical tags and improve their performance. For instance, both SNAP-tag and 
FlAsH tag have gone through directed evolution to achieve higher reactivity and/or 
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binding affinity. Moreover, the Cornish lab has strong expertise in developing new 
technologies for protein engineering, and the eDHFR/TMP tag would be an ideal test 
case for these novel tools in directed evolution. Therefore I decided to perform directed 
evolution on eDHFR:L28C to build the next-generation fluorogenic TMP-tag with 
superior reactivity and fluorescence enhancement. In the last section of this chapter I 
described general design of the directed evolution strategy and preliminary results on 
library construction. 
3.2 Results 
3.2.1 Attempts To Synthesize Fluorogenic TMP-Tag With Shorter Linker 
We have learned from the development and optimization of the covalent TMP-tag 
that the linker between the TMP and the electrophilic group was determinant to the 
reactivity of the tag.1,2 In brief, a short (6 – 10 atoms), flexible linker would potentially 
benefit the proximity-induced reactivity. In our first generation TMP-tag, the 4’-oxygen 
on TMP was 12 atoms away from the CH2 group to be attacked by the Cys nucleophile, 
with a triazole ring in the linker. This long distance and relatively high rigidity might 
probably result in the modest reactivity inside of cells. Therefore I designed the next 




   
Scheme 3-1 Structure of next generation fluorogenic TMP-tag 3-1 and its retro-synthetic 
design. 
In compound 3-1, the 4’-oxygen on TMP is only 7 atoms away from the quencher, 
and the retro-synthetic design centers a serine as the trimeric linker, eliminating the 
triazole ring formed by click reaction. As outlined in Scheme 3-2, the synthesis of 
compound 3-1 started with the coupling of BHQ1-SO2Cl 2-9 with the serine linker, 
which, however, did not afford the desired product. Instead I only isolated the hydrolysis 
product of compound 2-9, the BHQ1-SO3H 3-4. I then tried another reaction using 
differentially protected serine Boc-Ser-NHS, in hope that the carboxylic acid in Boc-Ser-
OH would no longer interfere with the coupling. Unfortunately, even with the Boc-Ser-




Scheme 3-2 Attempted synthesis of compound 3-2 and 3-3. 
Reaction condition: a. DIEA, DMF, RT, 16 h. 
After two failed attempts with the BHQ1 quencher, I then turned to another class 
of quencher, QSY7 (Abs: 562 nm) and QSY21 (Abs: 661 nm), to construct the next 
generation fluorogenic TMP-tag. The QSY quenchers benefit from higher extinction 
coefficient, red-shifted absorption spectra, and higher chemical stability compared to the 
BHQ quenchers. The synthesis of QSY7 and QSY21 was summarized in Scheme 3-3. 
 
Scheme 3-3 Synthesis of compound 3-7 and 3-9. 
Reaction conditions: a. Thionyl chloride, DMF, ethyl acetate, 0 °C for 1 h, reflux at 85 °C for 15 
min; b. Indoline, methanol, reflux at 85 °C, 3 h; c. Phosphoryl chloride, 70 °C, 6 h; d. N-
methylaniline, methanol, reflux at 85 °C, 5 h. 
The synthesis of QSY quenchers started with derivatizing the sulfonofluorescein 
using thionyl chloride, catalyzed by DMF, yielding the chlorinated product 3-5, which 
was then refluxed with excessive indoline in methanol to produce QSY21 3-6. To aid 
subsequent coupling reaction, compound 3-6 was transformed to 3-7 by using phosphoryl 
chloride. The QSY7 3-8 was synthesized using similar protocol, with the N-methylaniline 




In the first several attempts to synthesize the QSY-based fluorogenic TMP-tag, I 
initially planned to utilize the intrinsic sulfonate groups on the QSY quenchers as the 
electrophilic leaving group. As summarized in Scheme 3-4, I first tried to conjugate 
compound 3-9 to a serine derivative Boc-Ser-OH, which would serve as the trimeric 
linker to install TMP and fluorophore in the following steps. However, the reaction did 
not yield expected product 3-10. Instead only the hydrolysis product 3-8 was isolated. 
Then I decided to protect the carboxylic acid in Boc-Ser-OH by allyl group so that it 
would no longer interfere with the coupling reaction with alcohol. Specifically, Boc-Ser-
OH was reacted with allyl bromide to produce intermediate 3-11. After conjugating to the 
QSY7 quencher, the allyl group can be removed by using palladium(0) reagent, which is 
orthogonal to the deprotection of Boc group. However, the coupling with compound 3-9 
still did not work, yielding the hydrolysis product 3-8 instead of the desired product 3-12. 
Finally, I also synthesized a longer version of the serine linker, in hope that the hydroxyl 
group would be less hindered and therefore more reactive. Starting from (Boc-Cys-OH)2, 
I first protected the carboxylic acid group using allyl bromide; then coupled the thiol 
group to 3-iodopropanol after reduction, affording intermediate 3-14. Unfortunately, 
again, compound 3-14 was not able to derivatize compound 3-9, leading to hydrolysis 
only. Notably, the same series reactions have been repeated with QSY21 and I got the 




Scheme 3-4 Attempts to synthesize QSY7-serine dirivatives. 
Reaction conditions: a. DIEA, DMF, RT, 16 h; b. allyl bromide, Cs2CO3, DMF, RT, 4 h; c. (i) Tri-n-
butylphosphine, DMF, H2O, RT, 8 h; (ii) 3-iodopropanol, Cs2CO3, DMF, 70 °C, 6 h. 
Judging from these failed attempts it seemed that the QSY-sulfonyl chlorides 
(compound 3-7 and 3-9) strongly tended to hydrolyze. Therefore I turned to amine 
instead of alcohol as the nucleophile. Previous studies have shown that a primary amine 
reacting with QSY-sulfonyl chlorides would result in subsequent ring closure and 
interruption of the conjugating system.3 A secondary amine, on the other hand, is much 
less reactive than the primary amine. Finally I decided to make a cyclic secondary amine-
based linker between the quencher and the sulfonate leaving group (Scheme 3-5). 
 
Scheme 3-5 Synthesis of QSY7-azide 3-18. 
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 Reaction conditions: a. DIEA, DCM, 0 °C, 2 h; b. (i) 3-azidoethanol, DMAP, DIEA, DCM, RT, 4 h; 
(ii) 1:1 TFA:DCM, v/v, RT, 1 h; c. DIEA, DMF, 0 °C for 1 h, RT for 1 h. 
As depicted in Scheme 3-5, the synthesis of QSY-azide started from coupling of 
4-amino-1-Boc-piperidine with excessive 3-(chlorosulfonyl)benzoyl chloride at 0 °C, 
affording intermediate 3-16. Compound 3-16 was subsequently modified by reacting with 
3-azidoethanol at RT in presence of DMAP as catalyst, affording intermediate 3-17, 
which was then conjugated to QSY7-sulfonyl chloride 3-9 to form QSY7-azide 3-18. 
Curiously, when I tried to synthesize the QSY21-azide 3-19 following the same route, the 
coupling reaction did not proceed smoothly (Scheme 3-6). Only hydrolysis product 3-24 
was isolated instead of the desired product 3-19. I then switched to another route (also 
depicted in Scheme 3-6) starting by coupling 4-N-Boc-aminopiperidine with compound 
3-7, yielding intermediate 3-20. After removing the Boc protective group, I tried to 
conjugate compound 3-21 with 3-(chlorosulfonyl)benzoyl chloride, which, unfortunately 
did not proceed as expected. Again, the hydrolysis product 3-24 was isolate instead of the 




Scheme 3-6 Attempts to synthesize QSY21-azide 3-19. 
 Reaction conditions: a. DIEA, DMF, 0 °C for 1 h, RT for 1 h; b. DIEA, DCM, 0 °C, 2 h; c. 1.1 (v/v) 
TFA:DCM, RT, 1 h.; d. DIEA, DCM, 0 °C, 2 h. 
3.2.2 Synthesis Of TMP-Q-Atto655 
While alternative routes to synthesize QSY-based fluorogenic TMP-tag were 
being investigated, I backed up to black hole quenchers BHQ1 (Abs: 534 nm) and BHQ2 
(Abs: 579 nm) to make the first generation TMP-Q-Atto655. Besides the difficulties in 
synthesis, another concern about QSY quenchers was that they are positively charged, 
which may possibly result in non-specific staining and aggregation. Even with the 
fluorogenic design, we still want the fluorophore and quencher to be well-behaved inside 
of cells for maximal S/B.  
The synthesis of TMP-BHQ2-Atto655 was outlined in Scheme 3-7 and Scheme 
3-8. Briefly, the synthesis of the BHQ2 quencher was initiated from the common 
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intermediate 2-7 as used in synthesis of BHQ1, which was coupled to Fast Black K salt in 
an azo coupling reaction following the patent US 7019129 B1,4 yielding intermediate 3-
25. With the Boc protective group removed by TFA, the BHQ2-amine (intermediate 3-26) 
was then derivatized with 3-(chlorosulfonyl)benzoyl chloride to produce BHQ2-tosyl 
chloride 3-27. In the next step BHQ2-tosyl chloride was reacted with excess 2-
azidoethanol, catalyzed by DMAP, yielding BHQ2-azide 3-28.  
 
Scheme 3-7 Synthesis of BHQ2-azide 3-28. 
Reaction conditions: a. NaHCO3, MeOH, H2O, RT, 2 h; b. 1:1 (v/v) TFA:DCM; c. DIEA, DCM, 
0 °C, 2h; d. 3-azidoethanol, DMAP, DIEA, DCM, RT, 4 h. 
In parallel, the intermediate 2-5 synthesized in Section 2.3.2 was conjugated to an 
Atto655 analogue 3-295 via standard peptide coupling reaction. The product, TMP-
Atto655-alkyne 3-30 was finally coupled to BHQ2-azide 3-28 in a ‘click’ reaction, 




Scheme 3-8 Synthesis of TMP-BHQ2-Atto655 3-31. 
Reaction conditions: a. EDCI, HOBt, DIEA, DMF, RT, 16 h; b. CuSO4·5H2O, ascorbic acid, DMF, 
RT, 24 h. 
Following similar route, I also synthesized TMP-BHQ1-Atto655 which differed 
from TMP-BHQ2-Atto655 only at the quencher (Scheme 3-9). 
 
Scheme 3-9 Synthesis of TMP-BHQ1-Atto655 3-32. 
 Reaction condition: a. CuSO4·5H2O, ascorbic acid, DMF, RT, 24 h. 
Both final products 3-31 and 3-32 were purified by HPLC and dissolved in 
anhydrous DMF to make 2 mM stock solutions 
3.2.3 In Vitro Characterization Of TMP-Q-Atto655 
3.2.3.1 Quantification Of Compound 3-31 And 3-32. 
To quantify TMP-BHQ2-Atto655 3-31, I first made standard solution by mixing 
BHQ2 (from Biosearch Technology) and Atto655 analog 3-29 at 1:1 molar ration and 
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diluted to various concentration (2 – 10 µM). UV-visible absorption spectra were 
measured for all standard solutions in addition to the TMP-BHQ2-Atto655 solution (all 
compounds were dissolved and diluted in anhydrous DMF). As presented in Figure 3-1, 
interestingly, the absorption spectrum of the TMP-BHQ2-Atto655 was significantly 
different from that of the standard solutions, which may be caused by the quenching 
effect in the trimeric molecule. Therefore I determined the concentration of the TMP-
BHQ2-Atto655 solution by performing linear regression of the absorption values at 500 
nm, where the absorption profile of TMP-BHQ2-Atto655 matches that of the standard 
solution. The TMP-BHQ1-Atto655 3-32 was quantified using the same methods, with 




Figure 3-1 Quantification of TMP-Q-Atto655. 
 (A) Left: UV-visible absorption curves of standard solution of 1:1 BHQ2:Atto655 at various 
concentrations, as indicated in legend, in addition to the absorption curve of TMP-BHQ2-Atto655 
3-31 diluted by 500 times (d500). Anhydrous DMF was used as solvent for all solutions. Right: 
linear regression of absorption at 500 nm of standard solutions. (B) Experimental conditions and 
plotting methods were same to that of (A). To quantify the concentration of TMP-BHQ1-Atto655 
3-32, standard solutions were made of 1:1 BHQ1:Atto655. 
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3.2.3.2 Fluorometric Measurements. 
To verify that the fluorogenic TMP-tag undergoes efficient and specific quencher 
cleavage, the TMP-Q-Atto655 was first characterized in vitro using purified eDHFR:Cys 
variants, following similar protocols as described in Section 2.3.4. The library of 16 
different eDHFR:Cys mutants was initially screened by fluorometric measurement to 
identify the eDHFR:Cys mutant that induces the greatest fluorescence enhancement upon 
reacting with TMP-Q-Atto655. In brief, 1 μM of each eDHFR:Cys variant was incubated 
with 1 μM TMP-Q-Atto655 in PBS supplemented with 100 μM NADPH and 1 mM 
reduced glutathione (GSH) at 37 °C.  Figure 3-2 displays the fluorescence intensity over 
time for all 16 eDHFR:Cys variants, with eDHFR-2C and buffer without eDHFR variant 
as negative controls. Significantly, both TMP-BHQ2-Atto655 and TMP-BHQ1-Atto655 
showed the greatest fluorescence enhancement with eDHFR:L28C. At 120 min, 
eDHFR:L28C induced 11-fold and 7-fold fluorescence enhancement with TMP-BHQ2-
Atto655 and TMP-BHQ1-Atto655 in comparison to the buffer control, respectively. 
These results were consistent with our anticipation that the absorption spectrum of BHQ2 
was more red-shifted compared to that of BHQ1, and therefore the BHQ2 could quench 




Figure 3-2 Fluorometric measurement of TMP-Q-Atto655. 
(A) Screening of the eDHFR:Cys variant library using TMP-BHQ2-Atto655. Purified eDHFR:Cys 
variants at a concentration of 1 µM were incubated with 1 µM TMP-BHQ2-Atto655 in PBS (pH = 
7.40) with 100 µM NADPH and 1 mM glutathione at 37 ˚C.   Fluorescence intensity was 
measured at various time points. As controls, the eDHFR-2C variant that lacks Cys and the buffer 
without eDHFR induced little increase in fluorescence intensity. (B) Screening of the eDHFR:Cys 
variant library using TMP-BHQ1-Atto655 under the same condition as in (A). Relative standard 
deviations (RSD) were <10% for all data. Error bars were not plotted for clarity. 
109 
 
3.2.3.3 Gel-Shift Assay. 
The TMP-BHQ2-Atto655, which has proven to show higher fluorescence 
enhancement than TMP-BHQ1-Atto655, was further characterized for labeling kinetics in 
vitro. Specifically, the in vitro eDHFR:L28C labeling reaction with TMP-BHQ2-Atto655 
was quenched at various time points and analyzed with SDS-PAGE. With Coomassie 
staining, labeling of eDHFR:L28C produced a band-shift on the gel presumably due to 
the increase in molecular weight of the labeled protein, allowing the progress of the 
reaction to be monitored by densitometry analysis. Significantly, both in-gel fluorescence 
and gel-shift assay demonstrated the accumulation of covalently labeled eDHFR:L28C 
over time (Figure 3-3). The half time of the labeling reaction (t1/2) was estimated to be ~ 
10 min for TMP-BHQ2-Atto655 labeling eDHFR:L28C. 
 
Figure 3-3 Determination of the rate of covalent labeling. 
In the same buffer as in Figure 3-2, 2 µM of eDHFR:L28C was incubated with 10 µM TMP-BHQ2-
Atto655 at 37 °C. At various time points (ON: overnight), aliquots were quenched by boiling at 
95 °C with 6X SDS.  The reaction was analyzed by SDS-PAGE followed by fluorescence gel 
scanning and Coomassie staining, and it was determined that 50% labeling occurs in 
approximately 10 minutes. 
Taken together, the in vitro assays confirmed that TMP-Q-Atto520 rapidly 
produced a highly specific, covalent label with significant fluorescence enhancement, 
suggesting it would be robust enough to label proteins in living cells. 
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3.2.3.4 Live Cell Imaging With TMP-BHQ2-Atto655 
Encouraged by the efficient and rapid labeling reaction between eDHFR:L28C 
and TMP-BHQ2-Atto655 with strong fluorescence enhancement, I next evaluated the 
potential of the far red fluorogenic TMP-tag for live cell imaging. Specifically, HEK 
293T and RPTP cells were transiently transfected with plasmids encoding H2B-
eDHFR:L28C and incubated with 10 μM TMP-BHQ2-Atto655 in tissue culture media. 
Fluorescence and DIC images were acquired by confocal microscope and were presented 
in Figure 3-4A, in comparison to live cell imaging with TMP-Q-Atto520. Interestingly, in 
HEK 293T cells the TMP-BHQ2-Atto655 was able to specifically label cell nucleus with 
minimal background fluorescence. In RPTP cells, however, the background staining by 
TMP-BHQ2-Atto655 was much higher than that of TMP-Q-Atto520. Actually, in RPTP 
cells fluorescence signal from non-specific staining was even higher than that from 
specific labeling. 
 
Figure 3-4 Live cell imaging and in-gel fluorescence of TMP-BHQ2-Atto655. 
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(A) HEK293T cells and RPTP cells were transfected with plasmids encoding H2B-eDHFR:L28C 
and incubated with 10 µM TMP-BHQ2-Atto655 for 3 h at 37 °C for fluorescence (middle column) 
and DIC imaging (right column, merged with fluorescence images). Fluorescence images of 
H2B:eDHFR:L28C labeled with TMP-Q-Atto520 were displayed in the left column for comparison. 
(B) In-gel fluorescence of RPTP cells. L: ladder; UT: untransfected cells; H2B: H2B-eDHFR:L28C 
labeled with TMP-BHQ2-Atto655 as in (A). 
I then examined the nature of the non-specific staining in RPTP cells by 
performing SDS-PAGE and in-gel fluorescence scanning. In brief, RPTP cells were 
transfected and labeled with TMP-BHQ2-Atto655 following the same procedures as for 
live cell imaging. As negative controls, untransfected RPTP cells were stained with TMP-
BHQ2-Atto655 as well. After cell lysis, the supernatants of the lysates were loaded onto 
SDS-PAGE and the gels were scanned for in-gel fluorescence. As presented in Figure 
3-4B, in cells transfected with H2B-eDHFR:L28C only one major band correlating to the 
expected fusion protein (expected 33 kDa) was observed. The minor bands with lower 
molecular weights were hypothesized to be degradation products of labeled H2B. In 
untransfected cells some minor bands were visible, but were significantly weaker 
compared to the intensity of the H2B band in transfected cell. 
These results implied that the TMP-BHQ2-Atto655, like TMP-Q-Atto520, was 
also capable to label intracellular target proteins with high selectivity. The non-specific 
staining in RPTP cells might be explains as: (1) The fluorescence enhancement of TMP-
BHQ2-Atto655 with eDHFR:L28C was not as high as that of TMP-Q-Atto520. If the 
intracellular concentration of the small molecule was 10 time higher than that of the 
labeled protein, the background fluorescence from the unbound probes would be 
equivalent to that from specific labeling; (2) The TMP-BHQ2-Atto655 molecule was 
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highly hydrophobic and therefore tended to aggregate inside of living cells; and (3) The 
tosylate group in TMP-BHQ2-Atto655 was not stable enough. To solve these issues, I 
designed the next generation fluorogenic TMP-Atto655 with improved stability and 
meanwhile planned to accelerate the specific labeling reaction by directed evolution of 
eDHFR. 
3.2.4 Attempts To Synthesize TMP-QSY21-Atto655. 
The structure of TMP-QSY21-Atto655 along with the retro-synthetic design was 
displayed in Scheme 3-10. The TMP-QSY21-Atto655 3-33 featured (1) a far red 
quencher QSY21 that is supposed to efficiently quench Atto655, leading to remarkable 
fluorescence enhancement; (2) sulfonated Atto655 3-34 to increase solubility inside of 
live cells; and (3) the tosylate group directly integrated on the QSY21 quencher. Since 
the indoline rind on QSY21 was electron rich (verified by NMR signal shifted to upfield), 
the tosylate group in compound 3-35 was supposed to be more stable than that in TMP-
BHQ2-Atto655. In this way I hope to further suppress the spontaneous hydrolysis and/or 
non-specific cleavage of the fluorogenic TMP-tag. Notably, this latent tosylate group 
may also decelerate the specific labeling reaction with eDHFR:L28C. Therefore I 
planned to engineer the eDHFR via directed evolution to achieve optimal reactivity and 




Scheme 3-10 Structure and retro-synthetic design of TMP-QSY21-Atto655 3-33. 
The synthesis of compound 3-35 started with selective sulfonation of QSY21 3-6 
with one equivalent chlorosulfuric acid (Scheme 3-11). The intermediated 3-36 was 
isolated and subsequently transformed to compound 3-37. Then I tried to couple 
compound 3-37 to 3-azidoethanol using three different reaction conditions, with the 
DIEA, NaH, and tBuOK as the base, respectively. However, none of these reagents made 
this reaction occur as expected. The DIEA turned to be too weak so that no reaction was 
observed with it. On the other hand, NaH and tBuOK turned to be too strong, 





Scheme 3-11 Attempt to synthesize QSY21-azide 3-35. 
 Reaction conditions: a. 1 eq. chlorosulfuric acid, acetic anhydride, DCM; RT, 16 h; b. phosphoryl 
chloride, 70 °C, 6 h; c. 3-azidoethanol, DIEA, DCM, RT, 16 h; d. 3-azidoethanol, NaH, DMF, RT, 
16 h; e. 3-azidoethanol, tBuOK, DMF, RT, 16 h. 
One potential issue with the synthetic route in Scheme 3-11 was that there were 
two different tosylate chloride groups in compound 3-37. It was anticipated that only the 
one on indoline ring, which was less hindered, would be coupled to 3-azidoethanol. 
However, the other tosylate chloride may possibly cause complication in the reaction. 
Therefore, I redesigned an alternative route to ‘seal’ the tosylate group in QSY21 3-6 
before installing another tosylate group (Scheme 3-12). 
 
Scheme 3-12 Attempt to synthesize QSY21-tosylate 3-39. 
Reaction conditions: a. piperidine, DCM, 0 °C, 2 h; b. 1 eq. chlorosulfuric acid, acetic anhydride, 
DCM; RT, 16 h. 
To synthesize QSY21-tosylate 3-39, I first coupled compound 3-7 with piperidine 
to yield intermediate 3-38. Then I tried to sulfonate intermediate 3-38 under the same 
condition as for intermediate 3-36. Surprisingly, even with 1 equivalent chlorosulfuric 
acid, only bi-sofonated product 3-40 was isolated along with unreacted starting material; 
no formation of the desired product 3-39 was observed. 
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A new synthetic route is currently being investigated based on an oxazine-based 
quencher, instead of the rhodamine-based QSY quenchers, so that the intrinsic tosylate 
group would not interfere with the coupling reaction. 
3.2.5 Design Of eDHFR Library And Screening Strategy 
In parallel to the synthesis of next generation TMP-Q-Atto655, I also started to 
design and construct eDHFR library for directed evolution. As cartooned in Figure 3-5, I 
planned to screen the eDHFR library using the yeast surface display technology that has 
been developed by a previous student Matthew Merguerian in the Cornish lab. 
Specifically, we insert the eDHFR library in a scaffold protein Aga2p, which would be 
displayed on the surface of yeast cells by forming disulfide bonds with a membrane 
bound protein Aga1p. On the C terminus of eDHFR we also fuse a V5 epitope, which 
would be specifically recognized by fluorescent antibodies, producing control signal to 
indicate the expression level. The V5 epitope would not be expressed if the eDHFR is 
truncated, which would also help to eliminate false positives. 
 
Figure 3-5 Screening of eDHFR library using yeast surface display technology. 
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After Aga2p-eDFHR library is expressed and displayed on the surface of yeast 
cells (induced by galactose), the yeast library would be incubated with TMP-Q-Atto655. 
The concentration of the probe and incubation condition could be varied to achieve 
increasing stringency in multiple rounds of screening. Then the yeast cells will be washed 
to remove non-specifically bound probes and screened by using fluorescence-activated 
cell sorting (FACS), which could collect cells with the strongest Atto655 fluorescence 
signal. 
Two different strategies were commonly used to construct protein library: error-
prone PCR and cassette mutagenesis. The error-prone PCR can generate random 
mutations at random sites throughout the whole protein sequence. The cassette 
mutagenesis, on the other hand, is able to randomize a specific region while keeping the 
rest of the protein untouched. Each of these techniques has its own advantages and 
disadvantages. And I planned to use both of them, constructing different libraries, to 
engineer the eDHFR for fluorogenic TMP-tag. 
3.2.6 Construction Of eDHFR Libraries 
3.2.6.1 Library Construction By Error-Prone PCR 
The error-prone PCR utilizes low fidelity DNA polymerase (eg. GoTaq) to incorporate 
mis-paired bases while amplifying the target gene. The frequency of point mutation can 
be fine-tuned by varying the Mg2+ and Mn2+ concentration as well as the cycle number. 
We performed error-prone PCR based a previously published protocol while adjusting 
the MgCl2 and MnCl2 concentration to achieve the desired mutation rate (1 – 3 point 
mutations per sequence).6 Figure 3-6 represented the sequencing results of 6 colonies 




Figure 3-6 Sequencing result of 6 colonies from the eDHFR library constructed by error-
prone PCR. 
The first sequence was the wild type eDHFR. Point mutations were highlighted by red letters. 
3.2.6.2 Library Construction By Cassette Mutagenesis 
In cassette mutagenesis, a certain region on eDHFR was completely randomized 
by using randomized oligos as PCR templates. As represented in Figure 3-7, by modeling 
the eDHFR:L28C in complex with the fluorogenic TMP-tag (here I used TMP-Q-
Atto520) I identified two loops (named the yellow loop and the blue loop, respectively) 
that were potentially involved in interacting with the small molecule. The two loops were 
mutated by extending randomized oligos and ligated to the rest part of eDHFR via 




Figure 3-7 Library construction by cassette mutagenesis. 
 (A) eDHFR protein sequence, with the blue and yellow loops highlighted. (B) Molecular model of 
eDHFR/TMP-Q-Atto520 complex with the blue loop highlighted. To construct the blue library, the 
eDHFR gene was amplified in 3 fragments with 30 bp overlapping homologous regions. One of 
the three fragments contains the randomized sequence. After yeast transformation, the three 
fragments along with the pYD1 backbone would spontaneously undergo homologous 
recombination to form a circular plasmid. (C) Molecular model of eDHFR/TMP-Q-Atto520 
complex with the yellow loop highlighted. Since the yellow loop was close to the N-terminus of 
eDHFR gene, the library was constructed using two DNA fragments, one of which containing the 
randomized sequence. 
Two different libraries (named blue and yellow libraries, respectively) were 
constructed containing randomized blue and yellow loops, respectively. Sequencing 
results of the yellow library were displayed in Figure 3-8, confirming the randomization 
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of the yellow loop. The blue library was constructed in the same way and also confirmed 
by sequencing the eDHFR region (data not shown). 
 
Figure 3-8 Sequencing result of 5 colonies from the eDHFR library constructed by cassette 
mutagenesis. 
The first sequence was the wild type eDHFR. Point mutations were highlighted by red letters. The 
last sequence also appeared to be wt eDHFR, which might be caused by slight contamination 
during yeast transformation. 
3.3 Discussion 
The first generation fluorogenic TMP-tag has exceeded our expectation: with the 
initial design, the TMP-Q-Atto520 was demonstrated to have remarkable reactivity and 
selectivity both in vitro and inside of live cell, labeling not only nucleus localized H2B 
but also highly dynamic cytosolic proteins. Nevertheless, for sophisticated biological 
experiments it is crucial to further improve the labeling efficiency and reactivity. 
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Moreover, for multi-color and/or super-resolution live cell imaging a fluorogenic TMP-
tag in the far red region is highly desired. Therefore I tried several different routes to 
construct the next generation fluorogenic TMP-tag. 
Based on our experience optimizing the covalent TMP-tag, I suppose that a short, 
flexible linker between TMP and the tosylate electrophile would possible benefit the 
proximity-induced reaction. Specifically, I tried to replace the propagylglycine with 
serine derivatives as the trimeric linker. Besides BHQ quenchers I also focused on QSY 
quenchers with stronger absorption in the red to far red region. Hitherto most of the 
attempts to synthesize the next generation fluorogenic TMP-tag have been impeded by 
the sensitivity of the tosylate group: it was sometimes hard to form, and sometimes 
quickly hydrolyzing in subsequent steps. Since the tosylate group plays a key role in the 
proximity-induced SN2 reaction, more diverse tosylate chemistry will be strongly desired 
in future investigation. 
Meanwhile I successfully synthesized two fluorogenic TMP-Atto655s following 
the first generation design. Remarkably, the TMP-BHQ2-Atto655 demonstrated 
considerable reactivity and selectivity in in vitro assay, displaying more than 10 fold 
fluorescence enhancement and t1/2 ~ 10 min. This molecule was also able to label H2B-
eDHFR:L28C in HEK 293T cell with high S/B. However, in RPTP cells (a fibroblast cell 
line) it suffered from strong background staining. Using in-gel fluorescence I have 
confirmed that the TMP-BHQ2-Atto655 only specifically labeled target protein. So the 
non-specific background should be caused by aggregation and spontaneous 
decomposition of the molecule in live cells. 
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Notably, the fact that TMP-BHQ2-Atto655 showed higher fluorescence 
enhancement than TMP-BHQ1-Atto655 justified our hypothesis that, for efficient 
quenching, the absorption spectrum of the quencher should match the emission spectrum 
of the fluorophore. Therefore I also attempted to synthesize a TMP-QSY21-Atto655 
molecule that may potentially benefit from an efficient quenching effect, a soluble 
fluorophroe, and a latent electrophilic leaving group. Again, the complication in tosylate 
chemistry is currently the major technical hurdle, and other students in the Cornish lab 
will further investigate alternative routes. 
Finally, I also designed and built eDHFR libraries for directed evolution using 
yeast surface display and FACS technology. Specifically, three eDHFR libraries have 
been successfully constructed by using error-prone PCR and cassette mutagenesis 
strategies. This work would not only help us to improve the fluorogenic TMP-tag and 
covalent TMP-tag, but would also be a valuable test case for the new directed evolution 
technologies under development in the Cornish lab. 
3.4 Experimental Methods 
3.4.1 Attempts To Synthesize Fluorogenic TMP-Tag With Shorter Linker 
3.4.1.1 Synthesis Of Compound 3-5. 
In a 250 mL round-bottomed flask 5 g sulfonofluorescein (13.6 mmol) was 
suspended in 30 mL anhydrous EtOAc and was cooled to 0 °C in ice bath. Then 5 mL 
thionyl chloride was added dropwise to the suspension, followed by 15 mL DMF. The 
reaction mixture was stirred at 0 °C for 1.5 h before removing the ice bath and warming 
up to RT. The reaction was subsequently heated at 85 °C and reflux for 15 min before 
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cooling down again in ice bath. The color of the mixture should turn pale with white solid 
crushing out. Pour the reaction mixture into 500 mL ice water while stirring, in order to 
quench the unreacted thionyl chloride. Then filter the water suspension and collect 
yellow-brown solid. Wash twice with ice-cold EtOAc and dry solid in vacco. To refine 
the product, extract the dried crude product using 3 X 50 mL DCM and filter off residues. 
Compound 3-5 can then be obtained as light yellow powder by evaporating DCM by 
rotary evaporation (1.3 g, 24% yield). 1H NMR (400 MHz, CDCl3) δ ppm: 8.03 – 7.94 (m, 
1H), 7.69 (dtd, J = 20.2, 7.4, 1.2 Hz, 2H), 7.38 (t, J = 1.2 Hz, 2H), 7.15 (d, J = 1.3 Hz, 
4H), 7.05 – 6.97 (m, 1H).  MS (FAB+) m/z Calcd. For C19H10Cl2O4S [M+H]+:404.97. 
Found: 404.96. 
3.4.1.2 Synthesis Of Compound 3-6. 
Compound 3-5 (870 mg, 2.15 mmol) was suspended in 20 mL anhydrous MeOH, 
and the suspension was purge with Ar for 30 min. Then indoline (963 µL, 8.6 mmol) was 
added dropwise and the reaction mixture was refluxed at 85 °C for 3 h, during which dark 
blue solids precipitated. The reaction mixture was then cooled to RT and filtered and the 
solids were washed by 3 X 20 mL EtOH and 3 X 20 mL ethyl ether. The crude product 
was further purified by flash column chromatography on silica gel (15:1 DCM:MeOH, 
v/v) to yield compound 3-6 as dark blue-green crystals (780 mg, 63% yield). 1H NMR 
(400 MHz, Chloroform-d) δ ppm 8.51 – 8.44 (m, 1H), 7.67 (td, J = 7.8, 1.3 Hz, 1H), 7.59 
(d, J = 9.2 Hz, 2H), 7.54 – 7.45 (m, 3H), 7.33 (d, J = 2.3 Hz, 1H), 7.32 – 7.28 (m, 5H), 
7.25 – 7.19 (m, 2H), 7.13 – 7.03 (m, 3H), 4.16 (t, J = 8.0 Hz, 4H), 3.30 – 3.17 (t, J = 8.0 
Hz, 4H). MS (FAB+) m/z Calcd. For C35H26N2O4S [M+H]+:571.16. Found: 571.2. 
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3.4.1.3 Synthesis Of Compound 3-7 
Compound 3-6 (60 mg, 0.105 mmol) was dissolved in 1 mL phosphoryl chloride 
and stirred at 70 °C for 6 h. The phosphoryl chloride was then removed by rotary 
evaporation and the product was directed used for following reactions without 
purification (quantitative). MS (FAB+) m/z Calcd. For C35H26ClN2O3S [M]+:589.13. 
Found: 589.22. No m/z peak for the starting material 3-6 was found in MS. 
3.4.1.4 Synthesis Of Compound 3-8 
Compound 3-5 (350 mg, 0.86 mmol) was suspended in 5 mL anhydrous MeOH, 
and the suspension was purge with Ar for 30 min. Then N-methylaniline (375 µL, 3.45 
mmol) was added dropwise and the reaction mixture was refluxed at 90 °C for 5 h, during 
which the solution turned dark magenta. The reaction mixture was then concentrated by 
rotary evaporation and crude product was further purified by flash column 
chromatography on silica gel (15:1 DCM:MeOH, v/v) to yield compound 3-8 as dark 
magenta-purple crystals (320 mg, 68% yield). 1H NMR (400 MHz, Chloroform-d) δ ppm 
8.38 (dd, J = 8.0, 1.1 Hz, 1H), 7.62 (t, J = 7.6 Hz, 1H), 7.54 – 7.44 (m, 5H), 7.40 (t, J = 
7.3 Hz, 2H), 7.32 (d, J = 9.3 Hz, 2H), 7.25 (d, J = 7.3 Hz, 4H), 7.09 – 7.02 (m, 1H), 6.76 
(d, J = 9.3 Hz, 2H), 6.71 (s, 2H), 1.26 (s, 6H). MS (FAB+) m/z Calcd. For C33H26N2O4S 
[M+H]+:547.16. Found: 547.2. 
3.4.1.5 Synthesis Of Compound 3-9 
Compound 3-8 (60 mg, 0.11 mmol) was dissolved in 1 mL phosphoryl chloride 
and stirred at 70 °C for 6 h. The phosphoryl chloride was then removed by rotary 
evaporation and the product was directed used for following reactions without 
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purification (quantitative). MS (FAB+) m/z Calcd. For C33H26ClN2O3S [M]+:565.13. 
Found: 565.2. No m/z peak for the starting material 3-8 was found in MS. 
3.4.1.6 Synthesis Of Compound 3-11 
In a 50 mL round-bottomed flask Boc-Ser-OH (200 mg, 0.975 mmol), allyl 
bromide (84.4 µL, 0.975 mmol), and Cs2CO3 (320 mg, 0.975 mmol) were dissolved in 2 
mL DMF. The reaction mixture was stirred at RT for 4 h before concentrated by rotary 
evaporation. The residue was then diluted in 50 mL EtOAc and washed with 2X 30 mL 
saturated NaHCO3 solution followed by 2X 30 mL brine. The crude product was 
collected by removing EtOAc by rotary evaporation and further purified by flash column 
chromatography on silica gel (40:1 -> 20:1 DCM:MeOH, v/v), yielding compound 3-11 
(240 mg, 100% yield, Rf = 0.43 in 20:1 DCM:MeOH, v/v). 1H NMR (400 MHz, 
Chloroform-d) δ ppm 5.85 (ddt, J = 17.2, 10.5, 5.7 Hz, 1H), 5.64 (d, J = 8.2 Hz, 1H), 
5.28 (dq, J = 17.2, 1.5 Hz, 1H), 5.19 (dq, J = 10.4, 1.2 Hz, 1H), 4.60 (dt, J = 5.8, 1.4 Hz, 
2H), 4.32 (dt, J = 8.1, 3.5 Hz, 1H), 3.98 – 3.86 (m, 1H), 3.81 (dd, J = 11.2, 3.6 Hz, 1H), 
3.37 (s, 1H), 1.38 (s, 9H). MS (FAB+) m/z Calcd. For C11H19NO5 [M+H]+:246.13. Found: 
246.13. 
3.4.1.7 Synthesis Of Compound 3-13 
In a 50 mL round-bottomed flask (Boc-Cys-OH)2 (500 mg, 1.13 mmol), allyl 
bromide (196 µL, 2.26 mmol), and Cs2CO3 (920 mg, 2.83 mmol) were dissolved in 5 mL 
DMF. The reaction mixture was stirred at RT overnight before concentrated by rotary 
evaporation. The residue was then diluted in 100 mL EtOAc and washed with 2X 50 mL 
saturated NaHCO3 solution followed by 2X 50 mL brine. The crude product was 
collected by removing EtOAc by rotary evaporation and further purified by flash column 
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chromatography on silica gel (40:1 -> 20:1 DCM:MeOH, v/v), yielding compound 3-13 
(550 mg, 93% yield, Rf = 0.47 in 20:1 DCM:MeOH, v/v). 1H NMR (400 MHz, 
Chloroform-d) δ ppm 5.91 (ddt, J = 17.2, 10.4, 5.8 Hz, 1H), 5.39 (d, J = 9.1 Hz, 1H), 
5.33 (dq, J = 17.2, 1.4 Hz, 1H), 5.25 (dq, J = 10.4, 1.1 Hz, 1H), 4.64 (dq, J = 5.9, 1.3 Hz, 
2H), 4.62 – 4.55 (m, 1H), 3.16 (d, J = 5.4 Hz, 2H), 1.43 (s, 9H). MS (FAB+) m/z Calcd. 
For C22H36N2O8S2 [M+H]+:521.19. Found: 521.2. 
3.4.1.8 Synthesis Of Compound 3-14 
Compound 3-13 (227 mg, 0.436 mmol) and Tri-n-butylphosphine (114 µL, 0.458 
mmol) were dissolved in 5 mL DMF and 0.5 mL water. The reaction mixture was purged 
with Ar for 30 min and then stirred at RT for 8 h before concentrated by rotary 
evaporation and further dried in vacco overnight. The reduced intermediate was used for 
the next step without purification (Rf = 0.42 in 30:1 DCM:MeOH, v/v). 
The reduced compound 3-13 (0.872 mmol) was dissolved in 3 mL DMF and 3-
iodopropanol (84 µL, 0.872 mmol), Cs2CO3 (341 mg, 1.046 mmol) were added to the 
solution. The reaction mixture was stirred at 70 °C for 6 h before concentrated by rotary 
evaporation. The residue was then diluted in 50 mL EtOAc and washed with 2X 30 mL 
saturated NaHCO3 solution followed by 2X 30 mL brine. The crude product was 
recovered by removing EtOAc by rotary evaporation and further purified by flash column 
chromatography on silica gel (1:1 hexane:EtOAc, v/v), yielding compound 3-14 (230 mg, 
83% yield in 2 steps, Rf = 0.42 in 1:1 hexane:EtOAc, v/v). 1H NMR (400 MHz, 
Chloroform-d) δ ppm 5.89 (ddt, J = 17.3, 10.5, 5.8 Hz, 1H), 5.45 – 5.20 (m, 3H), 4.63 (dt, 
J = 5.9, 1.4 Hz, 2H), 4.53 (t, J = 5.4 Hz, 1H), 3.75 – 3.63 (m, 2H), 3.03 – 2.85 (m, 2H), 
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2.65 (p, J = 6.3, 5.9 Hz, 2H), 2.21 (s, 1H), 1.87 – 1.71 (m, 2H), 1.42 (s, 9H). MS (FAB+) 
m/z Calcd. For C14H25NO5S [M+H]+:320.15. Found: 320.16. 
3.4.1.9 Synthesis Of Compound 3-16 
In a 25 mL round-bottomed flask 3-(chlorosulfonyl)benzoyl chloride (318 µL, 2 
mmol) was dissolved in 2 mL anhydrous DCM and cooled to 0 °C by stirring in ice bath. 
Then 4-amino-1-Boc-piperiding (200 mg, 1 mmol, dissolved in 2 mL DCM) was added 
to the solution dropwise, followed by DIEA (370 µL, 5 mmol). The reaction mixture was 
stirred in ice bath for 20 min before warmed up to RT and stirred for another 2 h. The 
crude product was purified by flash column chromatography on silica gel (1:1 
hexane:EtOAc, v/v), yielding compound 3-16 (402 mg, 100% yield, Rf = 0.41 in 1:1 
hexane:EtOAc, v/v). 1H NMR (400 MHz, Chloroform-d) δ ppm 8.37 (t, J = 1.8 Hz, 1H), 
8.19 (dt, J = 7.8, 1.4 Hz, 1H), 8.15 (ddd, J = 8.0, 2.0, 1.1 Hz, 1H), 7.72 (t, J = 7.9 Hz, 
1H), 6.40 (d, J = 7.8 Hz, 1H), 4.20 – 4.12 (m, 3H), 2.89 (ddd, J = 13.7, 12.1, 2.6 Hz, 2H), 
2.08 – 1.98 (m, 2H), 1.45 (s, 9H). MS (FAB+) m/z Calcd. For C17H23ClN2O5S 
[M+H]+:529.27. Found: 529.3. 
3.4.1.10 Synthesis Of Compound 3-17 
Compound 3-16 (118 mg, 0.293 mmol) and DMAP (39 mg, 0.293 mmol) was 
dissolved in anhydrous DCM and then 2-azidoethanol (51 mg, 0.586 mmol) was added to 
the reaction mixture followed by DIEA (255 µL, 1.465 mmol). The reaction was stirred 
at RT for 4 h before loaded to silica column for purification (20:1 DCM:MeOH, v/v), 
yielding compound 3-17-Boc (113 mg, 85% yield, Rf = 0.58 in 10:1 DCM:MeOH, v/v). 
1H NMR (400 MHz, Chloroform-d) δ ppm 8.24 (t, J = 1.5 Hz, 1H), 8.14 (ddd, J = 7.8, 
1.7, 1.1 Hz, 1H), 8.05 (ddd, J = 7.8, 1.9, 1.1 Hz, 1H), 7.67 (t, J = 7.8 Hz, 1H), 6.29 (d, J 
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= 7.8 Hz, 1H), 4.23 (t, J = 4.8 Hz, 2H), 4.13 (m, 3H), 3.51 (t, J = 4.8 Hz, 2H), 2.86 (t, J 
= 12 Hz, 2H), 2.07 – 1.96 (m, 2H), 1.46 (m, 11H). MS (FAB+) m/z Calcd. For 
C19H27N5O6S [M+H]+:454.17. Found: 454.16. 
The intermediate 3-17-Boc was then converted to compound 3-17 by dissolving 
in 1 mL TFA and 1 mL DCM and stirred at RT for 1 h. The reaction was quantitative and 
the product 3-17 was used in the next step without purification. 
3.4.1.11 Synthesis Of Compound 3-18 
Compound 3-9 (96 mg, 0.17 mmol) was dissolved in 1 mL DCM and was cooled 
to 0 °C in ice bath. Compound 3-17 (88 mg, 0.25 mmol as TFA salt, dissolved in 1 mL 
DMF) was then added to the solution of compound 3-9, followed by DIEA (148 µL, 0.85 
mmol). The reaction was stirred in ice bath for 1 h and then warmed up to RT and stirred 
for another 1 h before concentrated by rotary evaporation. The crude product was purified 
by flash column chromatography on silica gel (10:1 DCM:MeOH, v/v), yielding 
compound 3-18 (4.5 mg, 3% yield, Rf = 0.33 in 10:1 DCM:MeOH, v/v). 1H NMR (400 
MHz, Chloroform-d) δ ppm 8.53 – 8.44 (m, 2H), 8.23 (m, 1H), 8.02 – 7.94 (m, 1H), 7.87 
(td, J = 7.8, 1.4 Hz, 1H), 7.82 – 7.75 (m, 1H), 7.68 – 7.60 (m, 1H), 7.54 – 7.46 (m, 4H), 
7.45 – 7.38 (m, 2H), 7.31 – 7.25 (m, 2H), 7.25 – 7.20 (m, 4H), 7.18 (d, J = 9.4 Hz, 2H), 
7.15 – 7.06 (m, 2H), 6.72 (d, J = 2.3 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.60 (s, 6H), 3.51 
(t, J = 5.0 Hz, 2H), 3.30 (dt, J = 12.6, 4.5 Hz, 2H), 2.91 (td, J = 9.8, 5.0 Hz, 2H), 1.99 – 
1.87 (m, 2H), 1.77 – 1.62 (m, 2H). MS (FAB+) m/z Calcd. For C47H44N7O7S2 
[M]+:882.27. Found: 882.43. 
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3.4.1.12 Synthesis Of Compound 3-20 
Compound 3-7 (97 mg, 0.164 mmol) was dissolved in 1 mL DCM and was cooled 
to 0 °C in ice bath. 4-N-Boc-aminopiperidine (165 mg, 0.82 mmol) was then added to the 
solution. The reaction was stirred in ice bath for 2 h before warmed up to RT and stirred 
for another 12 h. Then the solution was concentrated by rotary evaporation and crude 
product was used for the next step without purification. MS (FAB+) m/z Calcd. For 
C45H45N4O5S [M]+:753.31. Found: 753.4. 
3.4.1.13 Synthesis Of Compound 3-21 
Compound 3-20 (124 mg, 0.164 mmol, crude product) was dissolved in 1 mL 
DCM and 1 mL TFA. The reaction was stirred at RT for 1 h before concentrated. The 
product 3-21 was purified by flash column chromatography on silica gel (8:2 
DCM:MeOH with 0.5 % AcOH, v/v), yielding compound 3-21 (80 mg, 75% yield in two 
steps, Rf = 0.1 in 10:1 DCM:MeOH, v/v). 1H NMR (400 MHz, Methanol-d4) δ 8.28 – 
8.18 (m, 1H), 7.96 (dd, J = 5.8, 3.3 Hz, 2H), 7.61 (d, J = 8.1 Hz, 2H), 7.56 (ddd, J = 7.6, 
2.6, 1.5 Hz, 3H), 7.48 (d, J = 2.3 Hz, 2H), 7.40 – 7.35 (m, 2H), 7.33 – 7.24 (m, 4H), 7.20 
(m, 2H), 4.26 (t, J = 7.9 Hz, 4H), 3.60 (dp, J = 13.7, 2.1 Hz, 2H), 3.27 (t, J = 8.0 Hz, 4H), 
3.21 – 3.18 (m, 1 H), 2.72 – 2.62 (m, 2H), 1.96 (dt, J = 12.9, 2.5 Hz, 2H), 1.56 (qd, J = 
12.3, 4.3 Hz, 2H). MS (FAB+) m/z Calcd. For C40H37N4O3S [M]+:653.26. Found: 653.3. 
3.4.2 Synthesis Of TMP-Q-Atto655 
3.4.2.1 Synthesis Of Compound 3-25 
Fast Black K Salt (2.5 g, dye content 30%, 1.74 mmol) was suspended in 10 mL 
water and chilled to 0 °C in ice bath. Compound 2-7 (460 mg, 1.74 mmol) was dissolved 
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in 8 mL methanol and 6 mL 5% NaOH aqueous solution, and then added dropwise to the 
Fast Black K Salt solution. The reaction mixture was stirred in ice bath for 2 h during 
which the color changed from red to dark purple. The crude product was filtered and 
washed with 3 X 10 mL of cold water and then dried in vacuo. The product was purified 
by column chromatography on silica gel (1:1 EtOAc:hexane) to yield compound 3-25 as 
dark pueple solid (420 mg, 51% yield, Rf = 0.45 in 1:1 EtOAc:hexane). 1H NMR (400 
MHz, Chloroform-d) δ 8.40 – 8.34 (m, 2H), 8.08 – 8.01 (m, 2H), 7.97 – 7.92 (m, 2H), 
6.79 (d, J = 8.7 Hz, 2H), 4.09 (s, 3H), 4.05 (s, 3H), 3.51 (t, J = 7.3 Hz, 2H), 3.21 (q, J = 
6.6 Hz, 2H), 3.10 (s, 3H), 1.86 (p, J = 7.0 Hz, 2H), 1.46 (s, 9H). MS (FAB+) m/z Calcd. 
For C29H35N7O6 [M+H]+:578.27. Found: 578.22. 
3.4.2.2 Synthesis Of Compound 3-26 
Compound 3-25 was deprotected by dissolving in 10 ml 30% TFA in DCM (v/v) 
and stirring for 1 h; the color changes from purple to dark blue. Then the product was 
obtained by removing solvent by rotary evaporation, yielding compound 3-26 
(quantitative, not purified) as dark purple solid.  
3.4.2.3 Synthesis Of Compound 3-27 
Compound 3-26 (TFA salt, 201 mg, 0.42 mmol) was dissolved in 5 mL anhydrous 
DCM and chilled to 0 °C in ice bath. Then 3-(chlorosulfonyl)benzoyl chloride (134 µL, 
0.84 mmol) was added to the solution dropwise, followed by DIEA (370 µL, 2.1 mmol). 
The reaction mixture was stirred in ice bath under Ar for 30 min, and then warmed to RT 
and stirred for 1 h. The crude product was collected by evaporating the solvent, and was 
subsequently purified by column chromatography on silica gel (2:1 EtOAc:hexane, v/v), 
yielding compound 3-27 (71 mg, 25% yield) as dark purple solid. Rf = 0.34 in 2:1 
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EtOAc:hexane, v/v. 1H NMR (400 MHz, Chloroform-d) δ 8.48 – 8.41 (m, 1H), 8.39 – 
8.31 (m, 2H), 8.24 – 8.12 (m, 2H), 8.06 – 7.99 (m, 2H), 7.93 (d, J = 8.6 Hz, 2H), 7.71 (t, 
J = 7.9 Hz, 1H), 7.45 (d, J = 13.4 Hz, 2H), 6.93 (s, 2H), 4.08 (s, 3H), 4.04 (s, 3H), 3.66 – 
3.53 (m, 4H), 3.14 (s, 3H), 2.04 (m, 2H). MS (FAB+) m/z Calcd. For C31H30ClN7O7S 
[M+H]+:680.16. Found: 680.16. 
3.4.2.4 Synthesis Of Compound 3-28 
Compound 3-27 (62 mg, 0.091 mmol) and DMAP (11 mg, 0.091 mmol) was 
dissolved in 1 mL anhydrous DCM. Then 2-azidoethanol (16 µL, 0.182 mmol) and DIEA 
(80 µL, 0.456 mmol) were added and the reaction mixture was stirred under Ar at RT for 
4 h. After removing the solvent in vacuo, the product was purified by prep-TLC on silica 
gel (5:2 EtOAc:hexane, v/v), yielding compound 3-28 (9 mg, 14% yield) as dark purple 
solid. Rf = 0.31 in 5:2 EtOAc:hexane, v/v. 1H NMR (400 MHz, Chloroform-d) δ 8.45 – 
8.34 (m, 3H), 8.22 (m, 2H), 8.11 – 7.98 (m, 5H), 7.69 (td, J = 7.8, 1.6 Hz, 1H), 7.49 (d, J 
= 2.2 Hz, 2H), 7.27 (s, 1H), 4.26 (dt, J = 16.7, 5.0 Hz, 2H), 4.10 (d, J = 5.9 Hz, 3H), 
4.07 (d, J = 4.3 Hz, 3H), 3.74 (m, 2H), 3.60 (m, 2H), 3.52 (q, J = 4.8 Hz, 2H), 3.28 (s, 
3H), 2.11 – 2.08 (m, 2H). MS (FAB+) m/z Calcd. For C33H34N10O8S [M+H]+:731.23. 
Found: 731.3. 
3.4.2.5 Synthesis Of Compound 3-30 
DIEA (124 μL, 0.71 mmol) was added to a solution of compound 2-5 (7 mg, 13 
μmol), compound 3-29 (40 mg, 0.071 mmol), EDCI (33.1 mg, 0.213 mmol), and HOBt 
(29 mg, 0.213 mmol) in 1 mL anhydrous DMF. The mixture was stirred under Ar at RT 
for 12 h before diluted by 50 mL DCM and washed by 2X 30 mL saturated NaHCO3 
followed by 2X 30 mL brine. The organic layer was dried over Na2SO4 and then solvent 
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was removed. Crude product was purified by reverse phase HPLC to yield compound 3-
30 (TFA salt, 18 mg, 32% yield). 1H NMR (400 MHz, Methanol-d4) δ 7.40 (dt, J = 3.8, 
1.8 Hz, 2H), 7.25 (d, J = 1.0 Hz, 1H), 6.70 (d, J = 9.0 Hz, 2H), 6.55 (s, 2H), 4.50 – 4.43 
(m, 1H), 4.02 (q, J = 6.5 Hz, 4H), 3.94 (t, J = 5.9 Hz, 2H), 3.79 (s, 6H), 3.69 – 3.62 (m, 
4H), 3.62 – 3.55 (m, 2H), 3.47 – 3.38 (m, 2H), 3.28 (m, 4H), 2.67 (ddd, J = 16.8, 6.3, 2.7 
Hz, 1H), 2.57 (ddd, J = 16.8, 7.7, 2.7 Hz, 1H) 2.35 (t, J = 2.6 Hz, 1H), 2.32 (t, J = 6.7 Hz, 
2H), 1.85 (p, J = 6.4 Hz, 2H), 1.79 – 1.66 (m, 4H), 1.33 (t, J = 7.2 Hz, 3H). MS (FAB+) 
m/z Calcd. For C44H52N9O6 [M+H]+:802.40. Found: 802.4. 
3.4.2.6 Synthesis Of Compound 3-31 
Compound 3-30 (TFA salt, 13.2 mg, 16.4 μmol) and compound 3-28 (12 mg, 16.4 
μmol) were transferred to the same vial and dissolved in 0.2 mL DMF.  Then ascorbic 
acid (2.89 mg, 16.4 μmol) and CuSO4·5H2O (0.41 mg, 1.64 μmol) were added and the 
reaction mixture was stirred under Ar at RT for 24 h. After removing the solvent in vacuo, 
the product was purified by HPLC to yield compound 3-31 (5 mg, 20% yield) as dark 
blue solid. 1H NMR (400 MHz, Methanol-d4) δ 8.39 – 8.34 (m, 2H), 8.19 (dt, J = 1.8, 
1.0 Hz, 1H), 8.16 (ddd, J = 7.8, 1.8, 1.1 Hz, 1H), 8.02 – 7.98 (m, 2H), 7.96 (ddd, J = 7.9, 
1.9, 1.1 Hz, 1H), 7.78 – 7.72 (m, 2H), 7.70 (t, J = 7.8 Hz, 1H), 7.65 (s, 1H), 7.31 (s, 1H), 
7.27 (s, 1H), 7.23 (d, J = 1.1 Hz, 1H), 7.16 (q, J = 1.8 Hz, 2H), 6.85 – 6.78 (m, 2H), 6.54 
(s, 2H), 6.41 (d, J = 6.0 Hz, 2H), 4.66 – 4.59 (m, 3H), 4.49 (dt, J = 6.9, 4.3 Hz, 2H), 3.99 
(s, 3H), 3.95 (s, 3H), 3.94 – 3.86 (m, 2H), 3.82 – 3.73 (m, 10H), 3.63 (s, 2H), 3.59 (d, J = 
7.9 Hz, 2H), 3.57 – 3.51 (m, 1H), 3.51 – 3.41 (m, 5H), 3.37 (t, J = 6.3 Hz, 3H), 3.17 – 
3.10 (m, 4H), 3.10 – 3.03 (m, 4H), 2.97 (dd, J = 14.9, 8.8 Hz, 1H), 2.26 (q, J = 5.9, 4.7 
Hz, 2H), 2.01 (dd, J = 12.6, 5.5 Hz, 2H), 1.81 (p, J = 6.3 Hz, 2H), 1.63 – 1.56 (m, 4H), 
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1.25 (t, J = 7.2 Hz, 3H). MS (FAB+) m/z Calcd. For C77H86N19O14S [M]+:1532.63. 
Found: 1533.4. 
3.4.2.7 Synthesis Of Compound 3-32 
Compound 3-30 (TFA salt, 11 mg, 13.7 μmol) and compound 2-11 (15 mg, 20.5 
μmol) were transferred to the same vial and dissolved in 0.2 mL DMF.  Then ascorbic 
acid (2.4 mg, 13.7 μmol) and CuSO4·5H2O (0.34 mg, 1.37 μmol) were added and the 
reaction mixture was stirred under Ar at RT for 24 h. After removing the solvent in vacuo, 
the product was purified by HPLC to yield compound 3-32 (8 mg, 38% yield) as dark 
blue solid. 1H NMR (400 MHz, Methanol-d4) δ 8.82 (m, 1H), 8.01 – 7.95 (m, 2H), 7.77 
(d, J = 0.4 Hz, 1H), 7.77 – 7.75 (m, 2H), 7.70 (d, J = 8.0 Hz, 1H), 7.66 (d, J = 8.4 Hz, 
1H), 7.64 (s, 1H), 7.60 – 7.58 (m, 1H), 7.34 (s, 1H), 7.22 (s, 1H), 7.12 (m, 2H), 7.10(s, 
1H), 6.82 – 6.80 (m, 2H), 6.54 (s, 2H), 6.39 – 6.37 (m, 2H), 4.64 – 4.60 (m, 3H), 4.51 – 
4.47 (m, 2H), 3.92 – 3.88 (m, 5H), 3.81 – 3.72 (m, 10H), 3.62 (s, 2H), 3.61 – 3.50 (m, 
3H), 3.49 – 3.45 (m, 5H), 3.34 – 3.32 (m, 3H), 3.15 – 3.14 (m, 1H), 3.10 (s, 3H), 3.04 – 
3.03 (m, 4H), 3.00 – 2.94 (m, 1H), 2.54 (s, 3H), 2.53 (s, 3H), 2.26 – 2.25 (m, 2H), 2.00 (p, 
J = 7.2 Hz, 2H), 1.80 (p, J = 6.0 Hz, 2H), 1.60 (s, 4H), 1.24 (t, J = 7.2 Hz, 3H). MS 
(FAB+) m/z Calcd. For C78H88N19O13S [M]+:1530.65. Found: 1531.0. 
3.4.3 In Vitro Characterization Of TMP-Q-Atto655 
The protocols for fluorometric measurement, gel-shift assay, and live cell imaging 
were the same as those for TMP-Q-Atto520, as described in Section 2.6.3. 
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3.4.4 Attempts To Synthesize TMP-QSY21-Atto655. 
3.4.4.1 Synthesis Of Compound 3-36 
Compound 3-6 (780 mg, 1.37 mmol) was dissolved in 20 mL DCM. 
Chlorosulfuric acid (91 µL, 1.37 mmol) and 5 mL acetic anhydride were added and the 
reaction was stirred at RT for 16 h before concentrated. The crude product was purified 
by flash column chromatography (6:1 -> 3:1 DCM:MeOH with 0.5% TFA, v/v) to yield 
compound 3-36 (330 mg, 37% yield, Rf = 0.56 in 3:1 DCM:MeOH with 0.5% TFA, v/v). 
1H NMR (400 MHz, Methanol-d4) δ 8.29 – 8.25 (m, 1H), 7.81 – 7.76 (m, 2H), 7.76 – 
7.69 (m, 2H), 7.62 (t, J = 8.5 Hz, 2H), 7.57 – 7.50 (m, 3H), 7.47 (d, J = 2.3 Hz, 1H), 7.41 
(dd, J = 9.6, 2.9 Hz, 2H), 7.39 – 7.34 (m, 2H), 7.31 – 7.24 (m, 1H), 7.11 (td, J = 7.4, 0.9 
Hz, 1H), 4.26 (q, J = 7.9 Hz, 4H), 3.29 – 3.22 (m, 4H). MS (FAB+) m/z Calcd. For 
C35H26N2O7S2 [M+H]+:651.12. Found: 651.3. 
3.4.4.2 Synthesis Of Compound 3-37 
Compound 3-36 (100 mg, 0.154 mmol) was dissolved in 1 mL phosphoryl 
chloride and stirred at 70 °C for 6 h. The phosphoryl chloride was then removed by rotary 
evaporation and the product was directed used for following reactions without 
purification (quantitative). 
3.4.4.3 Synthesis Of Compound 3-38 
Compound 3-7 (98 mg, 0.166 mmol) was dissolved in 1 mL DCM and was cooled 
to 0 °C in ice bath. Piperidine (164 µL, 1.66 mmol) was then added to the solution. The 
reaction was stirred in ice bath for 2 h before warmed up to RT and stirred for another 12 
h. Then the solution was concentrated by rotary evaporation and crude product was 
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purified by flash column chromatograph on silica gel (15:1 DCM:MeOH. v/v), yielding 
compound 3-38 (133 mg with impurity, Rf = 0.14 in 15:1DCM:MeOH). 1H NMR (400 
MHz, Chloroform-d) δ 8.10 (dd, J = 7.8, 1.4 Hz, 1H), 7.89 (td, J = 7.5, 1.4 Hz, 1H), 7.84 
(td, J = 7.7, 1.4 Hz, 1H), 7.59 – 7.55 (m, 3H), 7.55 – 7.51 (m, 3H), 7.50 (dd, J = 7.6, 1.5 
Hz, 1H), 7.35 (dd, J = 7.4, 1.4 Hz, 2H), 7.29 (dd, J = 8.6, 2.8 Hz, 4H), 7.16 – 7.09 (m, 
2H), 4.38 (t, J = 7.9 Hz, 4H), 3.32 (t, J = 7.9 Hz, 4H), 2.95 (t, J = 4.3 Hz, 4H), 1.60 (m, 
6H). MS (FAB+) m/z Calcd. For C40H36N3O3S [M]+:638.25. Found: 638.2. 
3.4.5 Construction Of eDHFR Libraries 
3.4.5.1 Library Construction By Error-Prone PCR 
eDHFR:L28C gene from plasmid CJ-53 was amplified using primer pCJ-28 5’- 
TGG TGG TTC TGG TGG TGG TGG TTC TGG TGG TGG TGG TTC Tat cag tct gat 
tgc ggc gtt agc-3’ and pCJ-29 5’-GAG GGT TAG GGA TAG GCT TAC CTT CGA 
AGG GCC CTC TAG Acc gcc gct cca gaa tct caa ag-3’. The recipe for error-prone PCR 
mixture was listed in Table 3-1. 
Table 3-1 Composition of the error-prone PCR mixture. 
Reagent Volume / µL 
100 mM Tris buffer, pH8.3 10 
2 M KCl 2.5 
50 mM MgCl2 14 
25 mM dCTP 4 
25 mM dTTP 4 
5 mM dATP 4 
5 mM dGTP 4 
100 µM 5’ primer 2 
100 µM 3’ primer 2 
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200 pg/µL DNA template 10 
25 mM MnCl2 2 
GoTag DNA polymerase 1 
H2O 40.5 
Total volume: 100 
The PCR cycle was described in Table 3-2. 
Table 3-2 Thermal cycles for error prone PCR. 
Temprature / °C Time /min Cycle 
94 5 1 
94 0.5 20 
50 0.5 
72 1 
72 7 1 
8 Forever 1 
The PCR product was then purified by agarose gel electrophoresis and 
transformed into yeast strain EBY100 in addition to backbone vector pYD1 digested with 
NheI and XhoI. This digested pYD1 was also used as backbone vector for cassette 
mutagenesis. 
3.4.5.2 Cassette Mutagenesis To Construct The Yellow Library 
To construct the yellow library, eDHFR was amplified in two rounds of regular 
PCR: 
PCR 1. Template pCJ-32 5’- G GTA GAT CGC GTT ATC GGC ATG GAA 
NNK NNK NNK NNK NNK NNK NNK CCT GCC GAT TGC NNK TGG TTT NNK 
CGC AAC ACC TTA AAT AAA CCC GTG AT-3’. Primers pCJ-33 5’- TGG TGG TTC 
TGG TGG TGG TGG TTC TGG TGG TGG TGG TTC TAT CAG TCT GAT TGC 
GGC GTT AGC GGT AGA TCG CGT TAT CGG CAT GGA A-3’ and pCJ-34 5’- ATG 
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GCG GCC CAT AAT CAC GGG TTT ATT TAA GGT GTT GCG-3’. (N: any base; K: 
G or T. NNK encode relatively less stop codons compared to NNN.) 
PCR 2. Template plasmid V2607. Primers pCJ-35 5’-CGC AAC ACC TTA AAT 
AAA CCC GTG AT-3’ and pCJ-29 as described above. 
Products of PCR 1 and PCR 2 were transformed into yeast strain EBY100 in 
addition to the digested pYD1 backbone vector. 
3.4.5.3 Cassette Mutagenesis To Construct The Blue Library 
To construct the blue library, eDHFR was amplified in three rounds of regular 
PCR: 
PCR 1. Template pCJ-36 5’- ATG GGC CGC CAT ACC TGG GAA NNK NNK 
NNK NNK NNK NNK NNK GGA CGC AAA AAT ATT ATC CTC AGC AGT C-3’. 
Primers pCJ-37 5’- CTT AAA TAA ACC CGT GAT TAT GGG CCG CCA TAC CTG 
GGA A -3’ and pCJ-38 5’- CCG TAC CCG GTT GAC TGC TGA GGA TAA TAT TTT 
TGC GTC C -3’. 
PCR 2. Template plasmid V2607. Primers pCJ-28 as described above, and pCJ-
39 5’- TTC CCA GGT ATG GCG GCC C-3’. 
PCR 3. Template plasmid V2607. Primers pCJ-40 5’- GGA CGC AAA AAT 
ATT ATC CTC AGC AGT C-3’ and pCJ-29 as described above. 
Products of PCR 1, PCR 2, and PCR 3 were transformed into yeast strain 
EBY100 in addition to the digested pYD1 backbone vector. 
3.4.5.4 Yeast Transformation 
We used a high efficiency yeast electroporation protocol with slight modification. 
A 10 mL culture of FY251 was inoculated in fresh YPD and incubated at 30 °C overnight 
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(250 mL). The overnight culture was used to inoculate 100 mL of 30 °C YPD to reach an 
OD600 = 0.1. This culture was grown to an OD600 = 0.6 – 0.8 (~ 4.5 hr). Then 1 mL 
filter-sterilized 1,4-dithiothreitol (DTT) solution (1M Tris, pH 8.0, 2.5 M DTT) was then 
added to the 100 mL of YPD. The cells were grown at 30 °C for another 20 min. From 
this point forward, the cells were kept on ice. The cells were harvested in two 50 mL 
Falcon tubes at 2000 rpm at 4 °C for 5 min. For each tube, the supernatant was discarded 
and the cells were washed twice with 50 mL of E-buffer (10 mM Tris, pH 7.5, 270 mM 
sucrose, 1 mM MgCl2) by pipetting up and down. The cells were reharvested and 
resuspended in 1 mL of E-buffer and transferred to an autoclaved 1.5 mL microcentrifuge 
tube and spun down again in a tabletop centrifuge at 12000 rpm for 10-20 s. The 
supernatant was discarded and resuspended using 40 µL of E-buffer. The cells were 
distributed in 4 tubes containing pelleted vector and linear DNA cassette, and incubated 
on ice for 10 min (approximately 60 µL cells per tube). The gene pulser was set to 540 V, 
25 μF, 0 Ω, and the cells were transferred to 2 mm electroporation cuvettes. Immediately 
after electroporation the cells were recovered with 1 mL of 30 °C YPD. The cells were 
then incubated at 30 °C for 1 hr before plating on SC (HT- Glc) plate. 
3.4.5.5 Plasmid Mini-Prep From Yeast 
Regular colony PCR protocols do not work well with yeast cells. Therefore to 
sequence the plasmid in yeast cells, we first need to extract them and transform into 
E.coli cells. 
Yeast cells were harvested by scraping agarose plates and resuspeded in 250 µL 
P1 buffer from the Qiagen Mini-prep kit. Add 50 – 100 µL glass beads, seal the 
eppendorf and vortex at high speed for 5 min. Then the supernatant (means everything 
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except glass beads; no need to spin down) was transferred to a new eppendorf and 
processed following the Qiagen Mini-prep protocol. 
After yeast mini-prep, the DNA was tranformed into E.coli for colony PCR and 
DNA sequencing. 
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4 Chapter 4 





4.1 Chapter Overview 
In this chapter I describe our works in collaboration with the Sheetz lab applying 
out TMP-tag to study the molecular mechanism of cell motility. Specifically, we focus on 
the assembly and remodeling of the focal adhesion complex (FAC) in response to 
mechanical force. Remarkably, we have used the TMP-tag in combination with FPs to 
build a toolbox for multi-color live cell imaging with single-molecule resolution. 
Specifically, I synthesized a far red chemical tag TMP-Atto655 that featured a 
high photon output, photo-switching fluorophore. In previous studies this tag has enabled 
live cell super-resolution imaging of nucleus protein H2B. However, when we initially 
tried to apply it to label focal adhesion proteins, we found it quite challenging to achieve 
high labeling efficiency and selectivity. Therefore we first developed an electroporation-
based protocol to efficiently deliver the small molecule into fibroblasts. 
With the improved cell labeling protocol we have achieved multi-color live cell 
imaging with high S/B. Significantly, we have successfully used the TMP-Atto655 to 
label not only nuclear localized, but also highly dynamic cytosolic protein such as MLC, 
α-actinin, talin, and vinculin. We were also excited to learn that this probe also enabled 
one color and two color super-resolution imaging in living cells. 
Finally, we labeled a key component of FAC, the vinculin, with TMP-Atto655, 
and tried to observe its recruitment to FAC by talin stretching. We imaged the 
vinculin/talin interaction in live cells at both ensemble and single-molecule level, 
revealing interesting phenomenon that has never been observed in traditional in vitro 
experiments. Remarkably, to our best knowledge, this was the first example of three color 





The sensing of cellular forces and substrate rigidity plays fundamental roles in 
cell growth, death and differentiation. How cells transduce matrix forces into chemical 
responses, however, remains unclear. Previous studies on cytoskeletal and signaling 
proteins have formed a consensus that the mechanical stretching of proteins is a major 
mechanism for force sensing (Figure 4-1). The Sheetz laboratory has previously shown in 
vitro and in situ that mechanical unfolding of talin leads to vinculin binding.1 
Additionally, it has been recently found that during early adhesion formation in live cells, 
the vinculin is only recruited to the integrin cluster upon myosin II contraction.2 The next 
challenge now is to understand how stretch-relaxation cycles of talin and other focal 
adhesion complex (FAC) components signal to the whole cell through stretch-dependent 
binding proteins such as vinculin. 
 
Figure 4-1 Hypothesized mechanism of force sensing at FAC. 
The head domain of talin binds to transmembrane protein integrin, coupling actin filaments to 
exracellular matrix. Talin rod contains multiple vinculin binding sites that are buried in helix 
bundles. Upon stretching by mechanical force, talin rod is unfolded and the encrypted vinculin 
binding sites are exposed, inducing vindulin binding. In this way the mechanical signal is 
transduced into chemical response. 
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In the primary stage of achieving our goal of measuring talin stretching and 
correlated vinculin binding in vivo, the Sheetz laboratory first developed a single-
molecule (SM) imaging system to quantify the orientation and extent of talin stretching in 
live cells.3 In brief, they labeled the N- and C-termini of talin with EGFP and mCherry, 
respectively, and measured the length and orientation of the talin molecules by locating 
the centroid positions of the green and the red pair. SM resolution was achieved by 
selectively observing cells with low-level expression of the EGFP-talin-mCherry 
construct. The results showed that the C-terminal actin-binding site of talin was displaced 
in the direction of actin flow by 90 – 200 nm from the N-terminus and that relaxation and 
stretching of talin was at 10s of second scale along the direction of actin movement. 
Here we further challenge the potential of live cell SM imaging by adding a third 
color on top of EGFP and mCherry and evaluate talin stretching and vinculin binding 
simultaneously in intact cells. Notably, it is hard to achieve live cell SM imaging with 
three fluorescent proteins due to their overlapping excitation and emission spectra as well 
as limited photon output. Therefore we take advantage of the chemical tag technology, in 
specific the TMP-tag, to label intracellular proteins with a far-red organic fluorophore 
Atto655 (Ex: 655 nm, Em: 680 nm) that is not only spectrally resolvable with EGFP and 
mCherry, but also high photon output to enable live cell SM imaging. 
The TMP-tag relies on the high-affinity interaction between E. coli dihydrofolate 
reductase (eDHFR) and the folate analog trimethoprim (TMP). In brief, the target protein 
is tagged with eDHFR, which binds TMP with high affinity and selectivity.4  Organic 
fluorophores can be conjugated to TMP with only minor perturbation of the high-affinity 
binding to eDHFR. Among numerous chemical tags reported in the past decade, TMP-tag 
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is one of the few chemical tags that can label proteins with high efficiency and selectivity 
both in vitro and inside of live cells.5 Significantly, from the beginning the TMP-tag has 
been developed through applications to study adhesion-dependent signaling. Now we 
reach for the highly demanding goal of labeling highly dynamic intracellular protein 
vinculin and enabling three-color live cell SM imaging with high spatial and temporal 
resolution.  
4.3 Results 
4.3.1 Synthesis Of TMP-Atto655. 
The synthesis of TMP-Atto655 (Scheme 4-1) was performed following previous 
reports.6 (Details of some steps were not fully described in this publication.) 
 
Scheme 4-1 Synthesis of TMP-Atto655 (compound 4-5). 
 Reaction conditions: a. ethyl bromovalerate, K2CO3, DMF; b. i) 1N NaOH, MeOH, H2O, RT 3 h; ii) 
1N HCl;  c. Boc-1-amino-4,7,10-trioxa-13-tridecanamine (CAS: 194920-62-2), PyBOP, DIEA, 
DMF, RT, 16 h; d. 1:1 TFA:DCM (v/v), RT, 1 h; e. DIEA, DMF, RT, 16 h. 
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As outlined in Scheme 4-1, the synthesis of TMP-Atto655 started from selective 
hydrolysis of the 4’-methyloxy group in trimethoprim, which has been described in 
Chapter 2. Hydrolysis product compound 2-1 was purified by recrystallization from water 
and then alkylated using ethyl bromovalerate catalyzed by potassium carbonate, yielding 
intermediate 4-1. Saponification of compound 4-1 produced intermediate 4-2 which was 
coupled to mono-Boc-protected polyethylene glycol (PEG). After removing the Boc 
protective group, intermediate 4-4 was reacted with Atto655-NHS ester to yield final 
product TMP-Atto655 (compound 4-5). 
The final product TMP-Atto655 was purified by HPLC and dissolved in 
anhydrous DMF. The concentration was determined by UV-visible absorption (extinction 
coefficient ε663 = 1.25 X 105 cm-1M-1). 
4.3.2 Optimization Of The TMP-Tag Technology For Three-Color Live Cell 
Imaging.  
The chemical tag technology is undergoing the transition from proof-of-principle 
stage to enabling sophisticated biophysical measurements that are otherwise hard or 
impossible with fluorescent proteins. Previous reports using the high photon output dye 
Atto655 for live cell imaging have focused on labeling plasma membrane of nuclear 
localized protein. However, we found the traditional cell staining method is not capable 
to efficiently deliver the TMP-Atto655 into live fibroblasts (Figure 4-2). Therefore we 
developed the electroporation protocol to load the TMP-Atto655 simultaneously with 




Figure 4-2 Live cell imaging with TMP-Atto655 using conventional staining protocol. 
 RPTP cells (a cell line derived from mouse embryonic fibroblasts) were transiently transfected 
with TOMM20-eDHFR and α-actinin-eDHFR, respectively. Cells were co-transfected with H2B-
EGFP as transfection indicator. 24 h after transfection, cells were incubated with 5 µM TMP-
Atto655 in media for 1 h at 37 °C, and then washed twice before imaging with confocal 
microscopy. Although the cells were well transfected (indicated by the strong signal in EGFP 
channel), none of the target protein was specifically labeled by Atto655. The bright spots in 
Atto655 channel are presumably dye molecules accumulated in endosomes or non-specific 
aggregation. 
Electroporation has been previously used to deliver fluorophores into live 
mammalian cells and embryos. In these conventional protocols cells were transfected and 
then labeled in a two-step manner. Here we developed a new method for multi-color live 
cell imaging with chemical tags: mammalian cells were electroporated with plasmids 
encoding target protein-eDHFR and TMP-Atto655. During electroporation DNA and 
fluorophores were loaded simultaneously. After electroporation cells were incubated in 
fresh media at 37 °C overnight and briefly washed before imaging. As presented in 
Figure 4-3, loaded by electroporation, TMP-Atto655 labeled the target proteins MLC and 
α-actinin with high specificity, showing the desired sub-cellular localizations. 
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Significantly, the bright spots caused by non-specific staining have been eliminated with 
this new electroporation protocol. 
 
Figure 4-3 Live cell imaging with TMP-Atto655 loaded by electroporation. 
 RPTP cells were electroporated with plasmids encoding α-actinin-eDHFR and MLC-eDHF, 
respectively, with 5 µM TMP-Atto655 added to the electroporation buffer. Cells were co-
transfected with H2B-EGFP as transfection indicator. 18 h after transfection, cells were washed 
twice with media before imaging with confocal microscopy. Significantly, both target proteins 
showed desired localization with not non-specific staining observed.  
Next we further optimized the dye concentration and electroporation voltage to 
achieve maximal signal-to-background (S/B). Specifically, we have found that with the 
Invitrogen Neon® Transfection System, electroporation at 1700 V for 20 ms is optimal 
for RPTP cells, while the voltage should be adjusted to 1350 V for CV1 cells. With 20 
µM TMP-Atto655 in the electroporation buffer, the signal intensity in the Atto655 
channel has been comparable to that with FPs. As presented in Figure 4-4, using TMP-tag 
we have achieved multi-color live cell imaging with high S/B, labeling not only abundant 
and localized protein (such as H2B) but also diffused, highly dynamic target proteins. 
Remarkably, we observed no crosstalk between the mCherry and Atto655 channels when 




Figure 4-4 Multi-color live cell imaging with TMP-Atto655. 
Row 1: RPTP cells electroporated with EGFP-talin-mCherry (GTC), MLC-eDHFR, and 20 µM 
TMP-Atto655, imaged with confocal microscopy. Row 2: CV1 cells electroporated with GTC, 
eDHFR-vinculin, and 20 µM TMP-Atto655, imaged with total internal reflection fluorescence 
(TIRF) microscopy. Row 3: RPTP cells electroporated with MLC-eDHFR, EGFP-vinculin, H2B-
mCherry, and 20 µM TMP-Atto655, imaged with confocal microscopy.  
We have further confirmed the capability of the TMP-tag for labeling FAC 
components by performing fluorescence recovery after photobleaching (FRAP) 
experiments. Specifically, fluorescence recovery time constant τ, which is the reciprocal 
of koff (rate constant of protein unbinding), was measured for vinculin labeled with EGFP 
and eDHFR/TMP-fluorescein, respectively. Here fluorescein was used instead of Atto655 
because the former was prone to be photo-bleached. As displayed in Figure 4-5, no 
significant difference in τ, which indicates the dynamics of the target protein, was 
observed between the two tags. These results in addition to the facts that (1) the 
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eDHFR/TMP tag is about two thirds the size of FPs and (2) the dissociation half time of 
eDHFR/TMP complex was estimated to be tens of minutes, much longer than τ, together 
established the TMP-tag as a viable probe to study the dynamics of focal adhesion 
complex. 
 
Figure 4-5 FRAP experiments with TMP-tag. 
 RPTP cells were transfected with plasmids encoding eDHFR-vinculin and EGFP-vinculin, 
respectively. For eDHFR labeling, cells were stained with 5 µM TMP-fluorescein in media by 
incubating at 37 °C for 2 h. FRAP experiments were performed on confocal microscope using 488 
nm laser for photo-bleaching. (A) Representative images from FRAP experiments, showing cells 
before photo-bleaching, immediately after photo-bleaching and 60 s after photo-bleaching, 
respectively. Photo-bleaching produce a small area (indicated by white arrow) with low 
fluorescence intensity, which would recover over time. The kinetics of recovery is characterized 
by fluorescence recovery time constant τ. (B) τ value of vinculin labeled with GFP and TMP-tag, 
respectively. Error bars represents standard deviation calculated from 10 independent FRAP 
traces. 
In addition to the non-covalent TMP-tag, we have also applied the second 
generation covalent TMP-tag for imaging FAC components. Compared to non-covalent 
TMP-tag, the covalent TMP-tag has several advantages: (1) The covalent TMP-tag is 
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compatible with fixed cell imaging, while the non-specific TMP-tag is not. Super-
resolution imaging, which takes longer time (typically at scale of minutes to hours) than 
regular imaging (typically at scale of milliseconds to seconds), may benefit from fixed 
cells that do not move or metabolize. (2) The covalent TMP-tag provides a permanent 
protein label that allows monitoring live cell over long period of time (up to 72 h). With 
the non-covalent TMP-tag, the fluorescence signal would gradually diminish (koff ~ tens 
of minutes) after washing. (3) The covalent TMP-tag could enable pulse-chase 
experiments, in-gel fluorescence detection, and pull-down assays, which are not possible 
with non-covalent TMP-tag. Specifically, we fused vinculin to eDHFR:L28C and labeled 
the target protein by electroporation with 20 µM A-TMP-Atto655.7 As presented in 
Figure 4-6, the second generation covalent TMP-tag labeled vinculin with high efficiency 
and specificity. Particularly, the fluorescence signal is well-retained after cell fixation. 
 
Figure 4-6 Three-color imaging with TMP-tag in live and fixed cells. 
RPTP cells were electroporated with plasmid encoding EGFP-talin-mCherry and eDHFR:L28C-
vinculin, in addition to 20 µM covalent TMP-Atto655 (A-TMP-Atto655). 24 h after transfection, 
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cells were washed with media and imaged with TIRF microscopy for live cell imaging. After live 
cell imaging, cells were fixed with 10% paraformaldehyde and imaged with TIRF microscopy. 
In summary, we have successfully developed a new procedure for live cell 
imaging using TMP-Atto655. Using electroporation, we have labeled target proteins with 
TMP-tag and achieved live cell imaging with high s/b. Significantly, the TMP-Atto655 
developed strong and specific fluorescence signal and has been shown to be spectrally 
resolvable with EGFP and mCherry. Therefore we can use the TMP-Atto655 in 
combination with EGFP and mCherry for 3-color live cell imaging, monitoring talin 
stretching and vinculin binding simultaneously. 
4.3.3 Live Cell Super-Resolution Imaging With TMP-Tag 
Theoretically, the resolution of fluorescence microscopy is limited to ~200 nm 
(roughly half of the wavelength of visible light) because of the diffraction barrier. 
Experimentally, the real resolution achieved by confocal or TIRF microscopes is further 
impaired by imperfections in the optical system. Therefore individual proteins in a 
densely packed macromolecular complex appear as overlapping, resolution-limited spots 
with conventional methods. Promisingly, this diffraction barrier has now been broken by 
super-resolution (SR) imaging techniques. Stochastic SR imaging technologies including 
PALM (photo-activatable localization microscopy) and STORM (stochastic optical 
reconstruction microscopy) hinge on photo-switchable fluorophores with high photon-
output that enable the locations of subsets of the total fluorophore population to be 
determined precisely over time (Figure 4-7A). Until recently, SR imaging has typically 
relied on either photo-activatable FPs, which have limited photon-output and palletes, or 
antibodies conjugated with organic fluorophores, which offer higher resolution and many 
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more colors, but are incompatible with live cells.  Chemical tags have the potential to 
combine the advantages of these two contrasting labeling methodologies—they are 
genetically encoded and thus compatible with live cells, and they are modular and thus 
allow use of photo-switchable high photon-output organic fluorophores. 
In 2010, we achieved a significant breakthrough towards our goal of SM imaging 
in live cells with the development of a TMP-Atto655 label that enables detection of 
single molecules with sub-diffraction resolution in live cells via dSTORM (direct 
stochastic optical reconstruction microscopy) in collaboration with Prof. Markus Sauer.6  
Specifically, as detailed in Figure 4-7B, we demonstrated that TMP-Atto655 could label 
histone protein 2B (H2B) tagged with eDHFR with reasonable S/B in HeLa cells and 
individual labeled nucleosomes could be resolved in live cells in both static images and 
dynamic movies at resolutions approaching 50 nm.  This report is highly significant 
because it demonstrated for the first time that a chemical tag could be used for single-
molecule imaging in a living cell. While live cell super-resolution imaging of H2B is a 
critical first step, we have found that dynamic cytosolic proteins with low abundance are 
very challenging for live cell dSTORM using the traditional cell staining protocols. Here 
we used the electroporation method to achieve high transfection and dye loading 




Figure 4-7 Live cell super-resolution imaging with TMP-tag. 
 (A) In conventional TIRF microscopy, the resolution set by the diffraction limit of light is ~200 nm, 
and thus individual protein molecules cannot be resolved. In dSTORM, small percentages of the 
total population of fluorophores are randomly photo-activated over time, allowing all individual 
fluorophores to be localized to resolutions of ~20 nm from the Gaussian fits of their point spread 
functions. (B) Upon irradiation by high power far-red laser ATTO655 is efficiently transferred to a 
reduced non-fluorescent state in the presence of millimolar concentrations of reduced thiol 
species (RSH). The fluorescent state is recovered upon reaction with molecular oxygen. The 
fraction of Atto655 in “on state” can be tuned by excitation laser, therefore enabling dSTORM 
imaging. 
Here we achieved live cell dSTORM imaging by delivering TMP-Atto655 into 
fibroblast cells during transfection by electroporation. Specifically, RPTP cells were 
transfected with plasmid encoding MLC-eDHFR and 20 µM TMP-Atto655. After 
electroporation cell were incubated overnight at 37 °C and washed with fresh media 
before imaging. The power of 633 nm laser was adjusted so that significant blinking 
events at sub-second scale are clearly visible. The dSTORM image shown in Figure 4-8A 
was reconstructed from 900 live cell TIRF images taken over 90 sec (frame rate: 10 
frame/sec). The resolution is remarkably improved compared to TIRF image. As shown 
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in Figure 4-8B, two MLC bundles separated by several hundred nanometers were clearly 
resolved. Using a eDHFR-talin construct we have also acquired high resolution image of 
talin labeled by TMP-Atto655. 
 
Figure 4-8 Live cell dSTORM imaging using TMP-Atto655. 
 (A) TIRF and dSTORM images of MLC labeled with TMP-Atto655. (B) dSTORM images of MLC 
and talin, demonstrating superior special resolution. 
Additionally, we have also used the TMP-tag in addition to FPs for multi-color 
live cell dSTORM imaging. In addition to MLC labeled with TMP-Atto655, we labeled 
another FAC component paxillin with speckleGFP, which was EGFP controlled by a low 
expression promoter. As displayed in Figure 4-9, live cell dSTORM imaging reveals fine 




Figure 4-9 Two-color live cell dSTORM imaging using TMP-tag. 
 Live human foreskin fibroblast (HFF) cells were electroporated with plasmids encoding paxillin-
speckleGFP, MLC-eDHFR in addition to 20 µM TMP-Atto655. 24 h after transfection cells were 
washed with fresh media and imaged using a Nikon N-STORM TIRF microscope. The green (Ex: 
488 nm) and far-red (Ex: 633 nm) channels were acquired simultaneously with laser power 
adjusted for adequate fluorophore blinking. dSTORM images were reconstructed from 1800 
frames taken over 3 min (frame rate: 10 frame/sec). 
Together these results demonstrated that TMP-Atto655 is a viable tag for live cell 
dSTORM imaging of not only nuclear-localized by also dynamic cytosolic proteins. 
Significantly, live cell super-resolution, in particular multi-color super-resolution imaging, 
has been very challenging using FPs because of limited availability of high photon output, 
photoswitching FPs. By contrast, using organic fluorophores up to 4-color STORM 
imaging has been accomplished – in fixed cells with antibody labeling. The chemical tag 
technology benefits from using modular organic fluorophores while retaining the 
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compatibility with live cell imaging. With our new methods for dye delivery, routine 
super-resolution imaging in live cell with multiple colors has been made possible. 
Moreover, since the reconstruction of dSTORM is based on SM detection of individual 
fluorophores, the success in dSTORM imaging also promised the feasibility of multi-
color SM analysis in live cell, which will be discussed in Section 4.3.5. 
4.3.4 Analysis Of Talin Stretching And Vinculin Binding At Ensemble Level. 
Having confirmed that the TMP-Atto655 can be applied to live cell imaging of 
FAC components in addition to EGFP and mCherry, potentially reaching SM resolution, 
the next step is to measure the extend of talin stretching and vinculin recruitment in live 
cells. In previous study of talin stretching, the Sheetz lab has found that talin stretching 
patterns observed in SM traces are similar to those obtained from multi-molecule analysis. 
In the multi-molecule method, the uncertainty of direction and the averaging of the multi-
molecule analysis are the shortcomings, whereas the ease of experiments and higher S/B 
are major advantages. Therefore here we decided to examine the impact of talin 
stretching on vinculin binding starting from multi-molecule analysis. 
Primarily, we measured the extent of talin stretch and change in vinculin intensity 
in mature focal adhesions. In brief, we labeled the N- and C-termini of talin with 
eDHFR/TMP-Atto655 and mCherry, respectively, and the vinculin was labeled with 
EGFP. The extent of talin stretching at ensemble level was evaluated as the displacement 
of the mCherry signal from the Atto655 signal. In both previous3 and this study we have 
observed that the N-terminus of talin remains stationary while only C-terminus moves. 
Therefore we further simplified the data processing method to monitor the movement of 
mCherry patches, which indicates talin stretching, while simultaneously measure the 
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fluorescence intensity in the EGFP channel which represents vinculin binding (Figure 
4-10B). 
Figure 4-10C shows the results from a representative experiment. In brief, CV1 
cell were transfected with plasmids encoding eDHFR-talin-mCherry and EGFP-vinculin. 
For each experiment, 120 frames were acquired during 240 s (2 s frame interval) using 
TIRF microscopy. The 3-D plot shown in Figure 4-10C (right panel) summarized the 
results: the x axis was the relative distance along the axis of a FAC (the grey line in left 
panel); the y axis was time; and the z axis was fluorescence intensity in EGFP channel, 
which was also color coded. The displacement of C-terminus of talin was evaluated 
following the methods previously developed by the Sheetz lab,3 and was depicted as the 




Figure 4-10 Multi-molecular analysis of FAC. 
 (A) Hypothesized model of vinculin binding to stretched talin at FAC. (B) EGFP-vinculin and 
eDHFR-Talin-mCherry were used to monitor talin stretching and vinculin binding at ensemble 
level. Vinculin dynamics were traced by drawing a line diagonally across the long axis of FAC and 
measuring the intensity profile along this line over time. Talin stretching was monitored by using 
previously published multimolecule algorithm to trace the edge of C-terminus of talin (towards the 
cell pheripheral). (C) Live cell TIRF image of FAC and line of measurement. Measurements were 
done on single focal adhesions, as described above, a profile was drawn a long the long axis of 
an individual FAC. The X axis of the illustration on the right hand side corresponds to the pixel 
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location along the drawn profile, the z axis represent the fluorescence intensity in EGFP-vinculin 
channel in arbitrary unit, and the Y axis represents the time (in seconds). Finally, the sharp peaks 
at the purple region represent the location of the edge of the C-terminus of talin. (D) Top view of 
the 3-D plot in (C), in which the movement of C-terminus of talin can be clearly observed. 
Contrary to our original hypothesis, quantitative analysis showed that vinculin 
binding at ensemble level did not significantly depend on talin stretching. As represented 
in Figure 4-11B, talin in peripheral FACs was found to stretch to a greater extent 
compare with talin in central FACs, which was consistent to results from previous report. 
However, the fluctuation of vinculin binding in peripheral FACs was no greater than that 
of central FACs (Figure 4-11C). Therefore we suspected that the change in EGFP 
intensity we have observed may not be caused by specific vinculin/talin interaction. 
Instead, it might be merely intrinsic vinculin fluctuation that was not in response to 
mechanical force. 
On the other hand, we have also observed another interesting phenomenon: the 
internal tracking of vinculin within a FAC. As displayed in Figure 4-11D, in some FACs 
with vigorous talin stretching, the profile of vinculin intensity actively shifted along the 
axis of FAC over time, although the fluorescence intensity of the whole FAC did not 
significantly change. In contrast, in an inactive FAC without talin stretching, the vinculin 
also stayed stationary. As far as we know, this internal trafficking of vinculin within FAC 
has never been documented. This phenomenon may imply special mode of talin/vinculin 




Figure 4-11 Vinculin recruitment to mature adhesions was not stretching dependent. 
 (A) CV1 cells were transfected with plasmids encoding EGFP-vinculin and eDHFR-talin-mCherry. 
Live cell imaging of FAC dynamics was performed using TIRF microscopy, showing the merged 
EGFP and mCherry channels. The red and blue line indicated the peripheral and central FACs, 
respectively, analyzed in (B) and (C). (B) Stretch-relax cycle of talin measured as the relatively 
location of its C-terminus. The extent of stretch was reflected by the relative standard deviation 
(%RSD) of the trace. Talin in peripheral FAC stretched more actively (with greater %RSD) than 
talin in central FAC. (C) The fluctuation in EGFP-vinculin fluorescence intensity (in arbitrary unit, 
A.U.) within entire FAC. The peripheral and central FACs in (A) was circled individually, and 
fluorescence intensity within the whole FAC patch was measured for each time point. Standard 
deviation of the fluorescence intensity trace indicated the variability of vinculin binding at the FAC. 
We anticipated to see vigorous vinculin association/dissociation events at the peripheral FAC, 
reflected by a greater %RSD compared to that of central FAC. However, the results were the 
opposite: the %RSD of EGFP-vinculin intensity in central FAC was slightly greater than that of 
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peripheral FAC. Similar results were also observed in other independent experiments. (D) The 
internal vinculin trafficking may be stretching dependent. 3-D plots of FAC dynamics was 
obtained as described in Figure 4-10. Vinculin shifting was observed in some FACs with active 
talin stretching; while in FACs without active talin stretching the vinculin also remained stationary. 
At this point the anti-intuitive results from ensemble measurement of FAC may be 
explained by (1) our original hypothesis was disapproved; the recruitment of vinculin to 
FAC is not affected by talin stretching; (2) the multi-molecular measurement was not 
robust enough to reveal the subtle dynamics of vinculin binding; or (3) the ensemble 
analysis was mostly performed for mature FACs, which were not dynamic enough to 
observe vinculin recruitment. Before discarding our original hypothesis, we first need to 
rule out situation (2) and (3). 
It has been shown in previous reports that active vinculin recruitment could be 
observed in nascent FAC within a short period of time (< 1 h) after cell spreading.2 
Unfortunately, one limitation of our ensemble analysis was that the data processing 
algorithm was optimized for mature, highly localized FACs with clear boundary. With a 
nascent FAC that shows low fluorescence signal and poorly-defined shape the 
displacement of C-terminus of talin was not able to be determined accurately. In mature 
FACs the vinculin might be locked by interacting with many other proteins (eg. actin, 
paxillin, α-actinin) so that the association/dissociation no longer solely depends on talin 
stretching.  
In order to evaluate the effect of talin stretching on vinculin binding in nascent 
FAC we used a small molecule myosin inhibitor blebbistatin to manipulate talin 
stretching. Blebbistatin binds to myosin II with high affinity and specificity and therefore 
reversibly inhibits the talin stretching caused by contraction of myocrofilaments.8 
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Administrated at 10 µM, blebbistatin can effectively disrupt talin stretching in live CV1 
cells. As displayed in Figure 4-12, in newly spreading cells blebbistatin significantly 
interfered formation of FACs: vinculin and talin localization was impaired; and FACs 
were smaller in sizes in cells spreading with blebbistatin compared to that without 
blebbistatin. 
 
Figure 4-12 Blebbistatin impaired FAC formation in spreading cells. 
 Live CV1 cells expressing EGFP-vinculin and eDHFR-talin-mCherry were suspended in fresh 
media (A) and media with 10 µ blebbistatin (B), respectively, and incubated in centrifuge tube for 
1 h at 37 °C. Then cells were reseeded on cover slip and incubated for 30 min at 37 °C before 
imaged using TIRF microscope. (A) The cell incubated in media showed normal FAC with highly 
localized vinculin and talin. (B) The cell incubated with blebbistatin had smaller FACs and both 
vinculin and talin were less localized; instead they tended to diffuse around the cell. The right 
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column displays the pseudo-color images which result from dividing the EGFP intensity by 
mCherry intensity at each pixel: yellow-orange color represents high vinculin/talin ratio. 
Next we monitored the change in vinculin and talin intensity while washing off 
blebbistatin. With blebbistatin withdrawal, the myosin/actin contraction, and 
consequently talin stretching, was anticipated to be restored. Therefore we expected to 
observe active FAC assembly and vinculin recruitment. Here we quantified the 
stretching-dependent vinculin recruitment by normalizing EGFP-vinculin intensity over 
talin-mCherry intensity (Figure 4-12 right column). The reason to use vinculin/talin ratio 
instead of vinculin intensity alone was: if vinculin intensity increased after blebbistatin 
wash out, but talin intensity also increased by the same ratio, this vinculin recruitment 
might just be caused by the presence of talin, not talin stretching. After normalization 
over talin intensity, the vinculin/talin ratio would represent the stretching-dependend 
vinculin binding. 
Figure 4-13 shows the results from all 5 cells sampled. In less than half of the 
cells we have observed significantly increase in vinculin/talin ratio after blebbistatin 
washout, represented by cell 2 in Figure 4-13A. However, in the other cells (represented 
by cell 3 in Figure 4-13B) the overall vinculin/talin ratio either remained largely 
unchanged or slightly decreased after blebbistatin washout. From these results it was still 





Figure 4-13 Change in vinculin/talin ratio during blebbistatin washout. 
 Live CV1 cells expressing EGFP-vinculin and eDHFR-talin-mCherry were suspended and 
incubated with 10 µM blebbistatin before seeded on cover slip. TIRF images were taken at 30 
min after reseeding and then blebbistatin wash out with fresh media. After incubating in fresh 
media for another 20 min, the same cell was imaged again. (A) Pseudo-color images of 
vinculin/talin ratio in cells spreading with blebbistatin and after washout, respectively. Blue-black 
represents low vinculin/talin ratio and pink-orange color represents high ratio. All images were 
accompanied by histogram and statistics of intensity, which is the ration of EGFP-vinculin over 




Taken together, the analysis of vinculin recruitment at ensemble level provided 
mixed results. Basically we did not find strong evidence supporting our original 
hypothesis. On the other hand, it has been documented in literature that vinculin has 
complex dynamics interacting with itself and other cellular proteins: the head and tail 
domain of vinculin usually bind to each other with high affinity and cover most of the 
binding sites of vinculin, which is known as the autoinhibition of vinculin. As the head-
tail affinity of vinculin is higher than any cellular ligand-vinculin affinity along, the key 
mechanism of vinculin activation is believed to be the combinatorial binding of two 
ligands. In vitro experiments have shown that neither the talin rod nor F-actin alone can 
activate vinculin but the presence of both ligands can introduce a dose dependent 
activation of vinculin.9 Other evidences suggests that vinculin phosphorylation might 
play a role in vinculin activation as well,10 but how and what activates vinculin under 
physiological condition remains unclear. Besides, vinculin has been found to be able to 
bind more than 10 binding partners at FAC, and the molecular details of these 
interactions are mostly myths, especially in live cells. Using the multi-molecular methods 
what we observed was merely the sum of all these effects. Therefore based on these 
reports and our results at ensemble level, now we believe that single-molecule analysis 
could be the only viable tool to deconvolute the complex interaction network and study 
the dynamics of talin-vinculin interaction in live cells. 
4.3.5 Single-Molecule Analysis Of Vinculin Binding In Response To Talin 
Stretching 
In Section 4.3.3 we have demonstrated live cell dSTORM imaging using TMP-tag, 
which was based on single-molecule (SM) recognition. Here we further challenge our 
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technology to achieve analysis of vinculin binding simultaneous with talin stretching at 
SM level.  
In our previous studies, the orientation and extent of talin stretching has been 
evaluated at SM level by localizing the N- and C-termini of GFP-talin-mCherry in live 
CV1 cells. In cells with low expression and well-separated fluorophores, single talin 
dimer can be detected as two EGFP molecules next to at least one mCherry molecule (it 
has been reported that only about 50% of mCherry molecules are fluorescent upon 
expression in mammalian cells),3 separated by more than 500 nm from other emitters. On 
top of this system, here we label vinculin with TMP-Atto655 and evaluated the 
fluctuation of talin-bound vinculins. 
The major challenge in this experiment was that for SM detection, all three 
fluorophores must be present at optimal density inside of live cells. In our previous study 
only one protein (talin) was labeled so that two-color SM imaging can be achieved in low 
expression cells. When adding in another target protein, we need to maintain the 
expression of both eDHFR-vinculin and EGFP-talin-mCherry   at desired level – not too 
high so that adjacent FACs overlap; not too low to detect any binding. Experimentally, 
we took advantage of the facts that (1) the labeling efficiency of EGFP-talin-mCherry 
was generally much higher than that of eDHFR-vinculin; and (2) as cells proliferate, the 
expression level in each cell gradually decreases after transient transfection. Therefore we 
optimized the expression of the two target proteins by doing two rounds of transfection. 
In the first round cells were transnfected with plasmids encoding EGFP-talin-mCherry 
and then were incubated in fresh media for 3 – 7 days until the fluorescence signal from 
EGFP and mCherry was diluted. Then the cells were harvested and transfected with 
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plasmid encoding eDHFR-vinculin and 20 µM of TMP-Atto655 and then imaged after 
overnight incubation. 
For a single talin dimer, we measured fluorescence intensity in Atto655 channel 
within the triangle region formed by mCherry and GFP dimer (Figure 4-14A). 
Background from unbound and/or non-specifically bound vinculins was subtracted and 
frames in which the fluorescence signal (from either channel) did not meet SM criteria 
were filtered off. Then length of talin dimer (distance between mCherry and GFP dimer) 
and vinculin fluorescence intensity were both plotted versus time, as displayed in Figure 





Figure 4-14 Individual talin molecules bind vinculin upon stretch. 
(A) DHFR-Vinculin was labeled by TMP-Atto655. Two ends of talin were tagged with GFP and 
mCherry, respectively, as described in the previous report.3 Intensity of TMP-Atto655* (TMP 
Atto655 that’s between GFP and mChery which tagged on a single talin dimer) were monitored 
as indication of number of vinculin bound to talin. (B) Fluorescence micrograph of FACs where 
single talins and vinculins were detected. Green = GFP; Red = mCherry, Purple = Atto655. (C) 
Fluorescence intensity of vinculin and extent of talin stretch over time. X-axis is the time in 
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second. Y-axis indicates the talin stretching (in nm) and vinculin intensity in arbitrary units. R is 
the Pearson correlation coefficient between the two curves. N is the number of points when the 
single molecule algorithm successfully locates a single pair of talin dimer. Dotted line indicate the 
under sampled region, i.e. when the two measurement points are more than 5 seconds apart. 
Positive correlation between talin stretching and vinculin intensity (measured by single molecule 
recognition) was observed in most traces. 
Currently our confidence to draw conclusion on our hypothesis has been limited 
by the modest quality of the SM data. In one experiment 120 frames were typically 
acquired in each channel. However, for most of the traces more than 80% of frames have 
been discarded because of photo-bleaching and/or failure to meet the SM criteria (round 
point-spread function; single-step photo-bleaching etc.). Based on these encouraging 
preliminary results we are not improving our methods by (1) developing new algorithm 
for better recognition of specifically bound TMP-Atto655; (2) optimizing experimental 
procedure to achieve stable quality of expression; and (3) trying brighter fluorophores 
emitting more photons than Atto655 which helps in SM localization. Together we hope 
live cell SM imaging with TMP-tag would uniquely help us to unravel the molecular 
mechanism of FAC dynamics. 
4.3.6 Analysis Of Vinculin Dynamics Using FRAP 
The hypothesis that stretched talin recruits vinculin has been supported by 
previous in vitro studies and our SM measurements. However, previous studies have also 
shown that vinculin mutants lacking talin binding motif still localize to FAC. Our multi-
molecule measurements also found no significant correlation between talin stretching and 
vinculin binding events at ensemble level. Here we address this discrepancy by FRAP 
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experiments of wild type vinculin in comparison to vinculin variant A50I, in which a 
single amino acid mutation interrupts talin binding. 
 
Figure 4-15 Fluorescence recovery time constant (τ) of vinculin:A50I in contrast to wild 
type full length (FL) vinculin. 
 Cells were transfected with plasmids encoding EGFP-vinculin and EGFP-vinculin:A50I, 
respectively. FRAP experiment was performed using TIRF microscope with 488 nm laser for 
bleaching. The significance of τ has been defined in Section 4.3.2. 
Significantly, in a variety of cell lines vinculin:A50I variant showed a 
significantly faster dynamics than wild type vinculin. This result, together with live cell 
imaging, suggested during FAC assembly, vinculin might not be primarily recruited by 
stretched talin; however, talin stretching has a strong impact on vinculin dynamics, 
‘locking’ the vinculin recruited to FACs. 
4.4 Discussions 
Together these results have established the TMP-tag as a robust tool for multi-
color live cell imaging with high resolution, which is difficult with FPs. Atto655 features 
(1) far-red emission spectrum that is readily resolvable with mCherry, (2) high photon 
output which is crucial for super-resolution and SM imaging, and (3) intrinsic photo-
switching compatible with intracellular environment with blinking rate modulated by 
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excitation laser power - to date none of the FPs have all these three highly favorable 
properties. By improving the TMP-tag technology, we have enabled highly efficient and 
selective protein labeling inside of live cells and demonstrated high resolution imaging in 
various cell lines using confocal and TIRF microscopy. These achievements have been a 
major milestone marking the transition of the TMP-tag technology from proof-of-
principle stage to real world application. 
Moreover, we have also demonstrated multi-color super-resolution and SM 
imaging in live cells using the TMP-tag. Significantly, multi-color super-resolution 
imaging in live cells has been extremely challenging using FPs, due to their limited 
photon output. Similarly, SM detection in live cells using FPs remains a heroic effort was 
limited to two colors at best. The TMP-tag has solved the problem by selectively labeling 
proteins in live cells with a high photon output, photo-switching fluorophore. In our study 
of FAC dynamics, TMP-Atto655 combined with FPs has enabled 3-color SM imaging in 
live cells, providing remarkable insights in the molecular mechanism of force sensing. 
We envision the TMP-tag technology would bring more breakthroughs in future 
applications. 
Our previous hypothesis on talin stretch and vinculin recruitment was built mostly 
on in vitro evidences: force stretches talin and thus exposes vinculin binding sites; then 
vinculin is recruited to FACs by binding to stretched talin. The intriguing results from our 
ensemble and SM analysis of FAC dynamics implied that in live cells the scenario might 
be far more complicated than what we had proposed: (1) in mature FACs vinculin 
binding may not depend on talin stretch; (2) in newly spreading cells vinculin might not 
be primarily recruited to FACs by talin stretch; (3) at SM level vinculin binding and talin 
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stretching was likely to be correlated; and (4) binding to talin significantly reduced the 
rate constant of vinculin dissociation – in other words, locking the vinculin at FAC. All 
these results demonstrated the importance of live cell imaging experiment: the test tube is 
such a different environment from the cell that critical features may be lost—additional 
regulatory proteins, the role of the cellular architecture and compartmentalization, the 
impact of the cell being far from an equilibrium state, etc. A particularly interesting 
finding was that ensemble and SM imaging showed different correlation between talin 
stretching and vinculin binding, indicated how the imaging technology impacted our 
insight in molecular biology of the cell. 
The significance of our preliminary results in SM analysis has been limited by the 
quality of images. Particularly, the background fluorescence from unbound and/or 
specifically bound TMP-Atto655 plus the modest photon output and photo-stability of 
EGFP and mCherry were the two major technical hurdles. We envision overcoming these 
hurdles by (1) developing a fluorogenic TMP-Atto655 that is switched on by binding to 
eDHFR, thus reducing the background fluorescence; and (2) using multiple orthogonal 
chemical tags with high photon output fluorophores instead of FPs. Currently these two 
solutions are being investigated by the Cornish lab. 
The quantification of protein stretching, binding and release from FACs can 
discriminate between the major mechanotransduction models: (1) that stretch-relaxation 
cycles cause accumulation of modified adhesion protein signals or (2) that forces directly 
activate signaling pathways.  Further, the development of quantitative tools for in situ 
experiments will be broadly enabling for investigating molecular mechanism in biology. 
The long-term goal of our collaboration with the Sheetz lab is to study force sensing and 
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FAC remodeling in live cells with dynamic SM imaging. The 3D STORM using 
astigmatism should enable us to define how components are binding relative to the 
membrane as well as laterally. We are measuring the dynamics of adhesion protein 
movement to the nucleus and the studies of the dynamics in the adhesion appear to relate 
to rigidity sensing. The tools developed here will enable us to approach the problem at 
the level of single submicrometer pillars where it is clear that the cells are pulling to a 
constant displacement. 
4.5 Experimental Methods 
4.5.1 Synthesis Of TMP-Atto655. 
4.5.1.1 Synthesis Of Compound 4-1 
In a 100 mL round-bottomed flask, dissolve intermediate 2-1 (1.381 g, 5 mmol) in 
DMF (15 mL) and then add K2CO3 (3.46 g, 25 mmol) and ethyl 5-bromovalerate (1.58 
mL, 10 mmol). The TMP-OH and ethyl 5-bromovalerate will dissolve in DMF while the 
K2CO3 only partially dissolves, resulting a white suspension. Heat the reaction mixture in 
70 °C oil bath under Ar for 5 h while stirring, during which the solution may turn yellow 
or slightly brown. After cooling to room temperature, extract the reaction mixture with 
brine (100 mL) and EtOAc (3 X 40 mL). Combine the organic phase; dry over MgSO4 
and remove EtOAc by rotary evaporation. Purify the crude product by flash 
chromatography (MeOH/DCM, 1:10 v/v over silica gel) to yield compound 4-1 (1.1 g, 2 
mmol, 54 % yield; Rf = 0.48 in MeOH/DCM, 1:10  v/v). 1H NMR (400 MHz, CD3OD, 
25 °C): δ=7.50 (s, 1 H), 6.51 (s, 2 H), 4.11 (q, J = 9.6 Hz, 2H), 3.89 (t, J = 8.0 Hz, 2H) 
191 
 
3.77 (s, 6 H), 3.63 (s, 2H), 2.39 (t, J = 8.8 Hz, 2H), 1.86 – 1.65 (m, 4H), 1.23 (t, J = 9.6 
Hz, 3H). MS (FAB+) m/z Calcd. for C20H28O5N4 [M+H]+:405.21. Found: 405.31. 
4.5.1.2 Synthesis Of Compound 4-2 
In a 100 mL round-bottomed flask, dissolve compound 4-1 (404 mg, 1 mmol) in 
methanol (25 mL). Then add NaOH in water (1 N, estimated volume 3 mL) to this 
solution until a small amount of beige precipitate is formed. Then stir the reaction 
mixture under air for 4 h and the precipitate should disappear. Then titrate the reaction 
mixture to pH 4 with HCl (1 N, estimated volume 3 mL) and beige crystals will form 
from solution. Filter the crystal and wash with brine and water (cooled at 4 °C) to yield 
compound 4-2 (290 mg, 0.77mmol, 77%). 1H NMR (DMSO-d6): δ=7.51 (s, 1 H), 6.54 (s, 
2 H), 3.77 (t,J = 8.0 Hz, 2 H), 3.70 (s, 6 H), 3.51 (s, 2H), 2.26 (t, J = 9.2 Hz, 2H), 1.67 – 
1.62 (m, 4H).MS (FAB+) m/z Calcd. for C18H24O5N4 [M+H]+:377.17. Found:377.42. 
4.5.1.3 Synthesis Of Compound 4-3 
Prior to the synthesis, bake a 25 mL round-bottomed flask at 95 °C for 48 h. Right 
before setting up the reaction, the flask should be further dried by propane flame. Add 
compound 4-2 (56 mg, 0.15mmol), BocNH-PEG-NH2 (96 mg, 0.3 mmol, 2 equiv) and 
PyBOP (155 mg, 0.3mmol, 2 equiv.) to the hot flask and put under vacuum. After the 
flask cools to room temperature (after approximately 1 h), add DMF (10 mL) and DIEA 
(130 µL, 0.745 mmol, 5 equiv) to the flask under Ar. Stir the reaction mixture at room 
temperature overnight and then remove solvent by rotary evaporation and purify the 
crude product by flash chromatography (MeOH/DCM, 1:30 over silica gel) to yield 
compound 4-3 (37 mg, 36 % yield, Rf = 0.33 in DCM/MeOH 15:1 v/v). 1H NMR (400 
MHz, CD3OD, 25 °C): δ=7.24 (s, 1 H), 6.56 (s, 2 H), 3.93 (m, 2 H), 3.81 (s, 6 H), 3.52 (s, 
192 
 
2 H), 3.52–3.50 (m, 12 H), 3.26 (t, J = 6.8 Hz, 2 H), 3.12 (t, J = 6.4 Hz), 2.26 (t, J = 7.2 
Hz, 2 H), 1.80 – 1.70 (m, 8 H), 1.43 (s, 9 H). HRMS (FAB+) m/z Calcd. C33H54O9N6 
[M+H]+: 679.40. Found: 679.40. 
4.5.1.4 Synthesis Of Compound 4-4 
Compound 4-3 was deprotected by stirring in TFA in DCM (50 %, v/v) for 1 h 
and remove solvent by rotary evaporation. The deprotection reaction is quantitative so 
that the resulting compound 4-4 is used for the next step without further purification. 
4.5.1.5 Synthesis Of Compound 4-5 
In a 25 mL round-bottomed flask, mix compound 4-4 (2.3 mg, 3.9 μmol) with 
Atto655-NHS ester (1 mg, 1.6 µmol) and DIEA (2.8 µL, 16 µmol) in DMF (1 mL). Stir 
the reaction mixture overnight under Ar and remove solvent with rotary evaporation. 
Subsequently purify the crude product (~ 5 mg) by reverse phase HPLC to yield 
compound 1 (1 mg, 0.95 μmol, 57 %). HPLC condition for C18 semi-prep column: start 
with 10:90 acetonitrile:water (v/v), gradient elution for 80 min, end with 60:40 
acetonitrile:water (v/v). Retention time: 33 – 34 min. 1H NMR (400 MHz, CD3OD, 25 °C) 
δ=7.79 (d, J = 1.7 Hz, 1H), 7.47 (d, J = 1.5 Hz, 1H), 7.24 (s, 1H), 7.07 (s, 1H), 6.94 (s, 
1H), 6.45 (s, 2H), 3.82 (t, J = 6.2 Hz, 1H), 3.77 (m, 2H), 3.7 (s, 6H), 3.67 – 3.53 (m, 
18H), 3.51 (m, 2H), 3.23 (m, 2H), 3.06 – 2.90 (m, 4H), 2.52 (dd, J = 13.6, 4.4 Hz, 1H), 
2.45 – 2.36 (m, 2H), 2.24 (t, J = 7.4 Hz, 2H), 2.06 (m, 4H), 1.85 – 1.70 (m, 8H), 1.70 – 
1.61 (m, 2H), 1.52 (s, 3H), 1.43 (s, 3H), 1.38 (t, J = 7.2 Hz, 7H). MS (FAB+) m/z Calcd. 
for C55H78O12N9S [M]+: 1088.55. Found: 1089.15. 
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4.5.2 Optimization Of The TMP-Tag Technology For Three-Color Live Cell 
Imaging 
4.5.2.1 Vector Construction 
Construction of eDHFR-vinculin vector: The gene encoding eDHFR was 
amplified using PCR from the previously published V1008 vector4 with primers pDHFR-
AgeI2: 5’- CCA CCG GTA CCA TGA TCA GTC TGA TTG CGG CGT TAG -3’ (AgeI, 
coding strand) and pDHFR-SacI 5’- CCG AGC TCG GCC AGA ACC ACC AGA CCG 
CCG CTC CAG AAT CTC AAA GC -3’ (NotI, noncoding strand). The fragment was 
then inserted between the AgeI and SacI sites of vector encoding EGFP-vinculin 
replacing the EGFP gene.  
Construction of talin-eDHFR vector: The gene encoding eDHFR was amplified 
using PCR from the previously published V1008 vector with primers pDHFR-AgeI3: 5’- 
CCG CTA GCG CTA CCG GTC GCC ACC ATG ATC AGT CTG ATT GCG GCG T -
3’ (AgeI, coding strand) and pDHFR-MfeI 5’- CAG CTT CTG CCA ATT GAC CAG 
AAC CAC CAG AAC CCC GCC GCT CCA GAA TCT CA -3’ (MfeI, noncoding 
strand). The fragment was then inserted between the AgeI and EcoRI sites of vector 
encoding EGFP-talin replacing the EGFP gene. 
4.5.2.2 Mammalian Cell Electroporation 
This protocol is designed for the Neon electroporation system from Invitrogen. 
The general procedure also applies to other electroporation apparatus, potentially with 
minor modification according to the manufacturer’s manual. 
RPTP cells and CV1 cells were cultured in DMEM media supplemented with 10% 
FBS and 1% penicillin/streptomycin. For electroporations, ~ 5×105 cells were digested 
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with 0.25% trypsin and harvested by centrifuging at RT, 1000 rpm for 5 min. Cells were 
then washed once with 1 mL 1XPBS and resuspended in the Resuspension Buffer R with 
1 µg of DNA and 20 µM TMP-tag. The electrode chamber was filled with 2 mL of 
Electrolytic Buffer E. Carefully take up cell suspension using the Neon pipette and Neon 
tips, leaving absolutely no air bubble in the tip. Apply the Neon pipette and tip in the 
electroporation apparatus and run the electroporation program. For RPTP cell the voltage 
is 1700 V for 20 ms, 1 cycle. For CV1 cells the voltage is 1350 V for 20 ms, 1 cycle. 
After electroporation is finished, immediately transfer the cells to fresh media and 
incubate for 12 h. Prior to live cell imaging, wash the cells with 2X media and image the 
cells in the media. 
4.5.2.3 Live Cell Imaging 
TIRF and super-resolution images were acquired on a Nikon N-STORM system 
with 1.49NA 100x oil immersion plan apochromat objective with 120um working 
distance. Laser powers for excitation wavelengths at 488 nm, 561 nm, and 647 nm were 
65 mW, 150 mW, and 100 mW, respectively. Images were recorded on a Andor DU897 
cooled, back-thinned EMCCD, with 512x512 pixels and 16 µm width. The imaging 
system was calibrated for chromatic aberration, dark current, and read noise using Zeiss 
100 nm yellow beads and 250 nm Invitrogen Tetraspeck beads. 
Confocal images were acquired on a spinning-disk confocal inverted microscope 
(PerkinElmer UltraVIEW VoX), with 100x oil immersion lens (1.40 NA, UPlanSApo 




Both Nikon and PerkinElmer microscopes were equipped with an environmental 
chamber (37 °C and 5% CO2) for long-term time-lapse imaging. 
Acquired images were analyzed by ImageJ (NIH). 
 
4.5.3 Single-Molecule Analysis Of Vinculin Binding In Response To Talin 
Stretching 
4.5.3.1 Cell Transfection And Staining 
One week prior to SM imaging, CV1 cells were transfected by electroporation 
with plasmids encoding EGFP-talin-mCherry and then incubated with non-selective 
media for one week. Cells were then harvested and electroporated with plasmids 
encoding eDHFR-Vinculin and 20 µM TMP-Atto655 for SM imaging. 
4.5.3.2 Single-Molecule Analysis 
The SM localization methods have been previously reported by the Sheetz lab.3 
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5 Chapter 5 




5.1 Chapter Overview 
One major advantage of chemical tags over FPs is their potentially smaller sizes. 
In this chapter I described efforts towards developing a short peptide tag which was 
supposed to impose minimal perturbation on the function and dynamics of the target 
protein. In general, we used high throughput screening approaches to pull out TMP-
binding peptides from a constrained short peptide (CSP) library. Unlike other peptide-
based chemical tags, the peptide tag we designed was highly modular and did not require 
enzyme catalyzed modification, thus would be especially favorable for high resolution 
live cell imaging. 
Specifically, we designed and constructed a CSP library in which the random 
peptide sequence was flanked by two constraining motif to reduce the entropy lost during 
binding. We initially attempted to screen the library using the yeast-three-hybrid (Y3H) 
technology that was previously developed in the Cornish lab. The Y3H system allows the 
CSP library to be screened inside of living cells, which would potentially eliminate the 
commonly encountered issues of intracellular stability and solubility. 
To perform Y3H screening, I first synthesized various chemical inducers of 
dimerization (CIDs), including TMP-Dex and A-TMP-Dex and confirmed their efficacy 
and robustness in our Y3H model system. Then I tried to screen the real library using 
TMP-Dex but was obstructed by the high frequency of false positives. I then ran a series 
assays to understand the nature of these false positives. 
Meanwhile our collaborators also constructed several peptide libraries and 
screened them for TMP-binding peptides using phage display technology. After they 
picked up some primary hits, I took over the revalidation works and measured the 
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binding affinity of peptide/TMP complex by using fluorescence polarization technique. I 
also examined the specificity of binding by performing competition assays. 
5.2 Introduction 
As discussed in Chapter 1, a short peptide is the ideal chemical tag because it is 
less likely to interfere with the natural function of the protein. However, to date, none of 
the short peptide chemical tags reported have shown the robustness required for high 
resolution imaging. The FlAsH tag centering a tetracysteine core was by design an ideal 
peptide tag: it is small, covalent, and fluorogenic.1 However, the application of FlAsH tag 
in live cell imaging has been limited by (1) background labeling of endogenous Cys-rich 
proteins; (2) cytotoxicity of the arsenic reagent; and (3) incompatibility with high photon 
output fluorophores. Another plausible strategy is to tag the target protein with a peptide 
sequence that would be recognized and modified by an enzyme.2 Since most natural 
enzymes resist dramatic modification to enable direct incorporation of a fluorophore-
conjugated substrate, to date the reactivity and modularity of these enzyme-mediated 
peptide tags still cannot meet the criteria for high resolution imaging of intracellular 
proteins. 
Designing a peptide tag around the TMP ligand has the potential to overcome this 
bottleneck because the ligand has shown to selectively bind DHFR with low nonspecific 
background labeling of endogenous proteins in living cells. The recent demonstration that 
proximity-induced reactivity can be used to create a selective covalent linkage supports 
the possibility of further engineering the TMP-tag to a short peptide tag, potentially 
allowing for the creation of a covalent interaction between TMP and a peptide aptamer 
that non-covalently binds the ligand with moderate affinity (Figure 5-1). Moreover, 
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compared to the peptide tags directly binding to fluorophores (such like the FlAsH tag), 
the TMP-based peptide tag would benefit from being modular and thus compatible with 
high photon output probes. 
 
Figure 5-1 Covalent short peptide chemical tag. 
We propose to create a short peptide covalent chemical tag via proximity-induced reaction. A 
short peptide that binds non-covalently to TMP with high affinity will be selected from a random 
peptide library. Upon binding to the A-TMP-probe, the nucleophilic Cys residue on the peptide 
and the electrophilic acrylamide of A-TMP-fluorophore will be positioned to react and form a 
covalent bond. 
Precedent in the physical organic chemistry literature suggests that even a 
micromolar binding interaction should be sufficient for efficient proximity-induced 
reactivity.3 Since peptides with picomolar affinity to small molecules have been selected 
from random peptide libraries4, we propose to identify a short peptide that binds to TMP 
with moderate affinity and then covalently link the two via proximity-induced reaction. 
Here we designed a peptide library of a short random peptide flanked by two 7-
mer constraining moieties. We constructed the library in yeast via homologous 
recombination, and then screened the library using yeast-three-hybrid assay. Meanwhile, 
our collaborators in the Sidhu laboratory (Prof. Sachdev Sidhu, University of Toronto) 
also constructed similar peptide libraries and screened them using phage display assay. 
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Primary hits from the phage display screening were subsequently characterized by 
fluorescence polarization assay. 
5.3 Results 
5.3.1 Design Of A Constrained Peptide Library 
Studies have shown that structurally constrained peptide aptamers have much 
higher small molecule binding affinities than unconstrained peptides, because the former 
benefits from less entropy loss upon binding. Therefore, we designed a random 12-mer 
library to be screened for peptides that bind to acrylamide-TMP (A-TMP). The constraint 
is a dimerization domain that flanks the library, a repeated 7-mer sequence known to 
dimerize and fold into a stable β-sheet, EFLIVKS. This scaffold has previously been used 
to isolate peptides that bind TexasRed (a rhodamine-based fluorophore) with picomolar 
affinity from random libraries using phage display.4 
Short peptides that bind to A-TMP will be selected using the yeast three-hybrid 
(Y3H) assay. Preliminary research demonstrated that a TMP-dexamethasone (Dex) 
heterodimer can activate transcription in a yeast three-hybrid assay, successfully 
dimerizing two halves of a transcriptional activator, a dihydrofolate reductase (DHFR)-
DNA-binding domain (DBD) fusion protein and a glucocorticoid receptor (GR)-
transcriptional activator domain (AD)-fusion protein (Figure 5-2).5 Therefore, it is 
reasonable to assume that it would be possible to select for a short peptide that binds 
either noncovalently with high affinity or covalently to an acrylamide-trimethoprim-




Figure 5-2 The trimethoprim-dexamethasone (TMP-Dex) yeast-three-hybrid system. 
A heterodimeric ligand (TMP-Dex) bridges a DNA-binding domain-dihydrofolate reductase fusion 
protein (DBD-eDHFR) and a transcriptional activator domain-glucocorticoid receptor fusion 
protein (AD–GR), effectively reconstituting a transcriptional activator (DBD-AD) and activating 
transcription of a downstream reporter gene. 
To isolate a peptide aptamer of TMP, the same system would be used except that 
the DBD would instead be expressed as a fusion protein to the constrained short peptide 
(CSP) library (Figure 5-3). Peptides that bind to TMP of the heterotrimeric A-TMP-Dex 
with moderate affinity and contain a nucleophilic Cys residue would react with the 
acrylamide electrophile to form a covalent bond. Dex binding to the GR-AD fusion 
protein would dimerize the transcriptional activator (DBD-AD) and activate transcription 
of LEU2 reporter, allowing selection for peptide aptamers of A-TMP-Dex by growth in 
synthetic complete media without leucine (SC Leu-). Alternatively, if selection using the 
Y3H assay is not successful, more well-established binding selections such as phage 




Figure 5-3 Selection of a constrained short peptide that binds TMP. 
A constrained short peptide (CSP)-DNA-binding domain (DBD) fusion protein binds to TMP of the 
heterotrimeric ligand, A-TMP-Dex, with moderate affinity and consequently the acrylamide 
electrophile reacts with a Cys residue on the CSP to form a covalent bond. Dex binds to the 
glucocorticoid receptor (GR)-B42 transcriptional activator domain (AD) fusion protein, effectively 
reconstituting a transcriptional activator (DBD-AD) and activating transcription of a downstream 
reporter gene. The DBD we used was from repressor LexA that binds four tandem LexA 
operators integrated in yeast chromosome.  
5.3.2 Construction Of The Constrained Peptide Library 
To isolate a peptide that binds with high affinity to TMP, a library was 
constructed of a randomized 12-mer NNK (N represents A/T/C/G; K represents G/T) 
peptide library flanked by a repeated 7-mer sequence of the dimerization domain, 
EFLIVKS. Here we used NNK instead of NNN to reduce the probability of truncation 
(NNK encodes relatively less stop codons than NNN). Since the selection will be carried 
out using the Y3H assay, the entire library will not be able to be covered because the 
library size would be limited by the transformation efficiency of the DNA into the yeast. 
207 
 
To achieve the largest library size possible, the peptide aptamer library will be 
incorporated into the Y3H expression vector via S. cerevisiae in vivo homologous 
recombination (Figure 5-4), which has been demonstrated to yield a library size of 108 
unique transformants. Therefore, the constructed library was flanked on each end by ≥30 
bp of homology to the expression vector, which is required for in vivo homologous 
recombination to occur. 
 
Figure 5-4 Homologous recombination to generate short peptide library. 
The short peptide library was designed to be incorporated into the expression vector via in vivo 
homologous recombination. A random 12-mer NNK library was encoded between two 7-mer 
sequences, EFLIVKS, that is known to dimerize into a stable β-sheet. The repeated 7-mer 
sequence is represented in different colors because different alternate amino acid codons were 
used to prevent self- and cross-dimerization during cassette construction by PCR. The 
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constrained library is flanked on either end with >30 bp of homology (C-terminus of LexA gene 
and 5’-end of ADH terminator, respectively) to the vector to facilitate homologous recombination 
with the linearized expression vector in vivo. Transformation (via electroporation) of linearized 
vector DNA and cassette led to in vivo recombination to generate the vector encoding LexA-
constrained short peptide (CSP) library. 
For selection of peptide binders via the Y3H assay, the library will be expressed 
as a fusion to the DNA-binding domain LexA. As shown in Figure 5-4, the library would 
be designed to undergo homologous recombination with the vector pMW103 which 
encodes LexA. The 5’ end of the cassette encodes 33 bp of homology to the C-terminal 
end of LexA gene (pink), followed by a (GSG)2 linker which has been previously 
demonstrated to be a flexible enough linker prevent interference with proper folding of 
the separate domains.6 Following the linker are the codons encoding the amino acids MG, 
which would prevent proteolysis of an N-terminal fusion peptide. Next, is the peptide 
constraint, EFLIVKS (salmon), followed by the 12-mer NNK library (orange), and the 
repeated 7-mer of the constraint, EFLIVKS (light orange). After the constrained peptide, 
codons encoding GPP are included to prevent proteolysis of the C-terminal fusion 
followed by a stop codon and 33 bp of homology to the ADH terminator (yellow) for 
homologous recombination. After homologous recombination, the resulting plasmid 
would encode LexA-CSP library controlled by a GAL promoter, which can be induced 
by galactose and raffinose (Gal/Raf) in media. 
The parent strain CJ-34 (Figure 5-4) was constructed based on EGY48 which has 
four tandom LexA operators (purple) and a LEU2 reporter gene (dark green) integrated 
into yeast chromosome for growth selection. Two extra plasmids were introduced: V398 
encoding the rGR-B42 fusion protein in Y3H system; and pMW112 encoding LacZ gene 
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regulated by LexA operator for ONPG (ortho-Nitrophenyl-β-galactoside) colorimetric 
assay. The pMW103 plasmid has a HIS3 marker; pV398 has a TRP3 marker; pMW112 
has a URA3 marker. After library transformation and homologous recombination, the 
resulting yeast strain was named CJ-Library3, which normally grew in SC (Glc HTU-) 
media. When the carbon source is switched from glucose to Gal/Raf, the LexA-CSP 
library will be expressed, and the hits that binds A-TMP would induce dimerization of 
the LexA and B42, initiating the transcription of LEU2 reporter gene. Therefore, if we 
plate the library on SC (Gal/Raf HTUL-) plate supplemented with A-TMP-Dex, the 
library will be selected and only colonies encoding a TMP-binding peptide can grow up. 
5.3.3 PCR Amplification Of The CSP Library Cassette 
Initial experiments have optimized the library cassette construction to improve the 
efficiency of amplification of the desired DNA fragment using PCR (Figure 5-5A). 
Analysis of the PCR products of the initial library showed that the dimerization domains 
preferentially annealed to each other rather than to the library template and blocked the 
synthesis of the desired product. Therefore, a new library was constructed in which the 5’ 
and 3’ dimerization domains were encoded by alternate codons based on the preferred 
codon usage in S. cerevisiae. The amplification of Library3 was achieved by two rounds 
of PCR and the products were purified by PAGE gel, as shown in Figure 5-5B&C. The 
integrity of the Library3 was further established by restriction digestion by MboI and 
HpyCH4V, which recognized part of the EFLIVKS sequences on the upstream and 




Figure 5-5 Amplification of the library cassette. 
 The amino acids of the dimerization domain were encoded using (A) the same and (B-C) 
alternate codons. (A) Amplification of first PCR reaction of Library 1. Expected to get 162 bp 
product. Actually got a shot fragment (lane 1) presumably formed due to primer dimerization. (B) 
Amplification of first PCR reaction of Library 3 using alternate codons. Product was expected to 
be 162 bp, and was shown to be close to anticipation (lane 1). (C) Amplification of second PCR 
reaction of Library 3. Product was expected to be 180 bp, and was shown to be close to 
anticipation (lane 1). (D) Restriction digestion of Library 3. Lane 1: MboI digestion; expected to 
cut the 180 bp Library3 into two fragments: 66 bp + 114 bp, both visible on the gel. Lane 2: 
HpyCH4V digestion; expected to cut the 180 bp Library3 into two fragments: 32 bp + 148 bp. The 
148 bp piece was visible on the gel along with the intact Library3. The 34 bp fragment might be 
too short to resolve. In both lane 1 and 2 there were minor bands (~150 bp in lane 1; ~130 bp in 
lane 2) which were presumably formed due to non-specific digestion. In each gel “L” represents 
ladder and the lengths were indicated by short white bars and base pair numbers (bp) were 
labeled on the left side.  
5.3.4 Transformation Of Library3 
After amplifying the Labrary3 DNA cassette by two rounds of PCR, the DNA (~ 
2 µg) was then pelleted by ethanol and sodium acetate and combined with double 
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digested backbone pMW103 (1 µg) for electroporation into parent yeast strain CJ-34. 
After electroporation, the resulting yeast strain CJ-Library3 was plated on SC (Glc HTU-) 
plate so that all cells with successful homologous recombination could grow. After 3 days 
yeasts were growing on these plates forming a lawn. All cells were scraped and diluted to 
108 cells/mL (10X library size per mL) and stored in 15% glycerol at – 80 °C. Meanwhile, 
a small portion of CJ-Library3 was diluted by 1:105 and plated on SC (Glc HTU-) for 
colony counting, which confirmed the library size to be 107 different colonies. As control, 
1 µg of double digested pMW103 was also transformed into the same parent strain, and 
the total number of background colonies was estimated to be 104. 
Before going forward for library screening, I also investigated the integrity of the 
peptide library by sequencing. Specifically, I extracted plasmids from CJ-Library3 by 
yeast mini-prep. Then the DNA extracted was pelleted and introduced into E.coli TG1 
cells by electroporation. Hundreds of colonies formed on LB-Kan plate. I picked up 10 
colonies and amplified the CSP library region by colony PCR. Sequencing results of the 
colony PCR products were shown in Table 5-1 (Cys codon in green letters; stop codon in 
red letters). Briefly, 7 out of 10 colonies sampled encoded correct CSP; 2 colonies 
encoded truncated peptide (expected truncation rate was 32% for a 12-mer random 
peptide encoded by NNK); 1 colony had frame shift. Significantly, 3 out of 10 colonies 
encoded at least one Cys in the randomized region (expected percentage for Cys-
containing peptide was 32%), which would possibly form a covalent bond with A-TMP 
via proximity-induced reaction. 
Table 5-1 Sequencing results of 10 colonies in CJ-Library3. 
Colony No. DNA Sequence of the Randomized Region Comment 
1 ATG ATG ATT CTT GAG CTG TTG ATT AAG 
TCT TTG TGT 
Correct with Cys. 
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2 CAT TCT TTT TGT GTG TCG CTT CAT TCG 
GGG ACG AGT 
Correct with Cys. 
3 AAT TTT AGT TTT TGT ATG AGT AAG CGT 
ATT CAG TAG 
Truncated. 
4 AAG GTG TAT TTT AAG AAT CGT GTG ATT 
AGT GTG TAT 
Correct. 
5 GCT CCT CAT GAT CTT CAT TGT ATT GGT 
ATT AAT CCG 
Correct with Cys. 
6 AGT GTG AGG GTT TAG ACG ATG GAG CTT 
CGG TAG GCG 
Truncated. 
7 TTT ACT CTG GTG CCT GAG GTT TTG AAT 
CCT CAT CAT 
Frame shifted. 
8 GCG TCT AGT CGT CTG GTG ACG TGG ACT 
CTG TCG ATG 
Correct. 
9 TTT ACT CTG GTG CCT GAG GTT TTG AAT 
CCT CAT CAT 
Correct. 
10 GTT ATT GGG GTT AGG CAG TTT AAT AGT 
CAG  GGG CAT 
Correct. 
5.3.5 Synthesis Of A-TMP-Dex 
A previous study on another chemical inducer of dimerization (CID) 
methotrexate-dexamethasone (Mtx-Dex), which also induces dimerization of eDHFR and 
GR, has shown that the linker length between Mtx-Dex was crucial for efficient 
dimerization.7 For Mtx-Dex, a linker with 15 - 17 atoms in total between Mtx and Dex 
has been found to be optimal. Therefore, to synthesize the covalent CID A-TMP-Dex I 
decided to try two different linker lengths by using 1,6-diaminohexane and 1,10-
diaminodectane, corresponding to 16 and 20 atoms between TMP and Dex in total, 
respectively. 
The parallel synthetic route for A-TMP-C6-Dex (C6 represents 1,6-
diaminohexane used for spacer) is summarized in Scheme 5-1 and Scheme 5-2. In brief, 
the dexamethasone was derivatized by selectively oxidizing the β-keto alcohol using 
sodium periodate in acidic solution, following the previous report on synthesis of Mtx-
Dex.8 Then the carboxylic acid group in compound 5-1 was coupled to N-Boc-1,6-
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diaminohexane and the Boc protective group was subsequently removed by TFA, 
yielding intermediate 5-3. 
 
Scheme 5-1 Synthesis of compound 5-7 A-TMP-C6-Dex (part 1). 
Reaction conditions: a. NaIO4, H2SO4, EtOH, H2O, RT, 24 h; b. N-Boc-1,6-diaminohexane, 
PyBOP, DIEA, DMF, RT, 16 h; c. 1:1 TFA:DCM (v:v), RT, 1 h. 
The other half of the synthetic route was based on the synthesis of the second-
generation covalent TMP-tag.9 Specifically, H-Asp(OBu-t)-OH, a commercially available 
aspartic acid derivative, was treated with acryloyl chloride to yield carboxylic acid 5-4. 
Amine 2-3 was prepared by O-alkylation of 4’-hydroxy-TMP with a three-carbon Boc-
amino iodide followed by TFA deprotection of the Boc group, as described in Section 
2.3.2. Coupling of carboxylic acid 5-4 and amine 2-3 by EDCI led to tert-butyl ester 5-5, 
which was subjected to TFA deprotection to yield carboxylic acid 5-6, a key intermediate 




Scheme 5-2 Synthesis of compound 5-7 A-TMP-C6-Dex (part 2). 
Reaction conditions: a. acryloyl chloride, Na2CO3, H2O, RT, 1 h; b. EDCI, HOBt, DIEA, DMF, RT, 
16 h; c. 1:1 TFA:DCM (v/v); d. EDCI, HOBt, DIEA, DMF, RT, 16 h. 
Similarly, the synthesis of A-TMP-C10-Dex (C10 represents 1,10-diaminodecane 
used for spacer) was summarized in Scheme 5-3. The compound 5-1 Dex-COOH was 
coupled to excessive 1,10-diaminodecane by EDCI, and the amino group in crude 
product was protected by Boc group to facilitate flash chromatograph. After purification, 
compound 5-8 was treated with TFA to remove the Boc group, affording intermediate 5-9. 
Coupling of 5-9 with 5-5 yielded the final product 5-10 A-TMP-C10-Dex. 
 
Scheme 5-3 Synthesis of compound 5-10 A-TMP-C10-Dex. 
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Reaction conditions: a. i) 1,10-diaminodecane, PyBOP, DIEA, DMF, RT, 16 h; ii) Boc2O; b. 1:1 
TFA:DCM (v:v), RT, 1 h. c. EDCI, HOBt, DIEA, DMF, RT, 16 h. 
Both calculation and sequencing results has revealed that only ~30% of the 
peptide in the CSP contains Cys residue. That means if we screen the library using only 
A-TMP-Dex, 70% of the peptides in the library would not be able to for a covalent bond. 
Therefore we planned to screen the CSP library using not only A-TMP-Dex, but also 
non-covalent TMP-Dex as well. Once we pull out a hit that binds to TMP with moderate-
high affinity, we can then install a Cys residue via site-directed mutagenesis. Additional, 
we also need the non-covalent TMP-Dex as a control for characterizing the covalent A-
TMP-Dex, as to be described in the next section. 
The synthesis of TMP-Dex has been described in a previous publication.5 Here I 
synthesized a similar molecule via a shorter, more efficient synthetic route, as summarize 
in Scheme 5-4. Specifically, the Dex-C10-amine (compound 5-9) was conjugated to 
compound 4-2 TMP-COOH (synthetic route described in Section 4.3.1), yielding the 
final product 5-11.  
 
Scheme 5-4 Synthesis of compound 5-11 TMP-Dex. 




5.3.6 Characterization Of A-TMP-Dex 
5.3.6.1 Quantification 
All final compounds (5-7, 5-10, 5-11) were dissolved in anhydrous DMF, and 
concentrations were measured by using UV-Vis absorption spectrometry (Figure 5-6). 
Then the concentrations were adjusted to 5 mM by adding anhydrous DMF and the stock 
solution was stored at -80 °C before using for Y3H assays. 
 
Figure 5-6 Quantification of TMP-Dex and A-TMP-Dex. 
(A) Left: UV-visible absorption curves of standard solution of 1:1 trimethoprim:dexamethasone 
(TMP:Dex) at various concentrations, as indicated in legend, in addition to the absorption curve of 
compound 5-11 TMP-Dex diluted by 200 times (1:200). Anhydrous DMF was used as solvent for 
all solutions. Right: linear regression of absorption at 292 nm of standard solutions. (B) 
Experimental conditions and plotting methods were same to that of (A). To quantify the 
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concentration of A-TMP-Dex (compound 5-7 and 5-10), standard solutions were made of 1:1:1 
acrylamide:TMP:Dex. 
5.3.6.2 Lacz Assay 
After quantifying the CIDs, I then evaluated their dimerization activity by 
performing a LacZ assay in Y3H system. For non-covalent CID TMP-Dex (compound 5-
11) I used Y3H strain V830 which has a LEU2 reported controlled by pLexA integrated 
into yeast chromosome, along with three plasmids encoding LexA-eDHFR (pMW103), 
rGR-B42 (pV398), and a LacZ reporter controlled by pLexA (pMW112), respectively.10  
Notably, strain V830 has been previously used to evaluate other CIDs including Mtx-Dex 
and TMP-Dex.5 For covalent CIDs A-TMP-C6-Dex (compound 5-7) and A-TMP-C10-
Dex (compound 5-10), I created a yeast strain CJ-43 that was mostly the same as V830 
except for that LexA-eDHFR was replaced by LexA-eDHFR:L28C. Additionally, a 
yeast-two-hybrid (Y2H) strain V1017 and a deactivated Y2H strain V780 was used as 
positive and negative controls, respectively.10 
The LacZ assay utilized ortho-nitrophenyl-β-galactoside (ONPG; this assay is 
also called ONPG assay) that can be cleaved by LacZ gene product, β-galactosidase, 
producing a colored compound ortho-nitrophenol. The LacZ activity, a direct indicator of 
efficiency of the Y2H or Y3H system, can then be quantified by measuring absorption at 
420 nm after normalization by cell density and reaction time. The results of LacZ assay 
of compound 5-7, 5-10 and 5-11 were summarized in Figure 5-7. Briefly, all three TMP-
based CIDs showed significant dimerization efficiency in a dosage-dependent manner. At 
5 µM concentration, compound 5-10 A-TMP-C10-Dex showed highest dimerization 
activity, followed by compound 5-11 non-covalent TMP-Dex, and compound 5-7 A-
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TMP-C6-Dex. Significantly, the covalent A-TMP-Dex, with a favorable linker length 
(compound 5-10), has been demonstrated to be a stronger CID compared to the non-
covalent TMP-Dex. In compound 5-7 the linker might be too short to efficiently induce 
transcription. 
 
Figure 5-7 LacZ (ONPG) assay of CID 5-11, 5-7 and 5-10. 
The identity and concentration of CID and strain numbers were labeled at the bottom. Yeast cells 
were cultured in 96 well plate using SC (HTU- Gal/Raf) media containing various CIDs as 
indicated in figure legend. No CID was used for V1017 and V780 control strains. After 72 h 
incubation at 30 °C, yeast cells were harvested and resuspended in water to quantify cell density 
(measured as OD600, optical density at 600 nm) before lysed by Y-per reagent. Then the cell 
lysate was treated with ONPG and incubated at 37 °C for 10 min. Supernatant was isolated by 
centrifugation and OD420 was measured on a UV-visible absorption plate reader. 
Importantly, the LacZ assay readout for 5 µM compound 5-10 was comparable to 
that of 1 µM Mtx-Dex, which has been confirmed to be a very strong CID – strong and 
robust enough to enable high throughput screening.11 This result implied that the covalent 
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A-TMP-Dex may also be capable to pull out a peptide candidate from a large library. In 
specific, while the KD between A-TMP and eDHFR:L28C cannot be directly quantified 
(because they quickly form covalent bond after binding), it can be estimated based on the 
KDs listed in Table 5-2, which was measured by our collaborator Aaron Hoskins. Not 
surprisingly, both modification on TMP-probe and mutation on eDHFR would slightly 
impair TMP/eDHFR binding. Therefore we estimate the KD for A-TMP and 
eDHFR:L28C binding to be about tens to hundreds of nM. That means if there’s a 
peptide candidate in the library that binds to A-TMP with tens to hundreds of nM affinity, 
the proximity-induced reaction would strengthen this interaction and produce a 
remarkably high readout (comparable with that of eDHFR:L28C/A-TMP pair) so that this 
candidate can be pulled out among other negative colonies. Based on previous studies in 
high throughput screening, we believe the tens to hundreds of nM KD to be a quite 
reasonable goal for primary hits. 
Table 5-2 KD in MTEN buffer measured by fluorescence polarization assay. 
 wt eDHFR eDHFR:L28C 
Non-covalent TMP-Cy3 17 ± 12 nM 37 ± 12 nM 
Covalent A-TMP-Cy3 45 ± 15  nM –––– 
5.3.6.3 Yeast Growth Curve 
Although the LacZ assay is very sensitive and robust to quantify the activity of 
Y3H system, it is not a high throughput assay and therefore cannot be used for primary 
screening of the CSP library, which consists of 107 different colonies. As described in 
previous sections, we plan to screen the library by a growth assay taking advantage of the 
LEU2 reporter: only the winning colonies with TMP-binding peptide would express 
LEU2 gene product that allow them to grow in Leu- media. Before using this system for 
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high throughput screening, I first characterized its sensitivity and robustness by 
measuring growth curves of Y3H systems. 
The yeast cell density in liquid culture can be quantified by determining 
absorption (also called optical density, OD) at 600 nm (OD600). To evaluate the growth 
rate, yeast cells were inoculated on a 96-well plate, starting from OD600 ~ 0.01 (105 cell 
/ mL), and then OD600 was monitored every 3 hours. In a complete media, the density of 
yeast follows a sigmoid curve, starting with a short lag phase, and then grow 
exponentially until OD600 reaches 1 ~ 10. 
 
Figure 5-8 Growth curves of Y3H strains. 
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The density of yeast cells was measured as optical density at 600 nm (OD600) on 96-well plate. 
Yeast cells were inoculated at OD600 = 0.01 and cell density was monitored every three hours. 
(A) Yeast-two-hybrid (Y2H) control. The positive strain V1017 and negative strain V780 were 
cultured in nonselective (Glc HT-) and selective (Gal/Raf HTL-) media. (B) Y3H control using Mtx-
Dex as CID. Y3H strain V830 was cultured in i) nonselective media (Glc HT-); ii) selective media 
(Gal/Raf HTL-); and iii) selective media with 1 µM Mtx-Dex. (C) Y3H strain V830 was cultured in 
selective media with TMP-Dex (compound 5-11) at various concentrations. (D) Covalent Y3H 
strain CJ-43 was cultured in selective media with A-TMP-Dex (compound 5-10) at various 
concentrations. 
The yeast growth curves of control strains (V1017 for positive control; V780 for 
negative control) were displayed in Figure 5-8A. In SC (Glc HT-) media, both V1017 and 
V780 grew rapidly, because Leu is supplemented. In SC (Gal/Raf HTL-) media, the 
Gal/Raf induced expression of Y2H components in V1017, turning on the expression of 
LEU2 reporter gene, which allowed V1017 to grow normally in Leu- environment. By 
contrast, the Y2H system in V780 was inactivated and therefore it did not significantly 
proliferate in SC (Gal/Raf HTL-) media.  
Figure 5-8B showed growth curves of an Y3H strain (V830) with and without 
Mtx-Dex. In absence of CID, strain V830 could only grow in SC (Glc HT-) media, not in 
SC (Gal/Raf HTL-) media, which means the strain was not expressing the LEU2 gene. In 
presence of 1 µM Mtx-Dex, the V830 strain could express LEU2 gene and therefore 
grow in SC (Gal/Raf HTL-) media. Figure 5-8C and D showed the growth curves of Y3H 
strains V830 (for non-covalent CID 5-11) and CJ-43 (for covalent CID 5-10) in SC 
(Gal/Raf HTL-) media supplemented with various concentrations of CIDs, respectively. 
The growth curves of V830 and CJ-43 with TMP-Dex (compound 5-11) and A-
TMP-Dex (compound 5-10) at various concentrations were showed in Figure 5-8C&D, 
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respectively. Significantly, both TMP-Dex and A-TMP-Dex efficiently induced yeast 
growth at 5 µM and 10 µM, compared to the control groups without CID. For both TMP-
Dex and A-TMP-Dex, the activity at 5 µM was similar to that at 10 µM, and was 
comparable to the activity of 1 µM Mtx-Dex, which was consistent to the results of LacZ 
assay. Interestingly, and of importance for screening of the CSP library, we found that the 
CJ-43 strain also started to grow after 70 h even without CID. This background growth 
may cause false positives in library screening, and must be carefully controlled. We may 
also limit the time of growth screening (< 3 days) to suppress the background growth. 
5.3.6.4 Mock Selection 
We have further confirmed the viability of our Y3H screening strategy by 
performing a mock selection using CJ-43 and A-TMP-Dex. Mock selection is an 
experiment to evaluate the efficiency of a screening system to enrich cells with active 
Y3H system in presence of excessive negative candidates. Here we use a framework that 
has been developed in the Cornish lab that utilizes a colorimetric assay to monitor the 
enrichment of ‘positive’ vs. ‘null’ strains in a growth screening.12 Specifically, Strains 
representing positive Y3H interactions were constructed with a B42-GR chimera on a 
plasmid that also constitutively expressed β-glucuronidase (gusA) and turned blue in the 
presence of the compound X-Gluc.  Corresponding null strains contained a B42 construct 
with no GR on a plasmid constitutively expressing β-galactosidase (lacZ) and turned pink 
in the presence of the compound Magenta-Gal.  Both positive and null strains possessed 
LexA-eDHFR:L28C chimeras and a LEU2 reporter gene under the control of six Lex A 




The positive strains were diluted in a range of successively larger library sizes 
composed of the null strain to measure the enrichment in increasingly stringent selection 
conditions.  Strains were grown in the absence or presence of either 5uM A-TMP-Dex 
(compound 5-10) or Mtx-Dex, respectively, in SC (Gal/Raf HTL-) media.  Enrichment 
was measured by an X-Gluc and Magenta-gal overlay assay. 
 
Figure 5-9 Mock selection using A-TMP-Dex and Mtx-Dex. 
Y3H positive and null strains were mixed with different ratio, as indicated in the legend, and then 
cultured in SC (Gal/Raf HTL-) media with (A) no CID; (B) 5 µM Mtx-Dex and (C) 5 µM A-TMP-
Dex. On day 0, day 3 and day 6, small amount of culture from each group was plated on 
nonselective SC (Glc HT-) plate. After colonies developed, the identity of each colony can be 
determined by overlaying the plate with agarose containing X-Gluc and Magenta-Gal. Positive 
strain would turn blue; null strain would turn magenta, allowing the % positive strain to be 
measured by counting the colored colonies. 
The results of mock selection using Mtx-Dex and A-TMP-Dex were summarized 
in Figure 5-9. Significantly, Mtx-Dex and A-TMP-Dex were able to induce enrichment of 
positive cell from excessive null cells at 1:105 ratio, which means that if one single 
winning hit exists in a library of 105 colonies, the hit may be successfully pulled out 
using the Leu- growth assay. At 1:107 positive:null ratio, however, the Mtx-Dex showed 
poor capacity while the A-TMP-Dex still efficiently enriched the positive strain. 
Interestingly, with both Mtx-Dex and A-TMP-Dex, the enrichment peaked on day 3. 
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Longer incubation time did not benefit the selection. This result is consistent to what we 
have found in the growth curve assay: negative strains started to grow after 70 h.  
In summary, the LacZ assay, growth curve and mock selection together 
established the TMP-Dex and A-TMP-Dex as highly active CIDs. Based on these results, 
we expect to use the Leu- growth selection to screen the CSP library and find TMP or A-
TMP binding peptide. 
5.3.7 Screening Of The CSP Library 
After confirming the viability of TMP-Dex and A-TMP-Dex as active CIDs, we 
now apply them to screen the CSP library for TMP or A-TMP binding peptides. I first 
performed a growth screening in liquid culture, in a procedure very similar to that of the 
mock selection. Briefly, the CJ-library3 was cultured in SC (Gal/Raf HTUL-) selective 
media with 5 µM TMP-Dex. On the 4th day, the culture was diluted by 105X and plated 
on SC (Glc HTU-) nonselective plates (plate A). Part of the library was also diluted by 
100X on the 4th day and grown in SC (Gal/Raf HTUL-) selective media with 5 µM TMP-
Dex for another 4 days, in hope to further enrich the winning strains. On the 8th day, both 
diluted and undiluted library culture were plated SC (Glc HTU-) nonselective plates 
(plate B and C, respectively). After colonies developed on plate A, B, and C, I picked 16 
colonies from plate A, 16 colonies from plate B, and 60 colonies from plate C for LacZ 
and growth assay. The results were summarized in Figure 5-10. 
In brief, although we have found some colonies on plate A, B, or C showing 
remarkable LacZ activity (Figure 5-10A), unfortunately, they all appeared to be false 
positives. The V830 strain was used as a control which, as anticipated, demonstrated 
CID-dependent LacZ expression: the LacZ activity in presence of 5 µM TMP-Dex was 
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27 times higher than that in absence of TMP-Dex. By contrast, none of the colonies from 
library showed more than 3 fold increase of LacZ activity in presence of TMP-Dex 
compared to that with no CID. Similarly, we have also found that most of the colonies 
from the library rapidly grew in Leu- media even without TMP-Dex (Figure 5-10B). Here 
the V830 strain was used as a negative control that, as anticipated, did not grow 
significantly in Leu- media without CID. Another observation from Figure 5-10B was 
that, the CID-independent growth in Leu- media significantly relied on Gal/Raf induction, 
which implied that the false positive was indeed caused by the Y3H system, not the 
parent strain. 
 
Figure 5-10 Characterization of CJ-library3 after selection. 
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 (A) LacZ activity of colonies from growth screening. 16 colonies from plate A (4 days growing in 
Leu- selective media with 5 µM TMP-Dex); 16 colonies from plate B (8 days growing in selective 
media), and 60 colonies from plate C (8 days growing in selective media, diluted by 1:100 on the 
4th day) were picked up and cultured in SC (HTU- Gal/Raf) media with and without TMP-Dex. For 
each plate, colonies were numbered by ranking their LacZ activity in presence of TMP-Dex (from 
low to high). Three control strains were assayed under the same condition and listed on the right 
side: V830 the Y3H control showing CID-dependent LacZ activity; V1017 the positive control 
showing constitutive LacZ activity; and V780 the negative strain showing no LacZ activity. (B) 
Growth rate of colonies from screening. Colony numbers were corresponding to that in (A). 
Growth rate was determined in two different media (labeled in figure legend) as OD600 48 h after 
inoculation over OD600 right after inoculation (OD600 day2/day0). Three control strains were 
assayed under the same condition and listed on the right side: V830 the Y3H control not growing 
in Leu- media without CID; V1017 the positive strain growing in Leu- media depending on Gal/Raf; 
and V780 the negative strain not growing in Leu- media. 
Taken together, out first round of library screening using Y3H system failed to 
pick up a winning candidate due the overwhelming amount of false positives. Therefore I 
decided to carefully characterize the nature of these false positive strains before stepping 
forward to try different screening strategies. 
5.3.8 Characterization Of The False Positives 
In our CSP library screening procedure, a false positive referred to a yeast strain 
that grew rapidly and exhibited remarkable LacZ activity even in absence of any CID. A 
rigorous characterization of the frequency and nature of these false positives is highly 
desired in order to evaluate the efficiency of the Y3H technology and figure out strategies 
for improving the system.  
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Our questions about the false positives included: (1) were they spontaneously 
growing up in selective media, or induced by the selective media and/or the small 
molecule TMP-Dex? (2) were the short peptides normally expressed in those false 
positives? and (3) was the CID-independed growth and LacZ activity caused by the short 
peptide, or some mutations on other part of the yeast genome, or both? I designed and 
performed a series of experiments to answer these questions. 
First of all, I evaluated the growth efficiency and LacZ activity in the native CSP 
library that has never been screened. Specifically, I plated CJ-library3 on SC (HTU- 
Gal/Raf) non-selective plate without CID, and picked up 48 colonies to inoculate liquid 
culture on 96-well plate.  The growth efficiency in Leu- selective media and LacZ activity 
(both in absence of any CID) were assayed as described before. Figure 5-11 summarized 
the results: within 3 days 12 out of 48 colonies (20% false positive rate) significantly 
grew up in Leu- media, most of which even faster than the positive control (V830 Y3H 
strain in presence of TMP-Dex). One day 2 the false positive rate was much lower: only 
one colony from the library grew up. However, on day 2 the positive control did not 
significantly proliferate either. By contrast, the LacZ assay gave mostly negative results: 
all colonies displayed very low LacZ activity compared to the positive control. 
Unfortunately, the LacZ assay is not high throughput enough to screen a library 




Figure 5-11 Growth efficiency and LacZ activity of the native library. 
 48 colonies were picked up from the native CJ-library3 that had not been screened using any 
CID. (A) Growth rate was quantified as OD600 on day2 or day3 over that of day0 in SC (HTL- 
Gal/Raf) selective media without CID. All colonies were inoculated at OD600 = 0.01 – 0.07. CJ-34 
was the parent strain constructed by transforming EGY48 with plasmids V398 and pMW112. The 
positive control (+ control) was V830 culture with 5 µM TMP-Dex; the negative control (- control) 
was V830 cultured in selective media without CID. Colonies were numbered by ranking OD600 
day3/day0, low to high. (B) LacZ assay were performed as described before. All colonies were 
cultured in SC (HTU- Gal/Raf) media without CID. Positive and negative controls were the same 
as that of (A). Colony numbers were corresponding to that in (A). 
Remarkably, we have also found that the false positives were caused by the short 
peptide: the parent strain CJ-34, which encoded all other parts of the Y3H system except 
the LexA-CSP, proved to be negative in both growth and LacZ assays. Another evidence 
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was that all false positives were only active in media with Gal/Raf, but not Glc (results 
not shown). 
The growth and LacZ assays in liquid culture has demonstrated that our original 
screening strategy would not be able to pull a winning hit out of the overwhelming 
number of false positives. Therefore I switched to plate instead of liquid culture. I first 
estimated the background level by plating the CSP library on selective SC (HTL- Gal/Raf) 
plates without any CID (Figure 5-12). Within 3 days hundreds of colonies formed on the 
d100 plate (100X dilution of the CSP library) and the total number of false positives were 
estimated to be 15,000 colonies among the entire CSP library (0.15%). Although the false 
positive rate was much lower than that of the liquid screening, it was still too high to 
screen the entire library: I would need to manually pick up 15,000 colonies and perform 
LacZ assay on 96-well plates, which was unpractical. 
 
Figure 5-12 False positive colonies on selective plates. 
 The CJ-library3 was plated on SC (HTUL- Gal/Raf) plates without CID. The left plate (d10, 
meaning 10X dilution) and right plate (d100) represented the background level of 10% and 1% of 
the entire library, respectively. 
In summary, although the Y3H system and the TMP-Dex and A-TMP-Dex have 
proven to be highly active in model system and mock selection, they still need substantial 
improvement before being applied to screen a random peptide library. One possible 
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reason for the high false positive rate was that the target molecule TMP of A-TMP 
appeared to be very small compared to their binding partner GR-B42. Therefore, a 
peptide binding to any part of the GR-B42 protein or interacting with the transcription 
machinery would also be able to initiate the transcription of the reporter gene, in absence 
of any CID. One possible method to eliminate these false positives is to introduce another 
round of ‘counter selection’ aiming to kill the false positive strains. However, a practical 
counter selection system had not been developed until very recently (by a colleague in the 
Cornish lab). So at that time we decided to switch to another screening strategy for 
developing a TMP-binding peptide: the phage display. 
5.3.9 Synthesis Of A-TMP-Biotin For Phage Display 
For phage display, the target molecule (TMP or A-TMP) is immobilized via 
biotin/NeutrAvidin (NA) interaction. Therefore we first need to synthesize TMP-biotin 
and A-TMP-Biotin. 
The synthesis of TMP-biotin (compound 5-14) was summarized in Scheme 5-5. 
Briefly, the biotin-NHS ester was first coupled to N-Boc-1,6-diaminohexane catalyzed by 
base. Then the amino group was released by deprotecting the Boc group using TFA, 
yielding intermediate 5-13, which was subsequently conjugated to TMP-COOH 






Scheme 5-5 Synthesis of compound 5-14 TMP-biotin. 
 Reaction conditions: a. N-Boc-1,6-diaminohexane, DIEA, DMF, RT, 16 h. b. 1:1 TFA:DCM (v:v), 
RT, 1 h. c. EDCI, HOBt, DIEA, DMF, RT, 16 h. 
The A-TMP-biotin (compound 5-17) was also synthesized via the intermediate 5-
16, which was coupled to Biotin-NHS ester to yield the final product 5-17 (Scheme 5-6). 
 
Scheme 5-6 Synthesis of compound 5-17 A-TMP-biotin. 
 Reaction condition: a. EDCI, HOBt, DIEA, DMF, RT, 16 h. 
I also synthesized a TexasRed-biotin as a control for phage display. This molecule 




Scheme 5-7 Synthesis of compound 5-18 TexasRed-biotin. 
Reaction condition: a. DIEA, DMF, RT, 16 h. 
All final compounds were purified by HPLC and dissolved in anhydrous DMF. 
The concentration of the TMP-biotin was determined by measuring UV-visible 
absorption at 280 nm (Figure 5-13). The A-TMP-biotin 5-17 was quantified using the 
same method by another student Zhixing Chen (data not shown). The TexasRed-biotin 5-
18 was quantified by measuring absorption at 596 nm (ε = 85,000 M-1cm-1). 
 
Figure 5-13 Quantification of the TMP-biotin by UV-visible absorption. 
Left: UV-visible absorption curves of standard solution of 1:1 trimethoprim:biotin at various 
concentrations, as indicated in legend, in addition to the absorption curve of compound 5-14 
TMP-Dex diluted by 200 times (labeled as unknown). Anhydrous DMF was used as solvent for all 
solutions. Right: linear regression of absorption at 280 nm of standard solutions. 
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To revalidate the binding affinity of peptides with TMP and A-TMP using 
fluorescence polarization assay, we also synthesized TMP-fluorescein 5-21 and A-TMP-
fluorescein 5-22. The synthesis of compound 5-21 was described in Scheme 5-8. 
Importantly, considering the cost of the fluorophore, we first derivatized the TMP-COOH 
4-2 by coupling to N-Boc-1,6-diaminohexane, yielding intermedia 5-19. After removing 
the Boc protective group by TFA, intermediate 5-20 was conjugated to 6-
carboxyfluorescein-NHS ester in the final step, affording TMP-fluorescein 5-21. 
 
Scheme 5-8 Synthesis of TMP-fluorescein 5-21. 
Reaction conditions: a. N-Boc-1,6-diaminohexane, DIEA, DMF, RT, 16 h. b. 1:1 TFA:DCM (v:v), 
RT, 1 h. c. 6-carboxyfluorescein-NHS ester, DIEA, DMF, RT, 16 h. 
The compound 5-22 was synthesized by another student Zhixing Chen via the 
synthetic route previously reported.9 The structure of A-TMP-fluorescein 5-22 was 
shown in Scheme 5-9. 
 
Scheme 5-9 Structure of A-TMP-fluorescein 5-22. 
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Both compound 5-21 and 5-22 were dissolved in anhydrous DMF and the 
concentration was determined by diluting in PBS buffer and measuring visible absorption 
at 494 nm (ε = 80,000 M-1cm-1). 
5.3.10 Revalidation Of TMP-Binding Peptide From Phage Display 
The phage display screening was performed by our collaborators Dr. Gang Chen 
and Prof. Sachdev Sidhu (University of Toronto). Briefly, they constructed and screened 
two different short peptide library: (1) a random 16 mer with Cys5 and Cys13 forming an 
internal disulfide bond; and (2) a random 13 mer flanked with two EFLIVKS 
constraining motifs, with a PG sequence on the C-termini to increase intracellular 
stability. Figure 5-14 summarized the results of the first round of screening. Significantly, 
two peptides C02 and D10 from library (1) have demonstrated specific binding with both 
TMP and A-TMP. One peptide H07 from library (2), on the other hand, showed high 
affinity with TMP but modest affinity with A-TMP. 
 
Figure 5-14 Primary hits from phage display screening. 
The ELISA signal indicated amount of phages binding to the small molecule immobilized at the 
bottom of wells. Two different small molecules, TMP-biotin and A-TMP-biotin were used to screen 
two peptide libraries. The small molecules were immobilized via biotin/NeutrAvidin interaction. In 
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NeutrAvidin control group no small molecule was used; in the BSA control group bovine serum 
albumin was added instead of phage library. The three top hits which have considerable ELISA 
signal intensity with the small molecule (5-14 and/or 5-17) but not with the controls were listed in 
the right table. Black letters indicated randomized sequence; red letters were the constraining 
motif and the PG tag to increase peptide stability. 
After pulling out the winning peptides from the initial phage display screening, I 
first revalidated their binding affinity and specificity by performing fluorescence 
polarization (FP) assay. The FP assay measures the extent the fluorescence is polarized: 
ࡲࡼ ൌ 	 ࡵ‖ିࡵ఼ࡵ‖ାࡵ఼          Equation 5-1 
In Equation 5-1, Iǁ and I٣ represent emission light intensity parallel and 
perpendicular to the excitation light plane, respectively. With a certain fluorophore, the 
FP value increases as the dye is bound by or spatially close to a large molecule, such as a 
protein, hypothetically due to the restraint on the internal rotation of the fluorophore 
molecule around single bonds. Therefore in a solution of TMP-fluorescein (compound 5-
21) mixed with TMP binding peptides, the FP value was anticipated to show linear 
relationship versus the concentration of TMP-fluorescein in bound state: 
ࡲࡼ ൌ ࢑ሾ۱ሿ ൅ ࡲࡼ૙        Equation 5-2 
In Equation 5-2, k represents the proportionality constant; [C] refers to the TMP-
fluorescein in bound state (forming a complex with the peptide); and FP0 represents the 
intrinsic FP intensity with no TMP-fluorescein. 
When [peptide] is orders of magnitude larger than [TMP-fluorescein], it can be 
estimated that all TMP-fluorescein molecules are in bound state, and the FP value would 
platue: 
ࡲࡼ࢓ࢇ࢞ ൌ 	࢑ሾ܂ሿ࢚࢕࢚ࢇ࢒ ൅ ࡲࡼ૙        Equation 5-3 
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In Equation 5-3, [T]total represents the total concentration of the TMP-fluorescein. 




ሾ۱ሿ         Equation 5-4 
By the definition of dissociation constant KD and conservation of mass: 
ࡷࡰ ൌ ሾ܂ሿሾ۾ሿሾ۱ሿ          Equation 5-5 
ሾ܂ሿ ൌ ሾࢀሿ࢚࢕࢚ࢇ࢒ െ ሾ۱ሿ        Equation 5-6 
In Equation 5-5, [T] and [P] refer to the concentration of TMP-fluorescein and 






ሾ۱ሿ ൅ ૚ ൌ
ࡷࡰ
ሾ۾ሿ ൅ ૚       Equation 5-7 




ሾ۾ሿ ൅ ૚        Equation 5-8 
When the concentration of TMP-fluorescein is significantly smaller than KD 
(empirically, KD is anticipated to be in the order of hundreds of nM, while concentration 
of TMP-fluorescein used in experiments was 10 nM), most peptides were expected to be 
in free states. Thus [P] proximately equaled to the total concentration of peptide. Taken 
together, a linear regression of  ሺி௉೘ೌೣିி௉బி௉ିி௉బ െ 1ሻ versus 
ଵ
ሾ୔ሿ would result in KD as the slope. 
Notably, in this deviation I used TMP-fluorescein as an example. With the A-TMP-
fluorescein (compound 5-22), the calculation of KD was exactly the same as with TMP-
fluorescein. 
The two peptide hits showing highest specific binding affinity with TMP-biotin, 
H07 and D10, were chemically synthesized (by Peptide 2.0 Inc.) and purified by HPLC 
for the FP assay. The KD values were summarized in Table 5-3, with example FP data 




Figure 5-15 FP assay of peptide D10 binding TMP-fluorescein. 
 (A) 10 nM TMP-fluorescein 5-21 was mixed with peptide D10 at various concentration (0 – 2000 
nM) in presence of 10 mM DTT to reduce the disulfide bond. FP values were measured on 96 
well plate using a Perkin Elmer Victor3 plate reader equipped with a FP module. (B) Linear 
regression to calculate KD as the slope. 
Table 5-3 Dissociation constant (KD) of peptide H07 and D10 with TMP-fluorescein and A-
TMP-fluorescein. 
Peptide TMP-fluorescein A-TMP-fluorescein 
KD / nM R2 KD /nM R2 
D10 (oxidized)a 452 0.944 517 0.895 
D10 (reduced)b 207 0.991 575 0.917 
H07 323 0.982 373 0.913 
a. D10 peptide was synthesized with internal disulfide bond. 
b. The FP experiments were performed in solution with 10 mM DTT to reduce disulfide bonds. 
Significantly, both D10 and H07 were shown to bind TMP-biotin and A-TMP-
biotin with KD in the order of hundreds of nM, which were quite fair for the first round of 
library screening. Interestingly, the D10 peptide constrained via disulfide bond was 
anticipated to show considerably impaired affinity with TMP and A-TMP when the 
disulfide bond was reduced by DTT. However, the experimental results were reverse: the 
reduced D10 binded TMP-fluorescein even tighter than the oxidized form, while the 
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affinity with A-TMP-fluorescein was not significantly affected by DTT. This unexpected 
result might imply that the D10 peptide did not bind to TMP or A-TMP in a specific way. 
Instead the increase in FP value may be merely due to the aggregated peptide. 
In order to make sure that H07 and D10 specifically bind TMP and/or A-TMP, I 
designed a FP competition assay: 500 nM peptide (H07 or D10) was incubated with 50 
nM small molecule (TMP-fluorescein or A-TMP-fluorescein) in presence of TMP at 
various concentrations (0 – 10,000 nM). If the peptide recognizes TMP in a specific 
manner, the binding should be efficiently competed by TMP, showing a decrease in FP as 
TMP concentration increases. Unfortunately, in competition experiments I have never 
observed significant competition using either H07 or D10; in complex with either TMP-
fluorescein or A-TMP-fluorescein (Figure 5-16 showed representative results). 
 
Figure 5-16 FP competition assay. 
 (A) FP assay of 500 nM H07 peptide binded 50 nM TMP-fluorescein, incubated with TMP at 
various concentrations. (B) The same assay with eDHFR as a positive control: 1000 nM TMP 
could significantly interrupt the specific binding of eDHFR by TMP-fluorescein. 
Remarkably, the theoretical IC50 was estimated to be ~1000 nM (the calculation 
will be covered in Section 5.5.6.2) by assuming that the KD values for peptide/TMP-
fluorescein and peptide/TMP complexes were both 500 nM. Indeed, in the eDHFR 
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control group the TMP could efficiently inhibit the eDHFR/TMP-fluorescein binding. 
Therefore, the H07 seemed to bind the TMP-fluorescein in a non-specific manner. The 
same result was also observed for all other peptide/small molecule combinations. 
Taken together, although in the first round of phage display a couple of peptides 
have been pulled out as strong TMP and/or A-TMP binders, the peptide/small molecule 
interaction appeared to be non-specific. The peptide did not seem to recognize TMP 
molecule mimicking the eDHFR; instead the small molecules might be trapped by non-
specific hydrophobic interaction, or due to the aggregation of the peptide. 
5.4 Discussion 
In conclusion, we have successfully constructed a CSP library for Y3H screening. 
We synthesized TMP-Dex and A-TMP-Dex which have been demonstrated to be strong 
CIDs. However, the screening of the CSP library was impeded due to excessive amount 
of false positives. In addition, we have been able to pull out several hits in the first round 
phage display screening, with KD in the high nM range. However, using FP competition 
assay we have confirmed that these peptides did not specifically bind TMP or A-TMP. 
The most plausible explanation to the false positives in Y3H screening was that 
some peptides bind to the protein partner of the Y3H system, not the small molecule CID. 
Notably, when the TMP or A-TMP was displayed via interaction between Dex and GR-
B42 fusion protein, the TMP or A-TMP was only expected to occupy a very small 
fraction of the protein surface area. Therefore, theoretically the probability to pull out a 
false positive by the Y3H strategy would be much higher than that of a real hit. One 
possible solution of this problem is to perform another round of counter selection without 
CID, killing all the false positive colonies. Now the Cornish lab has developed a highly 
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efficient counter selection system based on URA3 under control by an inducible Tet 
promoter. We hope this new technology would significantly benefit the Y3H screening in 
future experiments. 
Although we were not able to pick up a TMP binding peptide using the Y3H 
screening strategy, we have established TMP-Dex and A-TMP-Dex as highly robust 
CIDs to induce the expression of the target gene. The efficiency of the Y3H system has 
been demonstrated using both LacZ and growth assays. Moreover, the A-TMP-Dex was 
believed to be the first covalent CID based on proximity-induced reaction. Significantly, 
the covalent conjugation of A-TMP and eDHFR:L28C leaded to higher signal readout in 
both LacZ and growth assays. This result was very important to guide future works to 
construct strong, permanent protein dimerizers. 
The phage display was supposed to be a well-established technology to develop 
peptide aptamers (peptides binding to a specific material). In previous studies this 
strategy has been successfully used to find a constrained peptide binding to TexasRed 
fluorophore, a rhodamine-based fluorophore with an extended conjugation system, which 
potentially aids the small molecule/peptide interaction. In our experiment, on the other 
hand, the target molecule TMP and A-TMP were smaller and less hydrophobic compared 
to the TexasRed and as a result, it has proven harder to pick up a binding peptide using 
the phage display technology. Possible improvement of the strategy may include (1) 
redesign the random peptide library using doped codon to encode more hydrophilic 
amino acids, which may reduce the tendency of aggregation; (2) integrate the TMP 
competition assay into the screening process, for example, elute the phage library with 
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TMP instead of non-specific eluent; and (3) use other screening technology, eg. ribosome 
display, which is able to cover a much larger library (up to 1012 different peptides). 
Finally, these results also made us to reflect on our original plan to construct a 
peptide chemical tag. In theory, it is supposed to be much more difficult for a short 
peptide, compared to a protein, to bind a small molecule with high affinity and specificity. 
And our efforts on developing a TMP-binding peptide have justified this difficulty. 
Indeed, to date there has been very few peptide-based chemical tags that have been 
demonstrated to have high reactivity and selectivity – none of them as robust as the 
SNAP-tag and TMP-tag that enable live cell imaging of intracellular proteins using 
modular fluorophores. On the other hand, a small fluorescent label has always been a 
dream for biologist to study biomolecules with minimal perturbation on function and 
conformation. Instead of peptide tags, we now believe that the true breakthrough in the 
field of chemical tags would be the unnatural amino acid (UAA) mutagenesis technology 
that can installs a fluorophore at any part of the target protein as an amino acid side chain. 
Currently several other students in the Cornish lab are trying to use the UAA technology 
to incorporate a far red dye Atto655 into proteins. 
5.5 Experimental Methods 
5.5.1 PCR Amplification Of The CSP Library Cassette 
The ssDNA library template encoding the scaffold and the randomized 12-mer 
NNK library, VWC2133, was amplified using Pfu Turbo and primers VWC2129 and 
VWC2134 to generate a 162 bp fragment. The DNA was purified by polyacrylamide gel 
electrophoresis. Then, the DNA product was amplified using Pfu Turbo and primers 
VWC2130 and VWC2132 and again gel purified to isolate the 180 bp cassette. 
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5.5.2 Transformation Of Library3 
The CJ-library3 cassette and the backbone vector pMW103 (digested by NotI and 
XhoI) were introduced into parent strain CJ-34. The yeast transformation protocol has 
been described in Section 3.4.5.4. 
For DNA sequencing, the plasmid encoding CJ-library3 was first extracted from 
yeast and then transformed into E.coli and amplified via colony PCR. The protocol for 
yeast mini-prep has been described in Section 3.4.5.5. 
5.5.3 Synthesis Of A-TMP-Dex 
5.5.3.1 Synthesis Of Compound 5-1 
Dexamethasone (1.18 g, 3 mmol) was dissolved in 234 mL EtOH and 93 mL H2O. 
NaIO4 (771 mg, 3.6 mmol) and 2 M H2SO4 (6 mL) was then added to the solution. The 
reaction mixture was stirred at RT for 24 h before removing ethanol by rotary 
evaporation (leave small amount of water). Then the solution was diluted in 48 mL brine 
and the pH was adjusted to 12.0 by adding 1 N NaOH. Wash the aqueous solution with 
3X 240 mL DCM and then adjust pH to 3.0 by adding NaHSO4. The product was 
extracted by 2X 240 mL EtOAc followd by 2X 240 mL 1:1 EtOAc:DCM (v/v). The 
organic layers were then combined and washed with 3X 100 mL brine before dried over 
Na2SO4 and concentrated, yielding compound 5-1 (1.07 g, 95% yield, Rf = 0.48 in 5:1 
DCM:MeOH, v/v). 1H NMR (400 MHz, DMSO-d6) δ 12.39 (s, 1H), 7.29 (d, J = 10.1 Hz, 
1H), 6.22 (dd, J = 10.1, 1.9 Hz, 1H), 6.00 (t, J = 1.6 Hz, 1H), 5.23 (dd, J = 4.0, 1.9 Hz, 
1H), 4.60 (s, 1H), 4.17 – 4.08 (m, 1H), 2.83 (ddd, J = 11.3, 7.1, 4.2 Hz, 1H), 2.68 – 2.56 
(m, 1H), 2.42 – 2.24 (m, 2H), 2.00 (td, J = 11.4, 7.5 Hz, 2H), 1.77 (dt, J = 11.2, 5.2 Hz, 
1H), 1.62 (q, J = 11.3 Hz, 1H), 1.53 (dd, J = 13.8, 1.9 Hz, 1H), 1.49 (s, 3H), 1.34 (qd, J 
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= 12.9, 4.9 Hz, 1H), 1.06 (ddd, J = 12.2, 8.2, 4.1 Hz, 1H), 1.00 (s, 3H), 0.86 (d, J = 7.1 
Hz, 3H). MS (FAB+) m/z Calcd. For C21H27FO5 [M+H]+:379.18. Found: 379.19. 
5.5.3.2 Synthesis Of Compound 5-2 
Compound 5-1 (200 mg, 0.528 mmol), N-Boc-1,6-diaminohexane (267 mg, 1.057 
mmol), EDCI (303.7 mg, 1.584 mmol), and HOBt (214 mg, 1.584 mmol) were dissolved 
in 5 mL DMF and then DIEA (0.92 mL, 5.28 mmol) was added to the solution. The 
reaction mixture was stirred at RT for 16 h before concentrated. The residue was then 
diluted with 100 mL EtOAc and washed with 2X 50 mL saturated NaHCO3 and 2X 50 
mL brine. After drying the organic layer over Na2SO4 and removing solvent, the crude 
product was purified by flash column chromatography on silica gel (1:2 hexane:EtOAc, 
v/v), yielding compound 5-2 (290 mg, 94% yield, Rf = 0.38 in 1:2 hexane:EtOAc, v/v). 
1H NMR (400 MHz, Chloroform-d) δ 7.32 (d, J = 10.1 Hz, 1H), 6.63 – 6.56 (m, 1H), 
6.27 (dd, J = 10.1, 1.8 Hz, 1H), 6.08 (s, 1H), 4.65 (s, 1H), 4.38 – 4.30 (m, 1H), 4.04 (s, 
1H), 3.54 (dq, J = 12.8, 7.1 Hz, 1H), 3.22 (ddp, J = 10.6, 7.3, 3.0 Hz, 1H), 3.16 – 2.94 
(m, 3H), 2.60 (tdd, J = 13.7, 6.0, 1.8 Hz, 1H), 2.46 – 2.28 (m, 3H), 2.25 – 2.07 (m, 2H), 
1.87 – 1.69 (m, 2H), 1.55 (s, 4H), 1.49 (td, J = 13.3, 6.0 Hz, 4H), 1.42 (s, 9H), 1.33 (dd, J 
= 7.9, 4.5 Hz, 4H), 1.20 (s, 1H), 1.12 (s, 3H), 0.92 (d, J = 7.3 Hz, 3H). MS (FAB+) m/z 
Calcd. For C32H49FN2O6 [M+H]+: 577.36. Found: 577.1. 
5.5.3.3 Synthesis Of Compound 5-3 
Compound 5-2 was deprotected by dissolving in 5 mL TFA and 5 mL DCM, 
stirring at RT for 1 h. Then the product was obtained by removing solvent by rotary 
evaporation, yielding compound 5-3 (quantitative, not purified) as colorless oil. 
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5.5.3.4 Synthesis Of Compound 5-4 
Acryloyl chloride (502 mg, 449 μL, 5.55 mmol) was added dropwise to a solution 
of L-aspartic acid 4-tert-butyl ester (1.00 g, 5.28 mmol) and sodium carbonate (840 mg, 
7.93 mmol) on an ice bath. The reaction was then warmed to RT and stirred for another 
1h. The pH of the solution was then adjusted to 2 by addition of 1M NaHSO4 aqueous 
solution. Then the mixture was extracted by ethyl acetate (2 x 100 ml). The organic 
layers were combined, dried over anhydrous Na2SO4 and concentrated to yield compound 
3 (0.93 g, 3.85 mmol, 73%) as a colorless oil. 1H NMR (300 MHz, CDCl3) δ ppm: 6.80 
(d, J = 7.5 Hz, 1 H); 6.35 (dd, J = 16.8 Hz, 1.2 Hz, 1 H); 6.16 (dd, J = 16.8 Hz, 10.2 Hz, 
1 H); 5.75 (dd, J = 10.2 Hz, 1.2 Hz, 1 H); 4.89(m, 1 H); 3.02 (dd, J = 17.1 Hz, 4.2 Hz, 1 
H); 2.78 (dd, J = 17.1 Hz, 5.4 Hz, 1 H); 1.44 (s, 9 H). HRMS (FAB+) m/z Calcd. for 
C11H18O5N [M+H]+:244.1185. Found: 244.1181 
5.5.3.5 Synthesis Of Compound 5-6 
DIEA (259 mg, 348 μl, 2.00 mmol)  was added dropwise to a solution of 
compound 5-4 (187 mg, 0.77 mmol), compound 2-3 (271 mg, 0.63 mmol, in the form of 
TFA salt), DMAP (39 mg, 0.30 mmol) and EDCI (241 mg, 1.26 mmol) in 10 ml 
anhydrous DMF at RT. The reaction was stirred for 20 h at RT and concentrated. The 
mixture was then purified by silica gel flash chromatography (10% MeOH in DCM) to 
give the coupling product 5-5 (co-eluted with starting material 5-4, no pure product 
obtained), which was directly dissolved in 20 ml TFA-DCM (1:1, v/v) and stirred for 4 h 
at RT. The solvent was removed in vacuo and the crude product was purified by column 
chromatography on silica gel (30% MeOH in DCM) to give carboxylic acid 5-6 (127 mg, 
253 μmol, 46%) as a colorless oil. 1H NMR (300 MHz, CD3OD) δ ppm: 7.25 (s, 1 H); 
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6.57 (s, 2 H); 6.24 (dd, J = 17.1 Hz, 9.0 Hz, 1 H); 6.16 (dd, J = 17.1 Hz, 3.0 Hz, 1 H); 
5.61 (dd, J = 9.0 Hz, 3.0 Hz, 1 H); 4.80 (m, 1 H); 3.98 (m, 2 H); 3.82 (s, 6 H); 3.68 (s, 2 
H); 3.46 (t, J = 6.0 Hz, 2 H); 2.87 (dd, J = 16.8 Hz, 6.0 Hz, 1 H); 2.72 (dd, J = 16.8 Hz, 
7.5 Hz, 1 H); 1.88 (m, 2 H). HRMS (FAB+) m/z Calcd. for C23H31O7N6 
[M+H]+:503.2254. Found: 503.2273. 
5.5.3.6 Synthesis Of Compound 5-7 
Compound 5-6 (50 mg, 0.0995 mmol), compound 5-3 (71 mg, 0.149 mmol), 
EDCI (57 mg, 0.298 mmol), HOBt (40 mg, 0.298 mmol) were dissolved in 1 mL DMF 
and then DIEA (0.92 mL, 5.28 mmol) was added to the solution. The reaction mixture 
was stirred at RT for 16 h before concentrated. The residue was then diluted with 50 mL 
EtOAc and washed with 2X 25 mL saturated NaHCO3 and 2X 25 mL brine. After drying 
the organic layer over Na2SO4 and removing solvent, the crude product was purified by 
flash column chromatography on silica gel (5:1 DCM:MeOH, v/v), yielding compound 5-
7 (36 mg, 37% yield, Rf = 0.33 in 5:1 DCM:MeOH, v/v). 1H NMR (400 MHz, Methanol-
d4) δ 7.52 (s, 1H), 7.42 (d, J = 10.1 Hz, 1H), 6.52 (s, 2H), 6.28 (dd, J = 10.2, 1.9 Hz, 1H), 
6.23 – 6.10 (m, 2H), 6.07 (t, J = 1.6 Hz, 1H), 5.58 (dd, J = 8.6, 3.4 Hz, 1H), 4.80 (dd, J = 
7.4, 6.0 Hz, 1H), 4.23 (dd, J = 11.2, 2.1 Hz, 1H), 3.95 (dq, J = 6.7, 5.2, 4.4 Hz, 2H), 3.79 
(s, 6H), 3.64 (s, 2H), 3.45 (td, J = 6.4, 3.6 Hz, 2H), 3.29 – 3.24 (m, 1H), 3.18 – 3.07 (m, 
4H), 2.77 – 2.66 (m, 2H), 2.59 (dd, J = 15.0, 7.4 Hz, 1H), 2.52 – 2.34 (m, 2H), 2.25 – 
2.12 (m, 2H), 1.86 (td, J = 8.1, 6.4, 4.0 Hz, 3H), 1.75 (d, J = 11.8 Hz, 1H), 1.58 (s, 3H), 
1.54 – 1.43 (m, 6H), 1.37 – 1.27 (m, 4H), 1.19 (s, 1H), 1.09 (s, 3H), 0.89 (d, J = 7.2 Hz, 
3H). MS (FAB+) m/z Calcd. For C50H69FN8O10 [M+H]+: 961.51. Found: 961.52. 
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5.5.3.7 Synthesis Of Compound 5-9 
Compound 5-1 (200 mg, 0.528 mmol), N-Boc-1,10-diaminodecane (288 mg, 
1.057 mmol), EDCI (303.7 mg, 1.584 mmol), and HOBt (214 mg, 1.584 mmol) were 
dissolved in 5 mL DMF and then DIEA (0.92 mL, 5.28 mmol) was added to the solution. 
The reaction mixture was stirred at RT for 16 h before concentrated. The residue was 
then diluted with 100 mL EtOAc and washed with 2X 50 mL saturated NaHCO3 and 2X 
50 mL brine. After drying the organic layer over Na2SO4 and removing solvent, the crude 
product was purified by flash column chromatography on silica gel (1:2 hexane:EtOAc, 
v/v), yielding compound 5-8 (co-eluted with starting material, no pure product obtained). 
Compound 5-8 was deprotected by dissolving in 3 mL TFA and 3 mL DCM, stirring at 
RT for 1 h. Then the product was obtained by removing solvent by rotary evaporation, 
yielding compound 5-9 (196 mg, 70% yield) as colorless oil. 1H NMR (400 MHz, 
Methanol-d4) δ 8.00 (d, J = 15.2 Hz, 1H), 7.42 (d, J = 13.6 Hz, 1H), 6.29 (d, J = 13.6 Hz, 
1H), 6.084 (s, 1H), 4.25 – 4.21 (m, 1H), 3.23 – 3.12 (m, 3H), 2.91 (t, J = 10 Hz, 2H), 
2.71 – 2.68 (m, 1H), 2.40 – 2.36 (m, 1H), 2.25 – 2.15 (m, 1H), 1.92 – 1.86 (m, 1H), 1.82 
– 1.75 (m, 1H), 1.70 – 1.61 (m, 2H), 1.59 (s, 3H), 1.48 – 1.57 (m, 2H), 1.34 (b, 12H), 
1.25 – 1.20 (m, 1H), 1.09 (s, 3H), 0.89 (d, J = 9.6 Hz, 3H). MS (FAB+) m/z Calcd. For 
C31H49FN2O4 [M+H]+: 533.37. Found: 536.49. 
5.5.3.8 Synthesis Of Compound 5-10 
Compound 5-6 (50 mg, 0.0995 mmol), compound 5-9 (79 mg, 0.149 mmol), 
EDCI (57 mg, 0.298 mmol), HOBt (40 mg, 0.298 mmol) were dissolved in 1 mL DMF 
and then DIEA (0.92 mL, 5.28 mmol) was added to the solution. The reaction mixture 
was stirred at RT for 16 h before concentrated. The residue was then diluted with 50 mL 
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EtOAc and washed with 2X 25 mL saturated NaHCO3 and 2X 25 mL brine. After drying 
the organic layer over Na2SO4 and removing solvent, the crude product was purified by 
flash column chromatography on silica gel (5:1 DCM:MeOH, v/v), yielding compound 5-
10 (30 mg, 30% yield). 1H NMR (400 MHz, Methanol-d4) δ 7.51 (s, 1H), 7.41 (d, J = 
10.1 Hz, 1H), 6.52 (s, 2H), 6.28 (dd, J = 10.1, 1.9 Hz, 1H), 6.25 – 6.09 (m, 2H), 6.07 (t, J 
= 1.6 Hz, 1H), 5.58 (dd, J = 8.7, 3.2 Hz, 1H), 4.79 (dd, J = 7.4, 6.1 Hz, 1H), 4.23 (ddd, J 
= 11.1, 4.0, 2.0 Hz, 1H), 3.95 (ddq, J = 8.0, 5.7, 3.7 Hz, 2H), 3.79 (s, 6H), 3.64 (s, 2H), 
3.45 (td, J = 6.5, 2.8 Hz, 2H), 3.25 (dt, J = 13.1, 7.2 Hz, 1H), 3.17 – 3.07 (m, 3H), 2.71 
(dt, J = 13.9, 5.6 Hz, 2H), 2.59 (dd, J = 15.0, 7.4 Hz, 1H), 2.53 – 2.34 (m, 2H), 2.24 – 
2.15 (m, 2H), 1.86 (tq, J = 11.7, 6.3, 5.2 Hz, 3H), 1.81 – 1.69 (m, 1H), 1.59 (s, 3H), 1.56 
– 1.48 (m, 3H), 1.48 – 1.41 (m, 3H), 1.37 – 1.25 (m, 12H), 1.19 (ddd, J = 12.5, 8.4, 4.3 
Hz, 1H), 1.09 (s, 3H), 0.89 (d, J = 7.2 Hz, 3H). MS (FAB+) m/z Calcd. For 
C54H77FN8O10 [M+H]+: 1017.57. Found: 1017.58. 
5.5.3.9 Synthesis Of Compound 5-11 
Compound 4-2 (151 mg, 0.4 mmol), compound 5-9 (107 mg, 0.2 mmol), EDCI 
(115 mg, 0.6 mmol), HOBt (81 mg, 0.6 mmol) were dissolved in 5 mL DMF and then 
DIEA (0.35 mL, 2 mmol) was added to the solution. The reaction mixture was stirred at 
RT for 16 h before concentrated. The residue was then diluted with 150 mL EtOAc and 
washed with 2X 50 mL saturated NaHCO3 and 2X 50 mL brine. After drying the organic 
layer over Na2SO4 and removing solvent, the crude product was purified by flash column 
chromatography on silica gel (4:1 DCM:MeOH, v/v), yielding compound 5-11 (70 mg, 
39% yield). MS (FAB+) m/z Calcd. 1H NMR (400 MHz, Methanol-d4) δ 7.50 (d, J = 2.4 
Hz, 1H), 7.41 (d, J = 10.1 Hz, 1H), 6.51 (s, 2H), 6.28 (dd, J = 10.1, 1.9 Hz, 1H), 6.07 (t, 
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J = 1.6 Hz, 1H), 4.23 (ddd, J = 11.3, 4.1, 2.0 Hz, 1H), 3.91 (td, J = 6.2, 3.4 Hz, 2H), 3.78 
(s, 6H), 3.65 (d, J = 8.7 Hz, 2H), 3.25 (dt, J = 13.0, 7.2 Hz, 1H), 3.15 (q, J = 5.4, 3.7 Hz, 
2H), 3.13 – 3.06 (m, 2H), 2.71 (dd, J = 6.2, 1.7 Hz, 1H), 2.53 – 2.42 (m, 1H), 2.42 – 2.34 
(m, 1H), 2.25 (t, J = 7.3 Hz, 2H), 2.19 (ddd, J = 15.7, 6.9, 3.2 Hz, 2H), 1.92 – 1.83 (m, 
2H), 1.83 – 1.74 (m, 2H), 1.74 – 1.65 (m, 2H), 1.59 (s, 3H), 1.55 – 1.42 (m, 6H), 1.32 (d, 
J = 3.9 Hz, 12H), 1.21 – 1.12 (m, 1H), 1.09 (s, 3H), 0.89 (d, J = 7.2 Hz, 3H). For 
C49H71FN6O8 [M+H]+: 891.53. Found: 891.54. 
5.5.4 Characterization Of A-TMP-Dex 
5.5.4.1 Lacz Transcription Assay. 
For the LacZ liquid assays, the yeast strains were grown to saturation, and 5 μL of 
the cultures were used to inoculate 95 μL of synthetic complete media lacking histidine, 
uracil, and tryptophan and containing no glucose, 2% galactose, and 2% raffinose both 
with and without small molecule. The cultures were then grown at 30°C for three days 
and then the cells were harvested by centrifugation and the pellets were resuspended in 
100 μL of distilled water and transferred to a flat-bottomed 96-well plate to measure the 
absorbance at 600 nm. Then, the cultures were transferred back to U-bottomed 96-well 
plate, centrifuged for 5 minutes at 2000 rpm, the supernatant was removed, and the 
pellets were resuspended in 100 μL of the Y-Per Protein Extraction Reagent and lysed for 
30 minutes. To measure the absolute β-galactosidase activity of the cells, the lysate was 
incubated with 8.5 μL of 10 mg/mL ONPG for about 10 min at 37°C until the positive 
control turned a yellow color. After the incubation, the reaction was stopped by adding 
110 μL of 1M Na2CO3. The lysates were centrifuged for 5 min at 2000 rpm and the 
supernatants were transferred to a flat-bottomed 96-well plate. The absorbance of the 
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solution at 420 and 550 nm was measured using the HTS 7000 Plus BioAssay Plate 
Reader. The β-galactosidase units were calculated using the following equation: β-
galactosidase = 1000 * (A420/[A600 * time in minutes * volume assayed in mL]). 
5.5.4.2 Growth Curves For LEU2 Selections 
To measure the growth rate of yeast strains under certain conditions, cells from 
glycerol stock or patches on plates were used to inoculate 1-mL overnight cultures in SC 
(Glc) media with amino acid dropouts to maintain the plasmids.  Cells were harvested 
(5000 rpm, 5 min, room temperature) and washed 2X with sterile water.  For each strain, 
the cells were first adjusted to OD600 = 1 and then 2 µL of cell culture was used to 
inoculate 198 µL selective media on 96-well plate.  At least 4 replicates were performed 
for each condition.  Growth was monitored by absorption at 600 nm. 
5.5.4.3 Mock Selectrion 
One mL of SC media containing 2% glucose and lacking histidine and tryptophan 
was inoculated from patches of the Y3H and null strains.  These starter cultures were 
used to inoculate overnight cultures (10-50 mL) of the same media except containing 2% 
galactose and 2% raffinose to pre-induce the yeast three-hybrid construct expression.  
Cells were harvested, washed 3X with sterile water, and resuspended in the SC media 
containing 2% galactose and 2% raffinose and lacking histidine, tryptophan and leucine 
for selection.  The OD600 of the each strain was determined and cells were mixed to give 
10:1, 103:1, 105:1, and 107:1 ratios of the null:positive strains.  For yeast three-hybrid 
selections, Mtx-Dex and A-TMP-Dex were added to a final concentration of 5 µM.  Each 
selection had a final volume of 3 mL and a calculated initial OD600 of 1.  Selections 
were shaken at 30 °C. On days 0, 3, and 6, cells were plated on plates containing SC 
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media with 2% glucose and lacking histidine and tryptophan and after 2 days of growth, 
plates were assayed using the overlay assay described below. After the plates developed, 
the number of red and blue colonies on each plate was counted. 
5.5.4.4 Magenta-Gal/X-Gluc Overlay Assay. 
Potassium phosphate buffer (0.5 M, pH 7.0), 19.8 mL of DMF, 3.3 mL of 10% 
SDS, and 3.3 g low-melting point agarose were combined in an Erlenmeyer flask.  The 
solution was microwaved until the SDS and agarose went into solution.  The flask was 
cooled in a 65C water bath.  Β-mercaptoethanol (165 µL), X-Gluc (165 mg dissolved in 
1 mL DMF), and Magenta-Gal (50 mg dissolved in 1 mL DMF) were added.  After 
gentle mixing, a pipette was used to carefully cover each plate with approximately 10 mL 
of the agarose solution.  The color usually developed sufficiently for plates to be counted 
within a few hours. 
5.5.5 Synthesis Of A-TMP-Biotin For Phage Display 
5.5.5.1 Synthesis Of Compound 5-12 
Biotin-NHS ester (100 mg, 0.293 mmol) and N-Boc-1,6-diaminohexane (74 mg, 
0.293 mmol) was dissolved in 2 mL DMF and then DIEA (0.51 mL, 2.93 mmol) was 
added to the solution. The reaction mixture was stirred at RT for 16 h before concentrated. 
The crude product was purified by flash column chromatography on silica gel (9:1 
DCM:MeOH, v/v), yielding compound 5-12 (32 mg, 13% yield). 1H NMR (400 MHz, 
Methanol-d4) δ 4.53 – 4.46 (m, 1H), 4.30 (dd, J = 7.9, 4.4 Hz, 1H), 3.19 (dddd, J = 12.9, 
8.6, 6.5, 5.0 Hz, 3H), 3.03 (q, J = 6.7 Hz, 2H), 2.93 (dd, J = 12.7, 5.0 Hz, 1H), 2.71 (d, J 
= 12.7 Hz, 1H), 2.20 (t, J = 7.3 Hz, 2H), 1.66 (ddtd, J = 30.3, 14.3, 7.7, 7.3, 5.6 Hz, 4H), 
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1.55 – 1.45 (m, 6H), 1.43 (s, 9H), 1.38 – 1.30 (m, 4H). MS (FAB+) m/z Calcd. For 
C21H38N4O4S [M+H]+: 443.26. Found: 443.3. 
5.5.5.2 Synthesis Of Compound 5-13 
Compound 5-12 was deprotected by dissolving in 1 mL TFA and 1 mL DCM, 
stirring at RT for 1 h. Then the product was obtained by removing solvent by rotary 
evaporation, yielding compound 5-13 (quantitative, not purified) as colorless oil. 
5.5.5.3 Synthesis Of Compound 5-14 
Compound 4-2 (22 mg, 0.059 mmol), compound 5-12 (13 mg, 0.039 mmol), 
EDCI (22 mg, 0.117 mmol), HOBt (16 mg, 0.117 mmol) were dissolved in 1 mL DMF 
and then DIEA (70 µL, 0.39 mmol) was added to the solution. The reaction mixture was 
stirred at RT for 16 h before concentrated. The residue was then diluted with 50 mL 
EtOAc and washed with 2X 25 mL saturated NaHCO3 and 2X 25 mL brine. After drying 
the organic layer over Na2SO4 and removing solvent, the crude product was first purified 
by flash column chromatography on silica gel (3:1 DCM:MeOH, v/v) and then by reverse 
phase HPLC, yielding compound 5-14 (7 mg, 26% yield). 1H NMR (400 MHz, 
Methanol-d4) δ 7.23 – 7.21 (m, 1H), 6.56 (s, 2H), 4.48 (ddd, J = 7.9, 5.0, 1.0 Hz, 1H), 
4.29 (dd, J = 7.9, 4.4 Hz, 1H), 3.92 (t, J = 6.1 Hz, 2H), 3.81 (s, 6H), 3.68 – 3.64 (m, 2H), 
3.22 – 3.12 (m, 5H), 2.92 (dd, J = 12.7, 5.0 Hz, 1H), 2.70 (d, J = 12.7 Hz, 1H), 2.25 (t, J 
= 7.3 Hz, 2H), 2.19 (t, J = 7.3 Hz, 2H), 1.85 – 1.76 (m, 2H), 1.71 (ddd, J = 13.3, 7.2, 4.2 
Hz, 4H), 1.67 – 1.55 (m, 2H), 1.50 (tt, J = 6.8, 3.4 Hz, 4H), 1.44 (q, J = 7.7 Hz, 2H), 
1.35 (td, J = 6.0, 4.5, 2.4 Hz, 4H). MS (FAB+) m/z Calcd. For C34H52N8O6S [M+H]+: 
701.37. Found: 701.38. 
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5.5.5.4 Synthesis Of Compound 5-15 And 5-16 
To the solution of compound 5-6 (82 mg, 163 μmol), N-Boc-1,6-hexanediamine 
hydrochloride (62 mg, 250 μmol), DMAP (10 mg, 80 μmol) in 5 ml anhydrous DMF was 
added EDCI (62 mg, 326 μmol) and DIEA (63 mg / 85 μL, 490 μmol) at RT. The 
reaction was stirred for 20 h at RT before concentrated in vacuo. The mixture was then 
purified by silica gel flash chromatography (10% MeOH in DCM) to give the coupling 
product. The coupling product was directly dissolved in 5 ml trifluoroacetic acid (TFA) 
and stirred for 4 h at RT. The solvent was removed in vacuo and a fraction of the amine 
product was further purified by reverse phase HPLC to give A-TMP-C6-NH2, compound 
5-16 (12.0 mg, in the form of TFA salt) as white solid. HPLC condition: starting with 
10%: 90% acetonitrile: Water, gradient elution for 50 min, end with 40%:60% 
ACN:Water. Retention time: 13-15 min. 1H NMR (300 MHz, CD3OD) δ ppm: 7.25 (s, 1 
H); 6.57 (s, 2 H); 6.22 (dd, J = 17.1 Hz, 9 Hz, 1 H); 6.14 (dd, J = 17.1 Hz, 3 Hz, 1 H); 
5.61 (dd, J = 9 Hz, 3 Hz, 1 H); 4.81 (m, 1 H); 3.96 (m, 2 H); 3.81 (s, 6 H); 3.67 (s, 2 H); 
3.48-3.4(m, 2 H); 3.16 (t, J = 6.9 Hz, 2 H); 2.91 (t, J = 7.5 Hz, 2 H); 2.74 (dd, J = 15 Hz, 
6 Hz, 1 H); 2.58 (dd, J = 15 Hz, 7.5 Hz, 1 H); 1.87 (m, 2 H); 1.64 (m, 2 H); 1.5 (m, 2 H); 
1.37 (m, 4 H). HRMS (FAB+) m/z Calcd. for C29H45O6N8 [M+H]+:601.3457. Found: 
601.3459 
5.5.5.5 Synthesis Of Compound 5-17 
5 μL DIEA was added to a solution of compound 5-16 (5.4 mg, 9 μmol) and 
Biotin-NHS ester (6 mg, 18 μmol) in 1 ml anhydrous DMF. The mixture was stirred at 
RT for 12 h before concentrated. Reaction residue was purified by preparative TLC to 
give compound 5-17 A-TMP-Biotin. 1H NMR (400 MHz, CD3OD) δ ppm: 7.52 (s, 1 H); 
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6.52 (s, 2 H); 6.19 (dd, J = 17.2 Hz, 8.6 Hz, 1 H); 6.14 (dd, J = 17.2 Hz, 2.4 Hz, 1 H); 
5.59 (dd, J = 8.6 Hz, 2.4 Hz, 1 H); 4.79 (m, 1 H); 4.48 (dd, J = 8 Hz, 4.4 Hz, 1 H); 4.29 
(dd, J = 8 Hz, 4.4 Hz, 1 H); 3.95 (m, 2 H); 3.79 (s, 6 H); 3.64 (s, 2 H); 3.48-3.4(m, 2 H); 
3.19 (m, 1 H); 3.17-3.1 (m, 4 H); 2.92 (dd, J = 12.8 Hz, 4.8 Hz, 1 H); 2.72 (dd, J = 15.2 
Hz, 6 Hz, 1 H); 2.70 (dd, J = 12.8 Hz, 4.4 Hz, 1 H); 2.59 (dd, J = 15.2 Hz, 7.6 Hz, 1 H); 
2.18 (t, J = 7.2 Hz, 2 H); 1.86 (m, 2 H); 1.78-1.55 (m, 4 H); 1.52-1.38 (m, 6 H); 1.37-
1.26 (m, 6 H). HRMS (FAB+) m/z Calcd. for C39H59O8N10S [M+H]+:827.4238. 
Found:827.4276. 
5.5.5.6 Synthesis Of Compound 5-18 
TexasRed-SO2Cl (5 mg, 8 µmol) and compound 5-13 (2.7 mg, 8 µmol) was 
dissolved in 0.5 mL DMF and then DIEA (14 µL, 80 µmol) was added to the solution. 
The reaction mixture was stirred at RT for 16 h before concentrated. The crude product 
was purified by reverse phase HPLC, yielding compound 5-18 (1 mg, 13% yield). 1H 
NMR (400 MHz, Methanol-d4) δ 8.57 (dd, J = 1.7, 0.4 Hz, 1H), 8.19 (dd, J = 7.9, 1.7 Hz, 
1H), 7.47 – 7.41 (m, 1H), 6.62 (s, 2H), 4.44 (ddd, J = 7.9, 5.0, 0.9 Hz, 1H), 4.26 (dd, J = 
7.9, 4.4 Hz, 1H), 3.57 (dd, J = 6.6, 4.6 Hz, 4H), 3.52 (t, J = 5.8 Hz, 4H), 3.17 (dd, J = 
9.1, 4.7 Hz, 1H), 3.15 – 3.12 (m, 2H), 3.12 – 3.05 (m, 4H), 2.89 (dd, J = 12.7, 5.0 Hz, 
1H), 2.77 (t, J = 7.1 Hz, 2H), 2.70 (d, J = 6.2 Hz, 3H), 2.66 (d, J = 12.8 Hz, 2H), 2.18 (t, 
J = 7.3 Hz, 2H), 2.12 (q, J = 6.2 Hz, 4H), 2.00 – 1.91 (m, 4H), 1.77 – 1.51 (m, 4H), 1.49 
– 1.33 (m, 6H), 1.28 – 1.21 (m, 4H). MS (FAB+) m/z Calcd. For C47H58N6O8S3 [M]+: 
930.35. Found: 930.5. 
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5.5.5.7 Synthesis Of Compound 5-19 
Compound 4-2 (20 mg, 0.053 mmol), N-Boc-1,6-diaminohexane (22 mg, 0.106 
mmol), EDCI (31 mg, 0.159 mmol), and HOBt (22 mg, 0.159 mmol) were dissolved in 1 
mL DMF and then DIEA (92 µL, 0.53 mmol) was added to the solution. The reaction 
mixture was stirred at RT for 16 h before concentrated. The crude product was purified 
by flash column chromatography on silica gel (4:1 DCM:MeOH, v/v), yielding 
compound 5-19 (10 mg, 33% yield). 1H NMR (400 MHz, Methanol-d4) δ 7.39 (s, 1H), 
6.53 (s, 2H), 3.93 (t, J = 4 Hz, 2H), 3.79 (s, 6H), 3.65 (s, 2H), 3.18 – 3.14 (m, 2H), 3.06 – 
3.01 (m, 2H), 2.94 – 2.89 (m, 2H), 2.27 – 2.23 (m, 2H), 1.78 – 1.61 (m, 4H), 1.51 – 1.47 
(m, 4H), 1.45 (s, 9H), 1.39 – 1.33 (m, 4H). MS (FAB+) m/z Calcd. For C29H46N6O6 
[M+H]+: 575.35. Found: 575.3. 
5.5.5.8 Synthesis Of Compound 5-20 
Compound 5-19 was deprotected by dissolving in 1 mL TFA and 1 mL DCM, 
stirring at RT for 1 h. Then the product was obtained by removing solvent by rotary 
evaporation, yielding compound 5-20 (quantitative, not purified) as colorless oil. 
5.5.5.9 Synthesis Of Compound 5-21 
6-carboxyfluorescein NHS ester (8.2 mg, 17.4 µmol) and compound 5-20 (8.3 mg, 
17.4 µmol) was dissolved in 1 mL DMF and then DIEA (15 µL, 0.087 mmol) was added 
to the solution. The reaction mixture was stirred at RT for 16 h before concentrated. The 
crude product was purified by reverse phase HPLC, yielding compound 5-21 (6.4 mg, 44% 
yield). 1H NMR (400 MHz, Methanol-d4) δ 8.16 – 8.05 (m, 2H), 7.62 (d, J = 1.3 Hz, 1H), 
7.21 (d, J = 1.1 Hz, 1H), 6.72 (d, J = 2.4 Hz, 2H), 6.64 (d, J = 8.8 Hz, 2H), 6.57 (dd, J = 
8.8, 2.3 Hz, 2H), 6.54 (s, 2H), 3.89 (t, J = 6.1 Hz, 2H), 3.78 (s, 6H), 3.65 (s, 2H), 3.35 (s, 
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2H), 3.13 (t, J = 6.9 Hz, 2H), 2.22 (t, J = 7.2 Hz, 2H), 1.76 (qd, J = 7.2, 3.5 Hz, 2H), 
1.69 (td, J = 9.4, 7.9, 5.2 Hz, 2H), 1.59 – 1.51 (m, 2H), 1.47 (t, J = 6.8 Hz, 2H), 1.38 – 
1.30 (m, 4H). MS (FAB+) m/z Calcd. For C45H48N6O10 [M+H]+: 833.34. Found: 833.4. 
5.5.6 Revalidation Of TMP-Binding Peptide From Phage Display 
5.5.6.1 Fluorescence Polarization Assay 
The affinity of TMP-fluorescein and for eDHFR was determined by fluorescence 
polarization. TMP-Fluorescein at a final concentration 10  nM, was incubated with 
purified peptide H07 and D10 at varying concentrations ranging from 0.1 nM to 500 nM 
in MTEN buffer (50 mM morphlinoethane sulfonic acid (MES), 25 mM Tris-HCl, 25 
mM ethanolamine, 100 mM NaCl, pH 7.2). By comparing the intensity of emitted 
fluorescence both parallel and perpendicular to incident light (measured on a Perkin 
Elmer Victor3 FP analyzer), it is possible to compute the amount of bound tracer. 
5.5.6.2 Calculation of IC50 
In the solution of short peptide, TMP-Fluorescein, and inhibitor (TMP or TMP-
Biotin), following two equilibriums exist: 
 
In which I: TMP or TMP-biotin; S: TMP-Fluorescein; E: peptide.  
The anticipated competition curve is cartooned in Figure 5-17. IC50 is defined as 
the total concentration of inhibitor when the concentration of ES (peptide binding with 




Figure 5-17  Anticipated result of competition assay. 
With no inhibitor, [ES] reaches maximum ESmax.  At ܫ଴ ൌ ܫܥହ଴, [ES] is half of 
ESmax. 
Therefore: ܫܥହ଴ ൌ ܫ଴ when ሾESሿ ൌ ଵଶ ܧܵ௠௔௫; 
ሾESሿ ൌ ܧܵ௠௔௫ when ܫ଴ ൌ 0. 
According to the definition of equilibrium constant and the law of conservation of 
mass: 
ࡷࡿ ൌ ሾࡱሿሾࡿሿሾࡱࡿሿ 	 	 	 	 	 	 	 	 	 Equation 5-9	
ࡷࡵ ൌ ሾࡱሿሾࡵሿሾࡱࡵሿ 	 	 	 	 	 	 	 	 	 Equation 5-10	
ሾࡱሿ ൅ ሾࡱࡿሿ ൅ ሾࡱࡵሿ ൌ ࡱ૙	ሺconstantሻ	 	 	 	 	 	 Equation 5-11	
ሾࡿሿ ൅ ሾࡱࡿሿ ൌ ࡿ૙	ሺconstantሻ		 	 	 	 	 	 	 Equation 5-12	
ሾࡵሿ ൅ ሾࡱࡵሿ ൌ ࡵ૙	ሺvariableሻ		 	 	 	 	 	 	 Equation 5-13	
General method to calculate IC50: 
Step 1: calculate ESmax. 
When ܫ଴ ൌ ሾIሿ ൌ ሾEIሿ, ሾESሿ ൌ ܧܵ୫ୟ୶: 
ࡱࡿ࢓ࢇ࢞ ൅ ሾࡿሿ ൌ ࡿ૙	 	 	 	 	 	 	 	 Equation 5-14	
ࡱࡿ࢓ࢇ࢞ ൅ ሾࡱሿ ൌ ࡱ૙	 	 	 	 	 	 	 	 Equation 5-15	
ሾࡿሿሾࡱሿ




ሾࡿሿ ൌ ࡿ૙ െ 	ࡱࡿ࢓ࢇ࢞,	ሾࡱሿ ൌ ࡱ૙ െ ࡱࡿ࢓ࢇ࢞	
Equation 5-16 can be rewritten as 
ሺࡿ૙ െ 	ࡱࡿ࢓ࢇ࢞ሻሺࡱ૙ െ ࡱࡿ࢓ࢇ࢞ሻ
ࡱࡿ࢓ࢇ࢞ ൌ ࡷࡿ	
and expanded as 
ࡱࡿ࢓ࢇ࢞૛ െ ሺࡱ૙ ൅ ࡿ૙	ሻࡱࡿ࢓ࢇ࢞ ൅ ࡱ૙ ∙ ࡿ૙ ൌ ࡷࡿ ∙ ࡱࡿ࢓ࢇ࢞,	
or 
ࡱࡿ࢓ࢇ࢞૛ െ ሺࡱ૙ ൅ ࡿ૙ ൅ ࡷࡿ	ሻࡱࡿ࢓ࢇ࢞ ൅ ࡱ૙ ∙ ࡿ૙ ൌ ૙.	
Therefore, 
ࡱࡿ࢓ࢇ࢞ ൌ ሺࡱ૙ାࡿ૙ାࡷࡿ	ሻିඥሺࡱ૙ାࡿ૙ାࡷࡿ	ሻ૛ି૝ࡱ૙∙ࡿ૙૛ .	
Step 2: calculate [E]. 
When ܫ଴ ൌ ܫܥହ଴, ሾESሿ ൌ ଵଶ ܧܵ௠௔௫. From Equation 5-12, 
ሾࡿሿ ൌ ࡿ૙ െ ሾࡱࡿሿ ൌ ࡿ૙ െ ૚૛ࡱࡿ࢓ࢇ࢞.	
From Equation 5-9, 





Step 3: calculate [I] and [EI]. 
From Equation 5-11, 
ሾࡱࡵሿ ൌ ࡱ૙ െ ሾࡱሿ െ ሾࡱࡿሿ ൌ ࡱ૙ െ ሾࡱሿ െ ૚૛ࡱࡿ࢓ࢇ࢞.	
From Equation 5-10, 
ሾࡵሿ ൌ ࡷࡵሾࡱࡵሿሾࡱሿ ൌ
ࡷࡵቀࡱ૙ିሾࡱሿି૚૛ࡱࡿ࢓ࢇ࢞ቁ
ሾࡱሿ .	
Step 4: calculate IC50. 
ࡵ࡯૞૙ ൌ ࡵ૙ ൌ ሾࡵሿ ൅ ሾࡱࡵሿ ൌ ࡷࡵቀࡱ૙ିሾࡱሿି
૚
૛ࡱࡿ࢓ࢇ࢞ቁ
ሾࡱሿ ൅ ቀࡱ૙ െ ሾࡱሿ െ
૚
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A1 Appendix 1 




A1.1 Chapter Overview 
Many key biological questions cannot be readily addressed with existing protein 
labeling technologies.  The discovery that fluorescent proteins could be used for tagging 
and visualizing proteins in vivo through simple genetic encoding was a significant 
advancement for the field.  However, the photophysical properties of the chromophore 
are highly dependent on the protein structure, and while directed evolution has led to 
improvements, organic fluorophores often still have superior photophysical properties. 
The chemical tags offer the advantage of being modular, allowing the incorporation of 
any organic fluorophore.  Despite this fact, the chemical tags have not yet been well 
developed for specialized imaging techniques, such as two-photon and single-molecule 
imaging in living cells.  Therefore, we developed the TMP-tag for these specialized 
imaging techniques by synthesizing and evaluating analogs containing fluorophores with 
the appropriate photophysical properties. 
A1.2 Introduction 
The development of two-photon microscopy over the last two decades has 
established its utility to biological imaging 1.  Two-photon excitation results from the 
absorption of two photons simultaneously by a fluorophore, and as a result many of 
fluorophores used for live cell imaging can be excited by light in the IR region.  
Therefore, two-photon microscopy is an attractive technique for live cell imaging, since 
IR light is less damaging to living cells and exhibits lower background from cellular 
autofluorescence 2.  Aside from lower photodamage, two-photon microscopy offers other 




photon absorption is limited to the focal plane where there is a high density of photons, 
which means there is very little background from out of focus excitation or scattering, 
resulting in an improved imaging resolution and a reduced volume of photobleaching 2.  
Also, two-photon microscopy allows for the study of thicker tissue samples because of 
the deep penetration IR light.   
Many fluorophores that are used for one-photon imaging do not possess ideal 
photophysical properties for two-photon microscopy.  And therefore, the development of 
a method to selectively label proteins of interest with a good two-photon dye would be an 
important advancement for the field of two-photon microscopy.  We have previously 
established that a chemical tag based on the high-affinity interaction between E. coli 
dihydrofolate reductase (eDHFR) and trimethoprim (TMP) can be used to selectively 
label proteins with fluorescent tags in vivo 3,4.  Cells expressing a fusion between eDHFR 
and the protein of interest can be selectively labeled by non-covalent binding to a cell-
permeable TMP-fluorophore heterodimer to eDHFR.  Thus, TMP-tag is one of the few 
chemical tags that allows intracellular proteins to be labeled in living cells with high 
signal-to-noise.  The synthesis of TMP derivatives is straightforward allowing for the 
modular incorporation of any desired fluorophore or probe.  Therefore, we sought to 
exploit the system in order to develop a TMP-two-photon dye heterodimer that would 






Figure A1-1 A Trimethoprim-Based Chemical Tag for Two-Photon Imaging. 
(A) Cartoon depicting two-photon imaging strategy using a chemical tag.  A protein of interest 
(POI) is expressed as a fusion to E. coli dihydrofolate reductase (eDHFR) and is then 
subsequently labeled with a trimethoprim (TMP)-two-photon dye (BC575) heterodimer. (B) 
Energy level diagram illustrating one– and two–photon excitation. Two-photon exciation occurs 
from the simultaneous absorption of two photons that are approximately half of the energy of one-
photon absorption. 
Here, we have developed a TMP-tag that can be used for two-photon imaging of 
intracellular proteins in vivo.  First, a two-photon dye, BC575, was selected not only 
based on its two-photon photophysical properties but also on its molecular structure, 
since the choice of dye has been demonstrated to affect the cell permeability of a TMP-
dye heterodimer.  Next, the dye was characterized in vitro in order to compare its two-
photon photophysical properties with well-studied fluorophores commonly used for two-
photon microscopy.  Then, the TMP-BC575 heterodimer was evaluated for its utility in 
vivo as a two-photon chemical tag.  Together, this work provides a two-photon chemical 
tag with good two-photon absorption characteristics that can be used immediately for 
biological studies and labeling of intracelluar proteins of interest in living cells. 
My main contributions to this project have been the design of the TMP-two-
photon dye heterodimer.  I also assisted in the training of the two junior graduate students 
TMP










who completed this project and served as their mentor.  The synthesis of the TMP-BC575 
heterodimer was completed by Mariam Konate when she was a rotation student in the 
laboratory.  The in vitro and in vivo characterization of the small molecule fluorophore 
were carried out by Chaoran Jing, a graduate student in the laboratory, and Darcy Peterka, 
a research scientist in Professor Yuste’s laboratory in Columbia University’s Department 
of Biological Sciences.  
A1.3 Results 
A1.3.1 Design of the TMP-2P Dye Heterodimer 
Designing a two-photon chemical tag required the selection of a fluorophore that 
has good two-photon photophysical properties and behaves well in the cell, being both 
cell-permeable and not partitioning to lipid vesicles.  The performance of a two-photon 
dye is determined by the two-photon action cross-section, which is both a measure of the 
likelihood of two-photon absorbance and the fluorescence quantum yield 5.  The two-
photon action cross section is reported in the units of Goeppert-Mayer, or GM (1 GM = 
10-50cm4s/photon). The action cross-sections of many two-photon dyes have been 
reported in the literature, however, the values for the majority of the dyes used for 
intracellular labeling of proteins are not that high 6.  Previous work from our lab has 
demonstrated that the ligand-dye combination is important for determining cell-
permeability, but is non-trivial to optimize 4.  As expected by its clinical use as an 
antibiotic, TMP has excellent cell permeability properties.  The molecular structures of 
the many two-photon dyes suggest that they should have good cell permeability 




The first two-photon dye pursued was 2H-benzo[h]chromene-2-one derivative, a 
dye recently reported by Kim et al. for two-photon imaging in live cells 7, which will be 
referred to as BC575.  The molecule has a cyclic planar frame, which increases the 
internal charge transfer, giving 2H-benzo[h]chromene-2-one a high two-photon action 
cross-section of 66.5 GM, and making it a reasonable first two-photon dye.  The dye 
structure also contains a methyl ester, enabling straightforward conjugation to a free 
amine (Error! Reference source not found.).  The dye has also been demonstrated to be 
membrane permeable 7, suggesting that conjugation to TMP would not interfere with cell 
permeability.   
A1.3.2 Synthesis of the TMP-BC575 Dye Heterodimer 
The synthesis of the TMP portion of the molecule has been described in Section 
4.3.1. 
Each of the steps for the synthesis of the 2H-benzo[h]chromene-2-one two-photon 
dye have previously been published 7.  The aniline of 6-amino-3,4-dihydronapthalen-
1(2H)-one was methylated by iodomethane in the presence of K2CO3 to yield the 
corresponding dimethylaniline A1-1.  Compound A1-1 was then formylated by treatment 
with ethyl formate to give A1-2.  Aromatization of the ring was then achieved by 
dehydrogenation with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) to produce A1-3.  
Finally, condensation with dimethyl malonate gave 8-dimethylamino-2-oxo-2H-





Scheme A1-1 Synthesis of Compound A1-6. 
Reaction conditions: a. K2CO3, MeI, CH3CN, 50˚C, 16 h, 21%; b. ethyl formate, NaOMe, benzene, 
62%; c. DDQ, 1,4-dioxane, 69%; d. dimethyl malonate, piperidinium acetate, reflux, toluene, 16 h, 
16%; e. i. KOH, EtOH, 5 h, ii. HCl, 66%; f. PyBOP, DIEA, DMF, RT, 16 h, 31%. 
To couple TMP to the two-photon dye, the methyl ester of compound A1-4 was 
hydrolyzed using KOH to produce A1-5, and the resulting carboxylic acid was coupled to 
the amine of compound 4-4 using standard peptide coupling conditions, generating the 




A1.3.3 In Vitro Characterization of BC575 
Since the action cross-section is not directly comparable to the brightness of 
traditional small molecule fluorophores, we plan to begin by simply characterizing the 
photophysical performance of the two-photon dye, BC575.  As a benchmark, the two-
photon dye was compared to RhodamineB, a small molecule dye known to have great 
two-photon properties 6.   
Rectangular glass capillaries were filled with solutions of BC575 and 
RhodamineB at a 100 µM concentration.  The capillaries were then sealed, fixed on a 
cover slip and immersed in a drop of water.  Then, a series of images were taken of the 
two-photon excited fluorescence intensity was collected with the 560 (BP 140) emission 
filter from excitation in the 750 to 1050 nm range.  The total signal intensities were then 
measured using the program ImageJ 10 and used to calculate the normalized fluorescence 
intensities for the dyes (Figure A1-2).  The results show that BC575 has a considerable 
two-photon cross-section from 750 to 950 nm.  
 




To evaluate the utility of the fluorophore for two-photon imaging, the two-photon excited 
fluorescence intensity was measured for a 100 µM solution of BC575 (red) from 750-1050 nm. 
For comparision, the spectrum for RhodamineB (black) was measured under the same conditions. 
A1.3.4 In Vivo Characterization of the TMP-BC575 Heterodimer 
Having demonstrated that the two-photon dye had appropriate two-photon 
photophysical properties, the utility of the TMP-BC575 heterodimer for in vivo imaging 
was evaluated.  The heterodimer was used to label an intracellular nucleus-targeted 
eDHFR fusion in living cells and imaged by both confocal and two-photon microscopy. 
First, the labeling specificity of the TMP-BC575 conjugate was evaluated using 
confocal microscopy.  Wild-type fibroblasts (NIH3T3) transiently transfected with vector 
DNA encoding a nucleus-targeted eDHFR fusion were incubated with 1 µM of TMP-
BC575 for 10 minutes.  Then, the cells were washed twice and imaged by confocal 
fluorescent microscopy (Figure A1-3).  Significantly, transfected cells showed distinct 
nuclear staining with no significant background fluorescence in the cytosol or in 
untransfected cells.  This result demonstrates that the TMP-BC575 molecule is cell 
permeable while not being hydrophobic enough to partition to lipid vesicles, allowing it 
to label intracellular proteins with high signal-to-noise in live cells. 
 




To evaluate the specificity of labeling, TMP-BC575 was used to label nucleus-targeted fusion 
proteins in wild-type fibroblasts.  Cells transiently transfected with vector encoding the nucleus-
targeted eDHFR fusion were incubated with 1 µM TMP-BC575 in Ringer’s buffer containing 10% 
newborn calf serum for ten minutes, washed twice with phosphate buffered saline (PBS) and then 
imaged using live cell, confocal microscopy.  (A-C) Confocal micrographs: (A) differential image 
contrast; (B) excitation of TMP-BC575 at 488 nm; (C) overlay of A and B.  The labeling with TMP-
BC575 showed distinct nuclear staining with no significant background fluorescence in the 
cytoplasm or untransfected cells.  
After demonstrating the specificity of TMP-BC575 labeling eDHFR in vivo, the 
dye was next evaluated for its utility for live cell two-photon microscopy. Human 
embryonic kidney (HEK) 293 cells transfected with nucleus-targeted eDHFR were 
incubated with 1 µM TMP-BC575 for 10 minutes and washed.  The cells were imaged 
using two-photon microscopy and an excitation wavelength of 940 nm (Figure A1-4).  
The results verify that two-photon imaging of eDHFR fusion proteins labeled with the 
TMP-BC575 heterodimer produces images with high signal-to-noise. 
 
Figure A1-4 In Vivo Characterization of Two-Photon Excitation of the TMP-BC575 
Heterodimer. 
 (A-D) HEK293 cells incubated with 1μM TMP-BC575 for 10min, washed in HEPES buffer, and 
then imaged using two-photon microscopy. (B,D) Two-photon micrographs from excitation at 940 




with nucleus-targeted eDHFR and (C-D) untransfected HEK293 cells. Transfected cells incubated 
with TMP-BC575 show clear nuclear staining, while only weak background staining can be 
observed in cytoplasm and in untransfected cells. 
A1.4 Discussion 
Thus, TMP-BC575 is an immediately viable tool for imaging proteins in live cells 
using two-photon microscopy.  This two-photon fluorophore expands the TMP-tag tool 
kit, adding to the value of this modular labeling technology.  A protein of interest can be 
tagged with eDHFR, and different labels can then be swapped in, allowing the protein to 
be readily analyzed by multiple techniques.  While cell permeability and lipid 
partitioning appear to be tag dependent, these experiments suggest BC575 may also be 
compatible with other chemical tags.  Given its broad excitation maxima and distinct 
emission wavelength, TMP-BC575 offers an alternative to other FPs for multi-color two-
photon imaging  with enhanced green fluorescent protein (EGFP), Alternatively, an 
orthogonal chemical tag with a non-overlapping two-photon fluorophore could be 
developed for multi-color two-photon microscopy.  Furthermore, TMP-BC575 may be 
advantageous in applications where the larger FP fusion interferes with biological 
function or where the reversibility of the fluorophore labeling can be exploited.  The next 
step is to challenge TMP-BC575 to label a variety of intracellular proteins.  We are also 
exploring the utility of TMP-BC575 for two-photon imaging of tissue sections and live 
animals.  This work opens the door for two-photon imaging with chemical tags and 
further illustrates how the modular organic label of chemical tags can be harnessed for 




A1.5 Experimental Methods 
A1.5.1 Synthesis of the TMP-BC575 Dye Heterodimer 
A1.5.1.1 Synthesis of Compound A1-1 
6-Amino-3,4-dihydronapthalen-1(2H)-one (0.34 g, 2.1 mmol) and K2CO3 (1.0 g, 
7.4 mmol) were added to a flame-dried 50 mL round bottom flask and then suspended in 
anhydrous CH3CN (11 mL).  Iodomethane (4.1 g, 29 mmol) was added and the reaction 
mixture was stirred under argon at 50˚C for 16 hours in the dark.  Then CH2Cl2 (10 mL) 
and H2O (10 mL) were added and the mixture was stirred.  The aqueous layer was 
extracted with CH2Cl2 (2x10 mL) and the organic layers were combined, dried with 
MgSO4, filtered, and concentrated to dryness.  The product was then purified by silica gel 
flash chromatography (8:2 Hex:EtOAc + 1% MeOH) to give 76 mg (21% yield) of 
compound A1-1: Rf = 0.32 in 9:1 CH2Cl2:MeOH. 1H NMR (400 MHz, CDCl3)  ppm: 
7.86 (d, 1H), 7.73, (d, 1H), 6.60 (dd, 1H), 6.40 (d, 1H), 3.05 (s, 6H), 2.81 (t, 2H), 2.50 (t, 
2H). 
A1.5.1.2 Synthesis of A1-2 
Sodium methoxide (1.2 g, 22 mmol), ethyl formate (0.94 mL, 12 mmol), and 
anhydrous benzene (9 mL) were added to a flame-dried round bottom flask.  Then, 
compound A1-1 (0.95 g, 5.0 mmol) was dissolved in anhydrous benzene (6 mL) and was 
added dropwise to the reaction mixture with stirring.  The reaction mixture was stirred 
overnight under argon at RT in the dark.  After 16 hours, ether (20 mL) and H2O (20 mL) 
were added to the reaction mixture and the layers were separated.  The aqueous layer was 




ether (20 mL).  The organic layer was washed with H2O (20 mL) and brine (20 mL) and 
then dried over MgSO4, filtered, and concentrated to dryness to yield 0.68 g (62%) of 
compound A1-2.  1H NMR (400 MHz, CDCl3)  ppm: 7.94 (d, 1H), 6.60 (dd, 1H), 6.41 
(d, 1H), 3.04 (s, 6H), 2.86 (t, 2H), 2.55 (t, 2H), 2.07 (m 2H); MS(FAB+), m/z 217.38 
(M+), calculated 217.11. 
A1.5.1.3 Synthesis of Compound A1-3 
To a flame-dried, 25 mL round bottom flask, compound A1-2 (38 mg, 0.17 
mmol), DDQ (43 mg, 0.19 mmol), and anhydrous dioxane (5 mL) were added.  The 
reaction was stirred at RT under argon in the dark for 20 hours.  The hydroquinone was 
removed by filtration and the solvent of the filtrate was removed in vacuo.  The product 
was purified by column chromatography on silica gel (9:1 Hex:EtOAc) to yield 
compound A1-3 (26 mg, 69%).  1H NMR (300 MHz, CDCl3)  ppm: 12.82 (s, 1H), 9.76 
(s, 1H), 8.24 (d, 1H), 7.29 (d, 1H), 7.10-7.04 (m, 2H), 6.74 (d, 1H), 3.12 (s, 6H); 
MS(FAB+), m/z 215.36 (M+), calculated 215.09. 
A1.5.1.4 Synthesis of Compound A1-4   
A mixture of compound A1-3 (26 mg, 0.12 mmol), dimethyl malonate (14 µL, 
0.12 mol), and a catalytic amount of piperidinium acetate in toluene (4.3 mL) was 
refluxed in a Dean-Stark trap for 16 hours.  The mixture was cooled and the solvent was 
removed in vacuo.  The product was purified by column chromatography on silica (6:1 
Hex:EtOAc) to yield compound 1-4 (5.9 mg, 16%).  1H NMR (300 MHz, CDCl3)  ppm: 
8.59 (s, 1H), 8.37, (d, 1H), 7.35 (dd, 2H), 7.14 (dd, 1H), 6.80 (d, 1H), 3.94 (s, 3H), 3.13 




A1.5.1.5 Synthesis of A1-5 
Compound A1-4 (15 mg, 51 µmol) and KOH (5.8 mg, 100 µmol) were suspended 
in EtOH (4.0 mL).  The reaction mixture was stirred at RT in the dark for 5 hours.  The 
reaction mixture was then diluted with ice water and the pH was adjusted to 3 using 
concentrated HCl and a dark red precipitate formed.  The crystals were collected by 
filtration giving compound A1-5 (9.6 mg, 66%). 
A1.5.1.6 Synthesis of A1-6 
Compound 4-4 (5.3 mg, 9.0 µmol), compound A1-5 (3.2 mg, 11 µmol), and 
PyBOP (7.4 mg, 14 µmol) were added to a flame-dried vial and dissolved in DMF (0.4 
mL).  DIEA (7.6 µL, 44 µmol) was added to the vial and the reaction was stirred under 
nitrogen overnight at RT in the dark.  Then, the solvent was removed in vacuo and the 
product was purified by column chromatography on silica (12:1 CH2Cl2:MeOH).  The 
product was then purified by HPLC to yield compound A1-6 (2.3 mg, 31 %).  1H NMR 
(400 MHz, CD3OD)  ppm: 8.79 (s, 1H), 8.26 (d, 1H), 7.51 (dd, 2H), 7.31 (dd, 1H), 7.20 
(s, 1H), 6.97 (d, 1H), 6.52 (s, 2H), 3.89 (t, 2H), 3.77 (s, 6H), 3.70-3.48 (m, 16H), 3.24 (t 
2H), 3.15 (s, 6H), 2.24 (t, 2H), 1.89 (t, 2H), 1.80-1.67 (m, 6H); MS(FAB+), m/z 844.58 
(MH+); HRMS(FAB+), m/z 844.4269 (MH+), calculated 844.42. 
A1.5.2 One-Photon Spectroscopic Measurements 
The one-photon absorption spectra were recorded on a Spectramax Plus384 UV-
visible spectrophotometer (Molecular Devices).  Both BC575 and TMP were dissolved in 




A1-5A).  For the TMP-BC575 heterodimer, the concentration was determined using 
Beer’s law and the extinction coefficient of the unconjugated BC575 two-photon dye.   
 
Figure A1-5 One-Photon Absorption and Emission Spectra. 
(A-B) In vitro characterization of the two-photon fluorophore, BC575.  (A) Determination of the 
extinction coefficient for BC575 and TMP.  (B) Normalized fluorescence spectrum of BC575. 
The one-photon fluorescence spectrum of BC575 was recorded on a LS 55 
luminescence spectrometer (Perkin Elmer).  BC575 was dissolved in water to a 0.25 µM 
concentration and excited at 453nm.  The normalized fluorescence emission is shown in 
Figure A1-5B. 
A1.5.3 Two-Photon Spectroscopic Measurements 
The two-photon fluorescence data was acquired using a custom made two-photon 
laser scanning microscope based on the Olympus FV-300 system (FV-300 side-mounted 
to a BX50WI microscope with a 60×, 1.1NA, water immersion objective) and a 
Ti:sapphire laser (Chameleon Ultra II, Coherent) 11.  Fluorescence was detected with a 
top-mounted Hamamatsu H7422-P40 PMT connected to a Hamamatsu C7319 
preamplifier whose output was connected to the FluoView system, and simultaneously 
recorded with a DAQ card (National Instruments PCI-6259).  Rectangular glass 




















































capillaries (inner dimensions 300x50 microns) filled with a 100μM solution of BC575 in 
DMF and a 100μM solution of RhodamineB in MeOH were sealed and fixed on a cover 
slide and covered by a drop of water.  The objective was immersed in the drop of water 
and a series of fluorescence images were collected for both BC575 and RhodamineB with 
the 560 (BP 140) emission filter for excitation from 750 to 1050 nm (Delta nm = 25).  
Total signal intensities were quantified using ImageJ, and adjusted to variance of laser 
power and laser pulse width, using equation A1-1.  The fluorescence intensities before 
and after adjustment are denoted as Fmea and Fadj, respectively.  P is the laser power on the 
sample; τ is estimated laser pulse width on sample; and c is concentration of the 
fluorophore. 
 
Figure A1-6 Two-Photon Excited Emission Spectrum.  
A solution of BC575 was excited by two-photon excitation.  The graph shows the normalized 
fluorescence spectrum from excitation with a laser at 900 nm. 
cP
FF meaadj 2
         Equation A1-1 
Power was measured using a calibrated power meter (Newport 818-ST).  The 




measured values (via intensity autocorrelation (Femtochrome FR-103TPM)).  Values of τ 
were measured at every 50nm from 750nm to 1050nm, and were interpolated for the 
wavelengths that τ was not measured using natural cubic spline interpolation (data shown 
in Figure A1-2). 
The same two-photon microscope setup was used to record the two-photon 
excited fluorescence spectrum, except that the photomultiplier tube (PMT) was replaced 
by a photospectrometer (Ocean Optics USB2000+).  Figure A1-6 shows the two-photon 
emission fluorescence spectrum of BC575 in DMF from excitation at 900 nm.  Excitation 
at wavelengths from 800-1000 nm yielded nearly identical emission profiles.  
A1.5.4 Tissue Culture and Transfections 
NIH3T3 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% (v/v) newborn calf serum (NCS), L-glutamine (2 mM), penicillin 
and streptomycin, HEPES (15 mM), and incubated in a humidified atmosphere at 37ºC 
and 5% CO2.  Adherent cells (ca. 80% confluent) were reseeded onto cover slips in 6-
well plates; cells were transfected with 2 μg of plasmid DNA using FuGENE HD 
Transfection Reagent.  Ca. 28 hours after transfection, cells were washed by phosphate 
buffered saline (PBS) and then incubated in 0.6ml Ringers buffer with 10% (v/v) NCS 
and 1 μM TMP-BC575 for 10 min at 37ºC.  After incubation, the cells were washed three 
times in PBS and then reimmersed in Ringers buffer with 10% (v/v) NCS and imaged. 
HEK293 cells were cultured in high glucose DMEM supplemented with L-
glutamine, pyruvate, and 10% (v/v) fetal bovine serum (FBS), and incubated in a 
humidified atmosphere at 37ºC and 5% CO2.  Adherent cells (ca. 80% confluent) were 




DNA using FuGENE 6 Transfection Reagent.  Ca. 36 hours after transfection, cells 
were incubated in HEPES buffer containing 1 μM TMP-BC575 for 10 min at 37ºC.  Then 
cells were washed once with HEPES buffer and imaged using two-photon microscopy 
A1.5.5 Confocal Microscopy 
Confocal fluorescent microscopy of live cells was preformed using an Olympus 
IX81 scanning laser microscope equipped with a 60X Plan Fluor oil immersion objective.  
Laser excitation at 488nm was used to excite the TMP-BC575 heterodimer fluorescence.  
Differential interference contrast (DIC) and fluorescent images were captured by the 
Fluoview FV500 software and processed using ImageJ 10.  Figure A1-3 shows confocal 
fluorescence imaging of NIH3T3 cells expressing nucleus-targeted eDHFR and labeled 
by the TMP-BC575 heterodimer. 
A1.5.6 Two-Photon Microscopy 
The microscope setup for epifluorescence and two-photon fluorescence imaging 
has been described before 11.  This microscope is equipped with an oblique illuminator 
(Olympus) to take transmitted optical micrographs.  Laser excitation at 940nm was used 
to excite TMP-BC575 fluorescence.  Images were processed using ImageJ (Figure A1-4). 
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A2 Appendix 2 





A2.1 List of Plasmids Used and Constructed Throughout These Studies 
Name Description Marker Source 
Chapter 2 
CJ-01 
eDHFR:E17C on pAED4 for bacteria 
expression 
Amp This study 
CJ-02 
eDHFR:N18C on pAED4 for bacteria 
expression 
Amp This study 
CJ-03 
eDHFR:A19C on pAED4 for bacteria 
expression 
Amp This study 
CJ-04 
eDHFR:M20C on pAED4 for bacteria 
expression 
Amp This study 
CJ-05 
eDHFR:P21C on pAED4 for bacteria 
expression 
Amp This study 
CJ-06 
eDHFR:N23C on pAED4 for bacteria 
expression 
Amp This study 
CJ-07 
eDHFR:P25C on pAED4 for bacteria 
expression 
Amp This study 
CJ-08 
eDHFR:L28C on pAED4 for bacteria 
expression 
Amp This study 
CJ-09 
eDHFR:A29C on pAED4 for bacteria 
expression 
Amp This study 
CJ-10 
eDHFR:K32C on pAED4 for bacteria 
expression 
Amp This study 
CJ-11 
eDHFR:S49C on pAED4 for bacteria 
expression 
Amp This study 
CJ-12 
eDHFR:I50C on pAED4 for bacteria 
expression 
Amp This study 
CJ-13 
eDHFR:G51C on pAED4 for bacteria 
expression 
Amp This study 
CJ-14 
eDHFR:R52C on pAED4 for bacteria 
expression 
Amp This study 
CJ-15 
eDHFR:L54C on pAED4 for bacteria 
expression 
Amp This study 
CJ-16 
eDHFR:P55C on pAED4 for bacteria 
expression 
Amp This study 
V1008 
Wild type eDHFR-His6 on pAED4 for 
bacteria expression 
Amp This study 
pH2B-GFP H2B-EGFP on pEGFP-N1 backbone Kan Addgene 
pH2B-
mCherry 
H2B-mCherry on pEGFP-N1 backbone Kan Addgene 
V2606 H2B-eDHFR on pEGFP-N1 backbone Kan This study 
V2607 
H2B-eDHFR:L28C on pEGFP-N1 
backbone 











V2492 Cox8A-eDHFR Amp This study 
V2605 TOMM20-eDHFR Amp This study 
V2608 TOMM20-eDHFR:L28C Amp This study 
pMLC-
eDHFR 





pMLC-eDHFR:L28C Kan This study 
V2611 Actinin-eDHFR Kan This study 
V2612 Actinin-eDHFR:L28C Kan This study 
pDHFR:L28C-
His6 
eDHFR:L28C-His6 for mammalian 
expression 
Kan This study 
Chapter 3 
CJ-53 
H2B-eDHFR:L28C on pEGFP-N1 
(Clontech) backbone. 
Kan This study 
pYD1 
Aga2-MCS-V5 epitope; backbone for yeast 
surface display. 




eDHFR-vinculin Kan This study 
eDHFR-talin eDHFR-talin on pEGFP-C1 backbone Kan This study 
Chapter 5 
pV398 
pGAL1-B42-(GSG)2-rGR2 2µ TRP1 pUC 
ori 
Kan; Trp B.Carter 
2
 
pMW103  pGAL1-B42 2µ TRP1 pUC ori Kan; Trp R. Brent 
3
 
pMW112  8LexAop-lacZ 2µ URA3 pBR ori Kan; Ura R. Brent 
3
 
A2.2 List of Oligonucleotides Used Throughout These Studies 
All oligonucleotides were purchased from either Invitrogen (Carlsbad, CA) or 
Integrated DNA Technologies (Coralville, IA). Restriction sites that were used for 
subcloning are underlined. Primers used for site-directed mutagenesis and saturated 
mutagenesis have the mutations and NNK codons shown in bold. A, G, C, and T 
represent the natural DNA bases, while N is an equal mixture of A, C, G, and T and K is 








ACG TCA CCG GTC GCC ACC ATG GTG GGT TCT 




ACG TCG CGG CCG CTT TAG TGA TGG TGA TGG 




GCA TAC GTC GAT ATC AAG CTT ACC ATG ATC 




GCA TAC GTC CTC GAG TTA CCG CCG CTC CAG AA This study 
pTOMM20-
ClaI 
GTC GAC ATC GAT ATG GTG GGT CGG AAC AG This study 
pTOMM20-
EcoRV 
GCA GTC GAT ATC ATC TAC GAC ATC TT This study 
pActinin-
SalI 
CGA ATT CTG CAG TCG ACG GTA CCG CCA TGG 




CAT GGT GGC GAC CGG TGG ATC GAG GTC ACT 









ACG TCG CGG CCG CTT TAG TGA TGG TGA TGG 
TGA TGC CGC CGC TCC AGA ATC T 
This study 
Chapter 3 
pCJ-28 TGG TGG TTC TGG TGG TGG TGG TTC TGG TGG 
TGG TGG TTC Tat cag tct gat tgc ggc gtt agc 
This study 
pCJ-29 GAG GGT TAG GGA TAG GCT TAC CTT CGA AGG 
GCC CTC TAG Acc gcc gct cca gaa tct caa 
This study 
pCJ-32 G GTA GAT CGC GTT ATC GGC ATG GAA NNK NNK 
NNK NNK NNK NNK NNK CCT GCC GAT TGC NNK 
TGG TTT NNK CGC AAC ACC TTA AAT AAA CCC 
GTG AT 
This study 
pCJ-33 TGG TGG TTC TGG TGG TGG TGG TTC TGG TGG 
TGG TGG TTC TAT CAG TCT GAT TGC GGC GTT 
AGC GGT AGA TCG CGT TAT CGG CAT GGA A 
This study 
pCJ-34 ATG GCG GCC CAT AAT CAC GGG TTT ATT TAA 
GGT GTT GCG 
This study 
pCJ-35 CGC AAC ACC TTA AAT AAA CCC GTG AT This study 
pCJ-36 ATG GGC CGC CAT ACC TGG GAA NNK NNK NNK 
NNK NNK NNK NNK GGA CGC AAA AAT ATT ATC 
CTC AGC AGT C 
This study 
pCJ-37 CTT AAA TAA ACC CGT GAT TAT GGG CCG CCA 
TAC CTG GGA A 
This study 
pCJ-38 CCG TAC CCG GTT GAC TGC TGA GGA TAA TAT 
TTT TGC GTC C 
This study 




Name Sequence (5’ – 3’) Source 









CCG AGC TCG GCC AGA ACC ACC AGA CCG CCG 




CCG CTA GCG CTA CCG GTC GCC ACC ATG ATC 




CAG CTT CTG CCA ATT GAC CAG AAC CAC CAG 
AAC CCC GCC GCT CCA GAA TCT CA 
This study 
Chapter 5 
VWC2133 TGG TAT GGG TGA ATT CTT GAT CGT TAA GTC 
TNN KNN KNN KNN KNN KNN KNN KNN KNN KNN 
KNN KNN KGA ATT TTT AAT TGT AAA ATC AGG 
TCC ACC A 
This study 
VWC2129 CGC AAC GGC GAC TGG GGT TCT GGT GGT TCT 
GGT ATG GGT GAA TTC TTG 
This study 
VWC2134 ATA AGA AAT TCG CCC GGA ATT AGC TTG GCT 
GCA TTA TGG TGG ACC TGA TTT TAC AA 
This study 
VWC2130 CTG GCG GTT GGG GTT ATT CGC AAC GGC GAC 
TGG G 
This study 
VWC2132 ATA AGA AAT TCG CCC GGA A This study 
A2.3 List of Yeast Strains Used Throughout These Studies 
Name Description Media Source 
Chapter 3 
EBY100 MATa ura 3-52 trp 1 leu2∆1 his3∆200 pep4:HIS3 





EGY48 MATa trp1 his3 ura3 6LexAop-LEU2 GAL+ HT
-
 R. Brent 
4
 
CJ-34 EGY48 with plasmids V398 and pMW112 TU
-
 This study 
V780 V760Y with plasmids pMW102 pMW112 HTU
-
 K. Baker 
5
 
V830 EGY48 with plasmids pKB521 pBC398 pMW112 HTU
-
 K. Baker 
5
 
V1017 EGY48 pBAIT pTarget pMW112 HTU
-
 K. Baker 
5
 
A2.4 General Materials and Methods for Molecular Biology 
Restriction enzymes, Vent DNA polymerase, and T4 DNA ligase were purchased 
from New England Biolabs (Beverly, MA). Pfu Turbo and Pfu Turbo II polymerases and 




Polymerase Chain Reaction (PCR) were purchased from GE Healthcare (Piscataway, NJ). 
Oligonucleotides were purchased from Invitrogen (Carlsbad, CA) or Integrated DNA 
Technologies (Coralville, IA) and are listed in Section #. For PCR, a MJ Research PTC-
200 Pellier Thermal Cycler was employed. Restriction digests were carried out as 
recommended by New England Biolabs. The transformation of E. coli was carried out by 
electroporation using a Bio-Rad E. coli Pulser. The bacto-agar, bactopeptone and bacto-
yeast extract were purchased from Beckton, Dickinson & Co. Corning Costar 96-well 
plates with V-shaped wells used for growing yeast and Corning Costar 96-well UV-plates 
used in liquid assays were purchased from Fisher. Single stranded DNA (DNA sodium 
salt type III, salmon testes) used for yeast transformation was purchased from Sigma. The 
phrog used to transfer cells into 96-well plates or onto petri plates containing agar media 
was purchased from Dan-Kar Corp. (Wilmington, MA). 5-Bromo-4-chloro-3-indolyl-β-
D-galactopyranoside (X-gal) for the plate assays was purchased from Diagnostic 
Chemicals (Oxford, CT). O-Nitrophenyl-β-Dgalactopyranoside (ONPG) for the liquid 
assays was purchased from Sigma. The Tuner BL21 (DE3) cells and the BugBuster 
protein extraction reagent used in protein purification were purchased from Novagen 
(Madison, WI). The yeast protein extraction reagent, Y-Per, was purchased from Pierce 
(Rockford, IL). Isopropyl-β-Dthiogalactoside (IPTG) was purchased from American Bio-
Organics. The Ni-NTA spin columns used to purify proteins as well as the Miniprep Spin 
Kits, PCR Purification Kits, and Gel Extraction Kits used to purify DNA were purchased 
from Qiagen (Valencia, CA). Centricon Centrifugal Filtre Units YM-3 for protein 
concentration and buffer change and the Immobilon-P 0.45 μm polyvinylidene fluoride 




MA). For protein molecular weight detection, the low range, biotinylated SDS-PAGE 
standards kit from Bio-Rad was used. PVDF membrane was blocked with Carnation 
nonfat dry milk (Nestle®). All other chemicals were purchased from Aldrich or Sigma. 
All aqueous solutions were made with distilled water prepared from a Milli Q Water 
Purification System. Sequencing was performed by GENEWIZ (South Plainfield, NJ). 
All standard molecular biology techniques were carried out essentially as described. The 
small molecules were dissolved in DMF or DMSO and stored at -80°C. For all 
compounds, the concentrations were determined using Beer’s law. The Y3H liquid assays 
were carried out using a Spectra Max PLUS 384 (Molecular Devices). 
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